
<html lang="en"     class="pb-page"  data-request-id="175b6234-ce2d-499a-abeb-e9020696e717"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm8006189;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2008.51.issue-18;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluation of Potent c-Met Inhibitors" /></meta><meta name="dc.Creator" content="Noel D.  D’Angelo" /></meta><meta name="dc.Creator" content="Steven F.  Bellon" /></meta><meta name="dc.Creator" content="Shon K.  Booker" /></meta><meta name="dc.Creator" content="Yuan  Cheng" /></meta><meta name="dc.Creator" content="Angela  Coxon" /></meta><meta name="dc.Creator" content="Celia  Dominguez" /></meta><meta name="dc.Creator" content="Ingrid  Fellows" /></meta><meta name="dc.Creator" content="Douglas  Hoffman" /></meta><meta name="dc.Creator" content="Randall  Hungate" /></meta><meta name="dc.Creator" content="Paula  Kaplan-Lefko" /></meta><meta name="dc.Creator" content="Matthew R.  Lee" /></meta><meta name="dc.Creator" content="Chun  Li" /></meta><meta name="dc.Creator" content="Longbin  Liu" /></meta><meta name="dc.Creator" content="Elizabeth  Rainbeau" /></meta><meta name="dc.Creator" content="Paul J.  Reider" /></meta><meta name="dc.Creator" content="Karen  Rex" /></meta><meta name="dc.Creator" content="Aaron  Siegmund" /></meta><meta name="dc.Creator" content="Yaxiong  Sun" /></meta><meta name="dc.Creator" content="Andrew S.  Tasker" /></meta><meta name="dc.Creator" content="Ning  Xi" /></meta><meta name="dc.Creator" content="Shimin  Xu" /></meta><meta name="dc.Creator" content="Yajing  Yang" /></meta><meta name="dc.Creator" content="Yihong  Zhang" /></meta><meta name="dc.Creator" content="Teresa L.  Burgess" /></meta><meta name="dc.Creator" content="Isabelle  Dussault" /></meta><meta name="dc.Creator" content="Tae-Seong  Kim" /></meta><meta name="dc.Description" content="c-Met is a receptor tyrosine kinase that plays a key role in several cellular processes but has also been found to be overexpressed and mutated in different human cancers. Consequently, targeting t..." /></meta><meta name="Description" content="c-Met is a receptor tyrosine kinase that plays a key role in several cellular processes but has also been found to be overexpressed and mutated in different human cancers. Consequently, targeting t..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 3, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8006189" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8006189" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8006189" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8006189" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluation of Potent c-Met Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8006189" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluation of Potent c-Met Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0001.jpeg" /></meta><meta property="og:description" content=" c-Met is a receptor tyrosine kinase that plays a key role in several cellular processes but has also been found to be overexpressed and mutated in different human cancers. Consequently, targeting this enzyme has become an area of intense research in drug discovery. Our studies began with the design and synthesis of novel pyrimidone 7, which was found to be a potent c-Met inhibitor. Subsequent SAR studies identified 22 as a more potent analog, whereas an X-ray crystal structure of 7 bound to c-Met revealed an unexpected binding conformation. This latter finding led to the development of a new series that featured compounds that were more potent both in vitro and in vivo than 22 and also exhibited different binding conformations to c-Met. Novel c-Met inhibitors have been designed, developed, and found to be potent in vitro and in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8006189"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8006189">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8006189&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8006189&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8006189&amp;href=/doi/10.1021/jm8006189" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 5766-5779</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800612u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm8006245" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluation of Potent c-Met Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Noel+D.++D%E2%80%99Angelo">Noel D. D’Angelo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+F.++Bellon">Steven F. Bellon</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shon+K.++Booker">Shon K. Booker</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuan++Cheng">Yuan Cheng</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Coxon">Angela Coxon</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia++Dominguez">Celia Dominguez</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ingrid++Fellows">Ingrid Fellows</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas++Hoffman">Douglas Hoffman</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Randall++Hungate">Randall Hungate</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paula++Kaplan-Lefko">Paula Kaplan-Lefko</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+R.++Lee">Matthew R. Lee</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chun++Li">Chun Li</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Longbin++Liu">Longbin Liu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Rainbeau">Elizabeth Rainbeau</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+J.++Reider">Paul J. Reider</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Rex">Karen Rex</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaron++Siegmund">Aaron Siegmund</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yaxiong++Sun">Yaxiong Sun</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+S.++Tasker">Andrew S. Tasker</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Xi">Ning Xi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shimin++Xu">Shimin Xu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yajing++Yang">Yajing Yang</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yihong++Zhang">Yihong Zhang</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Teresa+L.++Burgess">Teresa L. Burgess</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Dussault">Isabelle Dussault</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tae-Seong++Kim">Tae-Seong Kim</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Address: One Amgen Center Drive, Mail Stop 29-2-C, Thousand Oaks, CA 91320-1799. Phone: 805-313-6550. Fax: 805-480-3016. E-mail: <a href="/cdn-cgi/l/email-protection#4f2b2e21282a23200f2e22282a21612c2022"><span class="__cf_email__" data-cfemail="95f1f4fbf2f0f9fad5f4f8f2f0fbbbf6faf8">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Department of Medicinal Chemistry.</div><div class="corresp-fn" id="afn2">‡Department of Molecular Structure.</div><div class="corresp-fn" id="afn3">§Department of Oncology Research.</div><div class="corresp-fn" id="afn4">∥Department of Pharmaceutics.</div><div class="corresp-fn" id="afn5">⊥Department of Pharmacokinetics and Drug Metabolism.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8006189&amp;href=/doi/10.1021%2Fjm8006189" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 5766–5779</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 3, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 May 2008</li><li><span class="item_label"><b>Published</b> online</span>3 September 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 September 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8006189" title="DOI URL">https://doi.org/10.1021/jm8006189</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5766%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNoel%2BD.%2BD%25E2%2580%2599Angelo%252C%2BSteven%2BF.%2BBellon%252C%2BShon%2BK.%2BBooker%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D18%26contentID%3Djm8006189%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BPotent%2Bc-Met%2BInhibitors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5779%26publicationDate%3DSeptember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8006189"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3738</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">71</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8006189" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluation of Potent c-Met Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Noel&quot;,&quot;last_name&quot;:&quot;D. D’Angelo&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;F. Bellon&quot;},{&quot;first_name&quot;:&quot;Shon&quot;,&quot;last_name&quot;:&quot;K. Booker&quot;},{&quot;first_name&quot;:&quot;Yuan&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Coxon&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;Dominguez&quot;},{&quot;first_name&quot;:&quot;Ingrid&quot;,&quot;last_name&quot;:&quot;Fellows&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;Hoffman&quot;},{&quot;first_name&quot;:&quot;Randall&quot;,&quot;last_name&quot;:&quot;Hungate&quot;},{&quot;first_name&quot;:&quot;Paula&quot;,&quot;last_name&quot;:&quot;Kaplan-Lefko&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;R. Lee&quot;},{&quot;first_name&quot;:&quot;Chun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Longbin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Rainbeau&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;J. Reider&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Rex&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;Siegmund&quot;},{&quot;first_name&quot;:&quot;Yaxiong&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;S. Tasker&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Xi&quot;},{&quot;first_name&quot;:&quot;Shimin&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Yajing&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Yihong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Teresa&quot;,&quot;last_name&quot;:&quot;L. Burgess&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Dussault&quot;},{&quot;first_name&quot;:&quot;Tae-Seong&quot;,&quot;last_name&quot;:&quot;Kim&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;5766-5779&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8006189&quot;},&quot;abstract&quot;:&quot;c-Met is a receptor tyrosine kinase that plays a key role in several cellular processes but has also been found to be overexpressed and mutated in different human cancers. Consequently, targeting this enzyme has become an area of intense research in drug discovery. Our studies began with the design and synthesis of novel pyrimidone 7, which was found to be a potent c-Met inhibitor. Subsequent SAR studies identified 22 as a more potent analog, whereas an X-ray crystal structure of 7 bound to c-Met revealed an unexpected binding conformation. This latter finding led to the development of a new series that featured compounds that were more potent both in vitro and in vivo than 22 and also exhibited different binding conformations to c-Met. Novel c-Met inhibitors have been designed, developed, and found to be potent in vitro and in vivo.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8006189&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8006189" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8006189&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8006189" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8006189&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8006189" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8006189&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8006189&amp;href=/doi/10.1021/jm8006189" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8006189" /></input><a href="/doi/pdf/10.1021/jm8006189" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (764 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8006189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8006189%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DD%25E2%2580%2599Angelo%26date%3D2008%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BPotent%2Bc-Met%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D18%26spage%3D5766%26epage%3D5779%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0001.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">c-Met is a receptor tyrosine kinase that plays a key role in several cellular processes but has also been found to be overexpressed and mutated in different human cancers. Consequently, targeting this enzyme has become an area of intense research in drug discovery. Our studies began with the design and synthesis of novel pyrimidone <b>7</b>, which was found to be a potent c-Met inhibitor. Subsequent SAR studies identified <b>22</b> as a more potent analog, whereas an X-ray crystal structure of <b>7</b> bound to c-Met revealed an unexpected binding conformation. This latter finding led to the development of a new series that featured compounds that were more potent both in vitro and in vivo than <b>22</b> and also exhibited different binding conformations to c-Met. Novel c-Met inhibitors have been designed, developed, and found to be potent in vitro and in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">c-Met is a receptor tyrosine kinase that is normally activated by binding its natural ligand hepatocyte growth factor, also known as scatter factor (HGF/SF<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: Ac, acetyl; ANOVA, analysis of variance; ATP, adenosine triphosphate; BSA, bovine serum albumin; DCM, dichloromethane; DMAP, 4-dimethylaminopyridine; DME, 1,2-dimethoxyethane; DMF, <i>N</i>,<i>N</i>-dimethylformamide; ED, effective dose; HGF, hepatocyte growth factor; HTRF, homogeneous time-resolved fluorescence; IGFR, insulin-like growth factor receptor; IP, intraperitoneal injection; iv, intravenous; KDR, kinase insert domain receptor; LiHMDS, lithium hexamethyldisilazide; NBS, <i>N</i>-bromosuccinimide; PD, pharmacodynamic; PK, pharmacokinetic; RON, recepteur d’origine nantais; SAR, structure−activity relationship; SF, scatter factor; <i>S</i>-Phos, 2-Dicyclohexylphosphino-2′,6′-dimethoxybiphenyl; TFAA, trifluoroacetic anhydride; TFA, trifluoroacetic acid; THF, tetrahydrofuran.</p></div> ). The binding of HGF to c-Met induces several complex signaling pathways and results in cell proliferation, motility, migration, and survival.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> These cellular activities are important during normal development and wound healing but can lead to cancer when the pathway is deregulated. For example, c-Met has been found to be overexpressed or mutated in human cancers, and in many instances, the overexpression of c-Met has been correlated with advanced disease stage and poor prognosis.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> As a result, c-Met has attracted considerable attention as a potential target for cancer treatment.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a></div><div class="NLM_p">A variety of approaches have been used to target c-Met. These include antibody-based therapies,<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> truncated HGF fragments,<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> decoy receptors,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> the targeting of the extracellular c-Met semaphorin domain to prevent dimerization,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> ribozyme-based treatments,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> and small-molecule kinase inhibitors.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26 ref27 ref28">(22-28)</a> Most of the strategies prevent ligand-mediated activation of the receptor, but small-molecule inhibitors are predicted to inhibit c-Met activity irrespective of the activation mechanism. This is significant because it is known that c-Met can be activated in a ligand-dependent manner as well as in a ligand-independent manner.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Therefore, a small-molecule c-Met inhibitor could benefit a different, and potentially larger, cancer patient population.</div><div class="NLM_p">Several small-molecule c-Met inhibitors have recently been reported.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Examples of these include Pfizer’s PF-2341066 (<b>1</b>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Sugen’s SU11274 (<b>2</b>),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and Kirin’s acylthiourea <b>3</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Compound <b>3</b> was of particular interest because of its reported cellular activity (IC<sub>50</sub> = 8.7 nM in A431 cells). This led us to consider constrained versions of <b>3</b> as possible c-Met inhibitors. We first examined benzothiazole <b>4</b> and found it to be a potent c-Met inhibitor (c-Met <i>K</i><sub>i</sub> = 17 nM). However, its selectivity over other kinases such as kinase insert domain receptor (KDR), recepteur d’origine nantais (RON), and insulin-like growth factor receptor (IGFR) was modest (4- to 13-fold).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Our replacing the benzothiazole core with a naphthalene ring system (<b>5</b>) decreased c-Met potency (<i>K</i><sub>i</sub> = 89 nM) but had little effect on KDR and RON selectivity (9- and 3-fold, respectively). Greater selectivity, especially against KDR, was desired to limit potential off-target toxicity as well as to ensure that any in vivo activity was a consequence of targeting c-Met. Nevertheless, we were encouraged by the fact that a conformational restriction of compound <b>3</b> could provide potent c-Met inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Small-molecule c-Met inhibitors and the design of the pyrimidone series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Therefore, we considered an alternative mode of constraining the acylthiourea moiety of compound <b>3</b>, which lead to the design of pyridazine <b>6</b> and pyrimidone <b>7</b>. The former was actually more potent against KDR (<i>K</i><sub>i</sub> = 56 nM) and RON (<i>K</i><sub>i</sub> = 79 nM) than against c-Met (<i>K</i><sub>i</sub> = 201 nM) and was therefore not pursued further. However, <b>7</b> was found to inhibit the kinase activity of c-Met (<i>K</i><sub>i</sub> = 39 nM) potently. In addition, <b>7</b> was selective against KDR (greater than 30-fold), RON (20-fold), and IGFR (50-fold). With this promising result, we explored the SAR around the four main regions of <b>7</b> (rings A−D).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the D-ring analogs began with the alkylation of pyrimidone <b>8</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> at the N(3) position to provide pyrimidone <b>9</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Bromination, followed by a Suzuki coupling with 3-fluoro-4-methoxyphenylboronic acid that used the palladium-<i>S</i>-Phos complex afforded bicycle <b>10</b>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> O-demethylation, followed by the coupling of the methylthiopyrimidine moiety to various benzylzinc halides, afforded phenols <b>11</b>−<b>13</b>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Chlorides <b>16</b>−<b>21</b> were prepared in three routine steps via the debenzylation of quinoline <b>14</b>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> the attachment of the 3-chloropropyl group, and the displacement of the terminal chloride by the desired amine. Chlorides <b>16</b>−<b>21</b> were coupled to phenol <b>11</b> in the presence of pyridine or DMAP to produce analogs <b>22</b>−<b>27</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0003.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LiHMDS, DMF, MeI, 0 °C to rt; (ii) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C; (iii) 3-fluoro-4-methoxyphenylboronic acid, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>S</i>-Phos, K<sub>3</sub>PO<sub>4</sub>, PhMe, 100 °C; (iv) ArylZnCl, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, 60 °C; (v) HOAc, HBr, 120 °C; (vi) MeSO<sub>3</sub>H, TFA, reflux; (vii) Cl(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF; (viii) amine, NaI, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (ix) DMAP, 1,4-dioxane, 110 °C; (x) pyridine, 1,4-dioxane, 110 °C; (xi) DMAP, 1,4-dioxane, 120 °C, μW; and (xii) DMAP, pyridine, 1,4-dioxane, 90 °C, μW.</p></p></figure><div class="NLM_p">The B-ring analogs were prepared next. Bromination of pyrimidones <b>28</b> and <b>29</b>,<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> followed by Suzuki coupling to 3-fluoro-4-methoxyphenylboronic acid, afforded methyl ethers <b>30</b> and <b>31</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The removal of the methyl ether under acidic conditions produced phenols <b>32</b> and <b>33</b>, which were subjected to S<sub>N</sub>Ar coupling with 4-chloro-6,7-dimethoxyquinoline to afford analogs <b>34</b> and <b>35</b>. N-methylation of <b>34</b> by the use of sodium hydroxide and methyl iodide afforded compound <b>7</b>, thereby completing the synthesis of the B-ring set of analogs.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0004.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C; (ii) 3-fluoro-4-methoxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, 100 °C, μW; (iii) HOAc, HBr, 120 °C; (iv) 4-chloro-6,7-dimethoxyquinoline, DMAP, PhMe, CHCl<sub>3</sub>, 180 °C; and (v) 2 N NaOH, MeI, 1,4-dioxane, 40 °C.</p></p></figure><div class="NLM_p">Compound <b>7</b> served as a convenient intermediate to prepare analogs that are substituted at the benzylic position. Benzylic bromination converted <b>7</b> into bromide <b>36</b>, and the subsequent displacement of this bromide with sodium azide, followed by hydrogenation, afforded amine <b>37</b> as a racemic mixture (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Acylation of this amine under standard conditions afforded amides <b>38</b>−<b>40</b> and urea <b>41</b>. We prepared two other A-ring analogs by coupling phenols <b>12</b> and <b>13</b> to chloride <b>16</b> to produce compounds <b>42</b> and <b>43</b>, with a para-methyl and a para-fluoro substituent, respectively (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0005.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NBS, CHCl<sub>3</sub>; (ii) NaN<sub>3</sub>, DMF, 0 °C; (iii) H<sub>2</sub>, Pd/C, EtOAc, THF; and (iv) RCOCl, Et<sub>3</sub>N, DCM, 0 °C.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0006.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Cu, KOH, DMF, pyridine, 110 °C, μW.</p></p></figure><div class="NLM_p">The synthesis of the N-linked A-ring analogs began with the demethylation of biaryl <b>10</b> to produce phenol <b>44</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). The displacement of the thiomethyl group under acidic conditions with different anilines in the microwave produced phenols <b>45</b>−<b>47</b>. The coupling of these phenols to either chloride <b>16</b> or 4-chloro-6,7-dimethoxyquinoline produced compounds <b>48</b>−<b>51</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0007.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HOAc, HBr, 120 °C; (ii) RNH<sub>2</sub>, concd HCl, 120 °C, μW; (iii) 4-chloro-6,7-dimethoxyquinoline, DMAP, 1,4-dioxane, 120 °C, μW; and (iv) <b>16</b>, Cu, KOH, DMF, pyridine, 110 °C, μW.</p></p></figure><div class="NLM_p">Analogs <b>55</b> and <b>56</b> were prepared in a slightly different manner because phenol <b>44</b> was first coupled to 4-chloro-6,7-dimethoxyquinoline to produce intermediate <b>52</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). The thiomethyl group was hydrolyzed under oxidative conditions by the use of urea hydrogen peroxide in acetonitrile and TFA to produce <b>53</b>. The resultant hydroxyl moiety was converted to the corresponding chloride <b>54</b> by the use of POCl<sub>3</sub>. The subsequent displacement of the chloride with different amines, again under acidic conditions in the microwave, produced analogs <b>55</b> and <b>56</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0008.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4-chloro-6,7-dimethoxyquinoline, DMAP, pyridine, 1,4-dioxane, 110 °C; (ii) urea hydrogen peroxide, TFA, MeCN, 0 °C; TFAA, 0 °C to rt; (iii) POCl<sub>3</sub>, <i>N</i>,<i>N</i>-dimethylaniline, 125 °C to rt; and (iv) RNH<sub>2</sub>, concd HCl, 1,4-dioxane, 60 °C, μW.</p></p></figure><div class="NLM_p">We prepared C-ring pyridine analog <b>62</b> by beginning with the protection of commercially available 6-bromopyridin-3-ol as benzyl ether <b>57</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). Negishi coupling to 2-<i>tert</i>-butyoxy-2-oxoethylzinc chloride, followed by TFA hydrolysis, afforded acid <b>58</b>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The conversion of <b>58</b> to the corresponding acyl chloride, followed by the addition of <b>59</b> and Et<sub>3</sub>N, produced <b>60</b>. This was converted to phenol <b>61</b> in two steps and was then coupled to chloride <b>16</b> to afford <b>62</b>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0009.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, BnBr, DMF, 0 °C to rt; (ii) Pd(PPh<sub>3</sub>)<sub>4</sub>, <i>t</i>-BuOC(O)CH<sub>2</sub>ZnCl, THF, 60 °C; (iii) TFA, DCM, 0 °C to rt; (iv) (COCl)<sub>2</sub>, DCM, DMF; <b>59</b>, Et<sub>3</sub>N, 0 °C to greater than rt; (v) 4-fluoroaniline, concd HCl, 1,4-dioxane, 125 °C; (vi) BBr<sub>3</sub>, DCM; and (vii) <b>16</b>, DMAP, pyridine, 1,4-dioxane, 130 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> SAR and Lead Generation</h3><div class="NLM_p">The enzyme activity of <b>7</b> supported our hypothesis that the pyrimidone series could afford good enzyme potency against c-Met. To facilitate subsequent SAR studies, we examined the X-ray structure of a cocrystal of <b>7</b> bound to c-Met (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). This X-ray revealed that <b>7</b> occupies the ATP binding site of c-Met. As a result, <b>7</b> can be assumed to be an ATP-competitive inhibitor of c-Met. In addition, the benzyl moiety of <b>7</b> (ring A) fits into a hydrophobic pocket that is formed by ILE1145 at the back end, which we refer to as the ILE1145 binding pocket. This pocket could be probed with different phenyl substituents to improve potency. Also, the benzyl position is orientated toward a channel in the c-Met backbone, which suggests that benzyl substituents could fit into this channel and provide additional interactions with c-Met.</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal of <b>7</b> bound to c-Met.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In terms of the pyrimidone B ring, the X-ray revealed that the carbonyl is twisted away from the Asp1222 residue and directly forms a hydrogen bond with Lys1110. As a result, the polar Asp1222 residue is presented with the hydrophobic C−H group of the B ring, which suggests a potential energy penalty. In addition, there is a fairly tight steric environment around the B and C rings; therefore, we expected SAR opportunities here to be more limited.</div><div class="NLM_p">The quinoline portion (ring D) on the left side forms hydrogen bonds with the Pro1158 and Met1160 residues and also maintains van der Waals interactions with the c-Met backbone. In addition, this quinoline system is directed toward a solvent-exposed area, which provides an opportunity for the introduction of polar, water-solubilizing groups. We began our optimization studies of <b>7</b> here.</div><div class="NLM_p">The introduction of a carbon tether, which contains different tertiary amines, off of the quinoline D-ring was examined first. A three-carbon tether between these amines and the quinoline had previously been determined to be the optimal length for improving the potency; therefore, we examined different amines at the end of this tether.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> All of the amines improved the c-Met enzyme relative to <b>7</b>, a finding that can be explained by the van der Waals interactions that are gained between the carbon tether and the c-Met backbone (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Of these amines, the morpholine (<b>22</b>) and <i>N</i>-methylpyrazine (<b>25</b>) derivatives afforded the greatest increase in potency.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. c-Met Enzyme Activity of Analogs <b>22</b>−<b>27</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0011.gif" alt="" id="gr10" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0012.gif" alt="" id="gr11" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Average of four experiments.</p></div></div></div><div class="NLM_p">Substitutions of the B-ring pyrimidone core were explored next (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The removal of the <i>N</i>-methyl group (<b>34</b>) reduced enzyme potency by about 3-fold, whereas the introduction of a methyl group at the 6-position (<b>35</b>) lowered the potency by an additional factor of 5. Overall, these two changes reduced the potency more than 10-fold, which supports the hypothesis that this portion of the molecule is sensitive to substitution. In view of these results, we did not pursue further SAR studies around the pyrimidone core or on the fluorophenyl C ring.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. c-Met Enzyme Activity of B-Ring Analogs <b>7</b>, <b>34</b>, and <b>35</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0013.gif" alt="" id="gr12" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R</th><th align="center" valign="middle">R′</th><th align="center" valign="middle"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>7</b></td><td align="left">H</td><td align="left">Me</td><td align="left">39 ± 6</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left">H</td><td align="left">H</td><td align="left">107 ± 4</td></tr><tr valign="top"><td align="left"><b>35</b></td><td align="left">Me</td><td align="left">H</td><td align="left">489 ± 74</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Average of four experiments.</p></div></div></div><div class="NLM_p">We conducted SAR studies to explore different substituents at the benzyl position and on the phenyl A ring. For the former, the X-ray cocrystal structure of <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) suggested that substituents could gain van der Waals interactions with a channel in the c-Met backbone, thereby improving potency. In addition, because this channel was solvent accessible, polar substituents were considered. However, amine <b>37</b>, amides <b>38</b>−<b>40</b>, and urea <b>41</b> provided little improvement in potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In fact, <b>41</b> decreased the potency by about 10-fold. Overall, these results suggested that whereas the benzyl substitution could certainly be tolerated, no obvious benefit was gained from it.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. c-Met Enzyme Activity of Benzyl-Substituted A-Ring Analogs<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0014.gif" alt="" id="gr13" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R</th><th align="center" valign="middle"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>7</b></td><td align="left">H</td><td align="left">39 ± 6</td></tr><tr valign="top"><td align="left"><b>37</b></td><td align="left">NH<sub>2</sub></td><td align="left">72 ± 11</td></tr><tr valign="top"><td align="left"><b>38</b></td><td align="left">NH(CO)CH<sub>2</sub>NMe<sub>2</sub></td><td align="left">30 ± 5</td></tr><tr valign="top"><td align="left"><b>39</b></td><td align="left">NH(CO)CH<sub>2</sub>CH<sub>3</sub></td><td align="left">71 ± 14</td></tr><tr valign="top"><td align="left"><b>40</b></td><td align="left">NH(CO)CH<sub>2</sub>CH<sub>2</sub>SCH<sub>3</sub></td><td align="left">52 ± 11</td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="left">NH(CO)NMe<sub>2</sub></td><td align="left">368 ± 55</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">Average of four experiments.</p></div></div></div><div class="NLM_p">In terms of the phenyl ring SAR, two additional analogs were made that incorporated different substituents at the para position (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). These compounds had enzyme potencies that were similar to that of <b>22</b>, which suggests that small substituents were well tolerated at this position. Because these compounds had enzyme potencies that were similar to that of <b>22</b> and also because SAR studies on the nitrogen-linked A rings (see Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) indicated that these substituents provided the best increase in potency, further SAR studies were not pursued.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. c-Met Enzyme Activity of A-Ring Analogs <b>42</b> and <b>43</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0015.gif" alt="" id="gr14" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R</th><th align="center" valign="middle"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>22</b></td><td align="left">H</td><td align="left">8.9 ± 1.3</td></tr><tr valign="top"><td align="left"><b>42</b></td><td align="left">Me</td><td align="left">9.6 ± 0.7</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="left">F</td><td align="left">17 ± 2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Average of four experiments.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. c-Met Enzyme Activity of <i>N</i>-Phenyl A-Ring Analogs<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0016.gif" alt="" id="gr15" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0017.gif" alt="" id="gr16" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">Average of four experiments.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-Phenyl Analogs</h3><div class="NLM_p">To this point, the most potent compounds exhibited a <i>K</i><sub>i</sub> of around 10 nM in the enzyme assay. However, to improve the potency further, we next considered replacing the carbon linkage between the A and B rings with a nitrogen atom. This change would allow for an additional hydrogen bond to be gained with Phe1223 (adjacent to Asp1222, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), potentially via a bridging water molecule, thereby improving enzyme potency.</div><div class="NLM_p">To test this hypothesis, <i>N</i>-phenyl analog <b>48</b> was synthesized, and the SAR around the phenyl A ring was explored (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Our replacing the carbon linkage with a nitrogen linkage actually reduced the enzyme potency to a small extent, as a comparison of compounds <b>7</b> and <b>48</b> indicates. The introduction of a fluoro group at the ortho or meta position had a minimal impact on enzyme potency. However, substitution at the para position increased the potency because the 4-fluoro derivative (<b>50</b>) has a binding affinity of 14 nM. Larger groups at this position (e.g., <b>56</b>) decreased the potency, which suggests that the substitution at this position is fairly sensitive to a substituent’s steric size. Having determined that the 4-fluoro group provided the best potency for the <i>N</i>-phenyl A ring we decided to reintroduce the morpholine tail off of the quinoline D ring to improve the potency further. Toward this end, analog <b>51</b> was prepared and was found to be about 3 times more potent than both <b>50</b> and carbon-linked analog <b>43</b>, which indicates that our changing the carbon linkage to a nitrogen linkage has a beneficial impact on enzyme activity.</div><div class="NLM_p">An X-ray cocrystal structure of <b>50</b> provided some insight into this observation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Surprisingly, the binding conformation of <b>50</b> differed significantly from that of <b>7</b>. Most notably, the pyrimidone carbonyl of <b>50</b> forms a direct hydrogen bond with the backbone of Asp1222, whereas C-linked analog <b>7</b> has its carbonyl pointed toward the Lys1110 primary amine (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In addition, the N(1) pyrimidone nitrogen of <b>50</b> is bridged to Lys1110 through hydrogen bonding to a crystallographically resolved water molecule, which indirectly preserves the hydrogen bond between the pyrimidone carbonyl of <b>7</b> and this amino acid. Therefore, the different pyrimidone orientation results in the formation of an additional hydrogen bond with c-Met. A comparison of Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> reveals that the A and C rings of both compounds adopt the same orientation relative to the c-Met backbone. Therefore, the conformational preferences of these two compounds dictate their respective pyrimidone B-ring orientations and hence their binding conformations to the protein. The additional hydrogen bond that was gained as a result of the changed pyrimidone conformation and the introduction of the para-fluoro substituent are the most plausible explanations of the increase in potency that was observed with nitrogen-linked compounds (e.g., <b>50</b> and <b>51</b>) compared with carbon-linked compounds (e.g., <b>7</b>). It should be noted that <b>50</b>, like <b>7</b>, binds to c-Met in the ATP pocket which indicates that <b>50</b> is an ATP-competitive inhibitor. This conclusion can also be applied to other pyrimidone molecules such as <b>22</b> and <b>51</b> because of their structural similarities to <b>7</b> and <b>50</b>, respectively.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal of <b>50</b> bound to c-Met.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The X-ray cocrystal of <b>50</b> also provided another clue as to how enzyme potency could be further improved. The dihedral angle between the fluorophenyl C ring and the pyrimidone B ring is 18°. To determine whether this dihedral angle corresponds to an energetically favored conformation, we examined an energy diagram that used 5-phenylpyrimidone as a surrogate for the B and C rings (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, top). As this graph indicates, a dihedral angle of 18° is about 1.5 kcal/mol above the energy minimum, which suggests that compounds like <b>50</b> and <b>51</b> incur a significant energy penalty to adopt the conformation with which they bind to c-Met.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Torsional profiles of 5-phenyl pyrimidone (top) and pyridin-2-yl pyrimidone (bottom) for the dihedral angle highlighted in red. The coplanar structures shown are defined with a dihedral angle of 0°. Energy profiles were calculated on the basis of gas-phase quantum mechanic calculations by the use of density functional theory.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To eliminate this energy barrier, we envisioned replacing the fluorophenyl C ring with a pyridine ring on the basis of the energy diagram of pyridin-2-yl pyrimidone (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, bottom). This diagram suggests that for a pyridine ring a dihedral angle of 20° or less provides the lowest energy conformation, which is in contrast with the phenylpyrimidone systems in which such a dihedral angle is energetically disfavored. As a result, we expected analogs with a pyridine B ring to be more potent because of the low-energy barrier that is required for them to bind c-Met. On the basis of this reasoning, we examined analog <b>62</b> and found it to be one of the most potent analogs of the series thus far (<i>K</i><sub>i</sub> = 3.4 ± 0.7 nM). However, the increase in potency compared with that of <b>51</b> (<i>K</i><sub>i</sub> = 4.9 nM) was virtually negligible, at least in the enzyme assay. This could be the result of removing the C-ring fluoro group, a change that could offset any gain in potency that was obtained by the use of the pyridine ring.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vitro Cell Assays</h3><div class="NLM_p">Some of the more potent compounds that were identified in the enzyme assay were tested for their ability to inhibit HGF-mediated c-Met phosphorylation in PC3 cells, a human prostate cancer cell line, and CT26 cells, a murine cell line that is derived from a colon carcinoma (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). In general, the compounds were slightly more potent in PC3 cells than they were in CT26 cells. In addition, the compounds generally exhibited a 10-fold shift in potency from enzyme to cell. Most significantly, the trends observed for enzyme potency for these compounds correlated with those that were observed for their cellular activities. Thus, the conversion of <b>7</b> to <b>43</b> resulted in improved cell potency as well as improved enzyme potency. Our changing the carbon linkage of <b>43</b> to a nitrogen linkage (<b>51</b>) improved enzyme and cellular potencies by an additional factor of 3. Finally, our replacing the fluorophenyl C ring of <b>51</b> with a pyridine ring (<b>62</b>) further improved cellular potency and made <b>62</b> the most potent analog that was prepared in this series.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. IC<sub>50</sub> Values of Lead Analogs Against PC3 and CT26 Cell Lines<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle" char="."><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char=".">PC3 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char=".">CT26 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>7</b></td><td align="char" char=".">39</td><td align="char" char=".">313</td><td align="char" char=".">368</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="char" char=".">17</td><td align="char" char=".">161</td><td align="char" char=".">196</td></tr><tr valign="top"><td align="left"><b>51</b></td><td align="char" char=".">4.9</td><td align="char" char=".">64</td><td align="char" char=".">82</td></tr><tr valign="top"><td align="left"><b>62</b></td><td align="char" char=".">3.4</td><td align="char" char=".">39</td><td align="char" char=".">59</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">Average of four experiments, with the exception of the PC3 and CT26 values for <b>62</b>, which are the average of two experiments.</p></div></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Enzyme Selectivity</h3><div class="NLM_p">The selectivity of certain compounds against KDR, RON, and IGFR was examined next, and the results are outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. A noticeable trend is that the carbon-linked compounds (<b>7</b>, <b>22</b>, and <b>43</b>) were more selective against these enzymes than were the nitrogen-linked compounds (<b>50</b>, <b>51</b>, and <b>62</b>). This result might be explained by the differences in binding conformations that are demonstrated by <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and <b>50</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). In particular, the different selectivity profiles most likely are the result of the different pyrimidone orientations because the A and C rings virtually occupy the same space in both cases. Whereas the decrease in selectivity was undesirable, the selectivity, especially that against KDR, was still high enough for <b>51</b> and <b>62</b> to justify further in vivo studies on these compounds, as well as on <b>22</b>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Enzyme Selectivity of Key Compounds<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="middle" char=".">c-Met <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl7-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char=".">KDR <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl7-fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#tbl7-fn4" aria-label="d">d</a></th><th align="center" valign="middle" char=".">Ron <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl7-fn5" aria-label="e">e</a><sup>,</sup><a class="ref internalNav" href="#tbl7-fn6" aria-label="f">f</a></th><th align="center" valign="middle" char=".">IGFR <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl7-fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>7</b></td><td align="char" char=".">39</td><td align="char" char=".">>1300</td><td align="char" char=".">581</td><td align="char" char=".">1030</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="char" char=".">8.9</td><td align="char" char=".">422</td><td align="char" char=".">195</td><td align="char" char=".">1450</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="char" char=".">17</td><td align="char" char=".">>3000</td><td align="char" char=".">706</td><td align="char" char=".">860</td></tr><tr valign="top"><td align="left"><b>50</b></td><td align="char" char=".">14</td><td align="char" char=".">382</td><td align="char" char=".">80</td><td align="char" char=".">70</td></tr><tr valign="top"><td align="left"><b>51</b></td><td align="char" char=".">4.9</td><td align="char" char=".">139</td><td align="char" char=".">28</td><td align="char" char=".">22</td></tr><tr valign="top"><td align="left"><b>62</b></td><td align="char" char=".">3.4</td><td align="char" char=".">83</td><td align="char" char=".">1.3</td><td align="char" char=".">51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="tbl7-fn2"><sup>b</sup><p class="last">Average of four experiments.</p></div><div class="footnote" id="tbl7-fn3"><sup>c</sup><p class="last">Value is the result of a single measurement, with the exception of <b>22</b>, which is the average of two experiments.</p></div><div class="footnote" id="tbl7-fn4"><sup>d</sup><p class="last">Phosphorylated KDR.</p></div><div class="footnote" id="tbl7-fn5"><sup>e</sup><p class="last">Phosphorylated Ron.</p></div><div class="footnote" id="tbl7-fn6"><sup>f</sup><p class="last">Value is the result of a single experiment.</p></div></div></div><div class="NLM_p last">The selectivities of compounds <b>22</b>, <b>51</b>, and <b>62</b> were also examined against a larger panel of tyrosine kinases and serine/threonine kinases. In this panel, the three compounds exhibited low selectivity (less than 10-fold) against only a small number of kinases (LCK, BTK, and cFMS). For most of the other examined kinases, selectivities were greater than 100-fold.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Vivo Studies</h3><div class="NLM_p">Compound <b>22</b> from the carbon-linked series and compounds <b>51</b> and <b>62</b> from the nitrogen-linked series were evaluated for their pharmacokinetic (PK) properties and pharmacodynamic (PD) effects. All three compounds exhibited good PK profiles when they were given intravenously (iv) to rats, with half lives that ranged from 2.4 to 4 h, volumes of distribution that ranged from 3.0 to 5.4 L/kg, and clearances that ranged from 0.56 to 1.9 L/h/kg. Compound <b>22</b> had the highest bioavailability with a value of 100%, whereas <b>51</b> and <b>62</b> had values of 34 and 48%, respectively. Given the promising PK profiles of these compounds, we decided to evaluate all three compounds in a PD assay.</div><div class="NLM_p">These compounds were administered to mice by either oral gavage (PO) or intraperitoneal injection (IP) (10, 30, or 100 mg/kg). Recombinant human HGF was injected iv at 2 h postdose. Livers were then harvested, and c-Met phosphorylation was quantified. Treatment with <b>22</b>, <b>51</b>, and <b>62</b> led to the dose-dependent inhibition of c-Met phosphorylation (Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Compound <b>22</b> exhibited an ED<sub>90</sub> of approximately 100 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Consistent with the enzyme and cell data, analogs <b>51</b> and <b>62</b> exhibited increased potencies, with ED<sub>90</sub> values of ∼30 mg/kg (Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>22</b> and <b>51</b> on HGF-mediated c-Met phosphorylation at 2 h postdose. Asterisk denotes <i>p</i> < 0.0001 compared with the HGF group (black bar). Bars represent the mean ± standard deviation (<i>n</i> = 3). Circles represent mean plasma concentration ± standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of <b>62</b> on HGF-mediated c-Met phosphorylation at 2 h postdose. Asterisk denotes <i>p</i> < 0.0001 compared with the HGF group (black bar). Bars represent the mean ± standard deviation (<i>n</i> = 3). Circles represent mean plasma concentration ± standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Overall, we have developed a novel and potent chemical series for targeting c-Met in vitro and in vivo. Our initial lead compound <b>7</b> was found to be a potent c-Met inhibitor and was subsequently developed into the more potent analog <b>22</b>. However, an X-ray crystal structure of <b>7</b> bound to c-Met revealed an unexpected binding conformation. This result led to the design and synthesis of nitrogen-linked A-ring analogs <b>50</b> and <b>51</b>, which were more potent than <b>22</b> both in vitro and in vivo but were also less selective against other enzymes. The X-ray crystal structure of <b>50</b> revealed a binding conformation that was different from that of the carbon-linked analogs. This finding helps explain the potency and enzyme selectivity differences between the two series. This X-ray structure led to the design and synthesis of pyridine analog <b>62</b> as a means of minimizing dihedral angle strain between the B and C rings. As a result, <b>62</b> proved to be the most potent compound in this series both in vitro and in vivo.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p">All reactions were conducted on the benchtop and were run under nitrogen by the use of a Teflon-coated magnetic stir bar at the indicated temperature. Reactions that were run at an elevated temperature were run in an oil bath at the indicated temperature. Microwave reactions were run in a CEM Discover microwave that was equipped with the PowerMAX feature that used the settings described below. All solvents and reagents that were obtained from commercial sources were used without further purification. The removal of solvents was conducted by the use of a rotary evaporator, and the residual solvent was removed from nonvolatile compounds by the use of a vacuum manifold that was maintained at ∼1 torr. All reported yields are isolated yields.</div><div class="NLM_p">Analytical TLC was performed with EMD 0.25 mm silica gel 60 plates with a 254 nm fluorescent indicator. Plates were developed in a covered chamber and were visualized with ultraviolet light. Flash chromatography refers to column chromatography, as described by Still, that uses EMD silica gel 60 (230−400 mesh) as the stationary phase.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> ISCO purification refers to a Teledyne ISCO purification system that uses RediSep columns in the size that is noted as well as the solvent system and gradients that are noted.</div><div class="NLM_p"><sup>1</sup>H NMR spectra were obtained on a Bruker BioSpin GmbH magnetic resonance spectrometer. <sup>1</sup>H NMR spectra are reported as chemical shifts in parts per million (ppm) relative to an internal solvent reference. Peak multiplicity abbreviations are as follows: s (singlet), br s (broad singlet), d (doublet), dd (doublet of doublets), t (triplet), q (quartet), qn (quintet), and m (multiplet).</div><div class="NLM_p">We conducted analytical HPLC and mass spectroscopy by the use of a reverse-phase Agilent 1100 series HPLC−MS by using the methods that are noted for each compound in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>. The retention time (<i>t</i><sub>R</sub>) was recorded in minutes by the use of UV detection at 254 nm. High-resolution MS measurements were obtained by the use of electrospray ionization on a Thermo Scientific linear ion trap (LTQ) Orbitrap spectrometer.</div><div class="NLM_p last">Elemental Analyses (C, H, N) were obtained from Atlantic Microlab in Norcross, Georgia.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-Methyl-2-(methylthio)pyrimidin-4(3<i>H</i>)-one (<b>9</b>)</h3><div class="NLM_p last">Compound <b>8</b> (6.29 g, 44.2 mmol) was suspended in DMF (100 mL) and was cooled to 0 °C, and additional DMF (50 mL) was added. Solid LiHMDS (9.58 g, 57.3 mmol) was added in one portion, and the reaction was stirred at 0 °C. MeI (3.6 mL, 57.8 mmol) was added via syringe, and the reaction was warmed to room temperature and was stirred for 20.75 h. At this time, it was poured into 300 mL of H<sub>2</sub>O and was extracted exhaustively with EtOAc. The organic extracts were combined, were dried over Na<sub>2</sub>SO<sub>4</sub>, were filtered, were concentrated, and were purified on silica gel (3:1 → 3:2 → 1:1 hexanes/EtOAc) to produce <b>9</b> (3.79 g, 55%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 7.76 (d, <i>J</i> = 6.4 Hz, 1H), 6.20 (d, <i>J</i> = 6.4 Hz, 1H), 3.52 (s, 3H), 2.58 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 157 (M + H<sup>+</sup>).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-(3-Fluoro-4-methoxyphenyl)-3-methyl-2-(methylthio)pyrimidin-4(3<i>H</i>)-one (<b>10</b>)</h3><div class="NLM_p">Compound <b>9</b> (3.31 g, 21.2 mmol) was dissolved in chloroform (50 mL) and was cooled to 0 °C under argon. Bromine (1.25 mL, 25.4 mmol) was added via syringe, and the reaction was stirred at 0 °C for 35 min, at which time TLC analysis indicated the complete consumption of starting material. The reaction was quenched with 40 mL of saturated NaHCO<sub>3</sub>, was warmed to room temperature, and was stirred overnight. The reaction was extracted with DCM (3 × 25 mL), and the organic extracts were combined, were dried over Na<sub>2</sub>SO<sub>4</sub>, were filtered, and were concentrated to produce 5-bromo-3-methyl-2-(methylthio)pyrimidin-4(3<i>H</i>)-one (4.98 g, 100%), which did not require further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.07 (s, 1H), 3.58 (s, 3H), 2.58 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 235 (Br79, M + H<sup>+</sup>), 237 (Br81, M + H<sup>+</sup>).</div><div class="NLM_p last">5-Bromo-3-methyl-2-(methylthio)pyrimidin-4(3<i>H</i>)-one (14.77 g, 62.8 mmol), 3-fluoro-4-methoxyphenylboronic acid (20.11 g, 118.3 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (1.869 g, 2.04 mmol), <i>S</i>-Phos (3.45 g, 8.40 mmol), and K<sub>3</sub>PO<sub>4</sub> (42.27 g, 199.1 mmol) were suspended in PhMe (200 mL). Argon was bubbled through the solution for 5 min, and the reaction was then placed in a preheated oil bath (100 °C) and was stirred for 6.25 h, at which time LCMS analysis indicated a complete reaction. The reaction was cooled to room temperature and was allowed to stand overnight. It was then diluted with DCM (200 mL) and was filtered through a 1in plug of silica gel that was washed exhaustively with MeOH, EtOAc, and DCM. (Some solid material that was stuck in the flask had to be taken up in water and extracted with EtOAc separately). The filtrate (and EtOAc extracts) were combined and concentrated, which resulted in an orange solid. This was treated with hexanes and was filtered, and the resultant light-yellow solid was repeatedly washed with hexanes and was dried under high vacuum to afford <b>10</b> (15.85 g, 90%) as a light-yellow solid. For analytical purposes, a sample was washed with EtOAc, and the resultant white solid was dried under vacuum. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 7.93 (s, 1H), 7.46 (d, <i>J</i> = 12.8 Hz, 1H), 7.40 (d, <i>J</i> = 8.8 Hz, 1H), 6.99 (t, <i>J</i> = 8.8 Hz, 1H), 3.94 (s, 3H), 3.59 (s, 3H), 2.61 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 281 (M + H<sup>+</sup>).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for the Synthesis of <b>11</b>−<b>13</b>. 2-Benzyl-5-(3-fluoro-4-hydroxy-phenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>11</b>)</h3><div class="NLM_p">To a 500 mL three-necked round-bottomed flask that contained <b>10</b> (10 g, 36 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (4.5 g, 3.9 mmol) in THF (50 mL) was added benzylzinc bromide (100 mL, 0.5 M in THF, 42 mmol). The flask was then placed in a preheated (60 °C) oil bath, and the reaction was stirred for 2 h and was then allowed to cool to ambient temperature. The reaction was quenched with saturated NH<sub>4</sub>Cl, DCM (300 mL) was added, and the mixture was stirred overnight. The layers were separated, and the organic phase was collected, was dried over Na<sub>2</sub>SO<sub>4</sub>, was filtered, and was concentrated.</div><div class="NLM_p last">The crude material was put in a 1000 mL three-necked round-bottomed flask, and acetic acid (140 mL, 31 mmol) and hydrobromic acid (340 mL, 48%, 31 mmol) were added. The flask was fit with a reflux condensor, and the mixture was stirred at 135 °C for 4 h. The mixture was filtered while it was still hot, and the filtrate was cooled to ambient temperature. The filtrate was filtered, and the solid that was collected was washed with hexanes to afford <b>11</b> (9.2 g, 82% over two steps) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.05 (s, 1H), 7.52 (dd, <i>J</i> = 12.1, 2.0 Hz, 1H), 7.40−7.21 (m, 6H), 7.00 (t, <i>J</i> = 8.8 Hz, 1H), 6.20 (br s, 1H), 4.20 (s, 2H), 3.51 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 311 (M + H<sup>+</sup>).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-Chloro-6-methoxyquinolin-7-ol (<b>15</b>)</h3><div class="NLM_p last">7-(Benzyloxy)-4-chloro-6-methoxyquinoline (36 g, 0.11 mol) was dissolved in TFA (200 mL), and CH<sub>3</sub>SO<sub>3</sub>H (13.9 mL, 0.214 mol) was added in one portion. The reaction was heated at reflux for 3 h and was then cooled to room temperature and concentrated. Aqueous 2.5 N NaOH was added to raise the pH of the solution to 7, which caused precipitation. The resultant solid was crushed, was stirred vigorously for 1 h, and was then filtered. The solid was collected and was dried under high vacuum to afford <b>15</b> (22 g, ∼100%) as a brown solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 8.66 (d, <i>J</i> = 5.0 Hz, 1H), 7.64 (d, <i>J</i> = 5.0 Hz, 1H), 7.42 (s, 1H), 7.40 (s, 1H), 4.00 (s, 3H), 2.31 (s, 1H). MS (ES) <i>m</i>/<i>z</i>: 210 (M + H<sup>+</sup>).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Procedure for the Synthesis of <b>16</b>−<b>21</b>. 4-Chloro-6-methoxy-7-(3-morpholino-propoxy)quinoline (<b>16</b>)</h3><div class="NLM_p">Compound <b>15</b> (11 g, 53 mmol), 3-chloro-1-bromopropane (26 mL, 265 mmol), and K<sub>2</sub>CO<sub>3</sub> (69 g, 500 mmol) were suspended in DMF (400 mL) and were stirred at room temperature for 16 h. The suspension was filtered, and the filtrate was concentrated and diluted with EtOAc and water. The organic layer was separated, was dried over Na<sub>2</sub>SO<sub>4</sub>, was filtered, and was concentrated to afford a brown solid, which was directly used in the next step.</div><div class="NLM_p last">This brown solid was diluted with DMF (800 mL) and NaI (11.8 g, 79 mmol), and K<sub>2</sub>CO<sub>3</sub> (36 g, 265 mmol) and morpholine (27.7 mL, 318 mmol) were added. The reaction was heated to 70 °C and was stirred for 16 h. It was then cooled to room temperature, was diluted with water (2 L), and was extracted two times with EtOAc. The organic extracts were combined, were dried over sodium sulfate, were filtered, and were concentrated to produce a dark-brown solid. This material was recrystallized in DCM−hexanes to afford <b>16</b> (12 g, 67% over two steps) as a light-brown solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 8.60 (d, <i>J</i> = 4.5 Hz, 1H), 7.55 (d, <i>J</i> = 4.5 Hz, 1H), 7.45 (s, 1H), 7.37 (s, 1H), 4.21 (t, <i>J</i> = 6.3 Hz, 2H), 3.97 (s, 3H), 3.60−3.55 (m, 4H), 2.46 (t, <i>J</i> = 7.0 Hz, 2H), 2.41−2.35 (m, 4H), 1.97 (qn, <i>J</i> = 6.0 Hz, 2H). MS (ES) <i>m</i>/<i>z</i>: 337 (M + H<sup>+</sup>).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Synthesis of <b>22</b>−<b>24</b> and <b>26</b>. 2-Benzyl-5-(3-fluoro-4-(6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yloxy)phenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>22</b>)</h3><div class="NLM_p last">Phenol <b>11</b> (200 mg, 0.645 mmol), chloride <b>16</b> (261 mg, 0.774 mmol), and DMAP (24 mg, 0.20 mmol) were suspended in 1,4-dioxane in a microwave vial. The vial was then sealed and was heated in the microwave to 120 °C at 300 W for 20 min. The reaction was then concentrated and was purified on prep HPLC (1 → 80% MeCN/water with 0.1% TFA over 60 min). The fractions with product were collected, were concentrated, and were diluted with DCM. MP-carbonate beads were added, and the suspension was stirred for 10 min and was filtered. The beads were washed with MeOH and CH<sub>2</sub>Cl<sub>2</sub> three times, and the filtrate was concentrated to afford <b>22</b> (154 mg, 39%) as a yellow glass. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.50 (d, <i>J</i> = 5.3 Hz, 1H), 8.15 (s, 1H), 7.72 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 7.59−7.53 (m, 2H), 7.45 (s, 1H), 7.41−7.25 (m, 6H), 6.49 (dd, <i>J</i> = 5.3, 0.9 Hz, 1H), 4.28 (t, <i>J</i> = 6.7 Hz, 2H), 4.23 (s, 2H), 4.04 (s, 3H), 3.75−3.70 (m, 4H), 3.55 (s, 3H), 2.58 (t, <i>J</i> = 7.2 Hz, 2H), 2.53−2.46 (m, 4H), 2.19−2.08 (m, 2H). MS (ES) <i>m</i>/<i>z</i>: 611 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>35</sub>H<sub>35</sub>FN<sub>4</sub>O<sub>5</sub>·0.2CH<sub>2</sub>Cl<sub>2</sub>): C, H, N.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Benzyl-5-(3-fluoro-4-(6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinolin-4-yloxy)-phenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>23</b>)</h3><div class="NLM_p last">By using chloride <b>17</b> and by following the procedure that was used to prepare <b>22</b>, we obtained <b>23</b> (4%) as a white solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 8.50 (d, <i>J</i> = 8.0 Hz, 1H), 8.30 (s, 1H), 7.93 (dd, <i>J</i> = 16.0, 4.0 Hz, 1H), 7.74 (d, <i>J</i> = 8.0 Hz, 1H), 7.53 (s, 1H), 7.51 (t, <i>J</i> = 8.0 Hz, 1H), 7.41−7.26 (m, 6H), 6.51 (d, <i>J</i> = 8.0 Hz, 1H), 4.29 (s, 2H), 4.21 (t, <i>J</i> = 8.4 Hz, 2H), 3.96 (s, 3H), 3.52 (s, 3H), 2.62−2.52 (m, 2H), 2.52−2.40 (m, 4H, buried under DMSO peak), 2.04−1.97 (m, 2H), 1.73−1.65 (m, 4H). MS (ES) <i>m</i>/<i>z</i>: 595 (M + H<sup>+</sup>). HRMS calcd for C<sub>35</sub>H<sub>36</sub>FN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 595.2721; found, 595.2712. Analytical HPLC: 97.9%. <i>t</i><sub>R</sub> = 5.47.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-(4-(7-(3-(1<i>H</i>-1,2,4-Triazol-1-yl)propoxy)-6-methoxyquinolin-4-yloxy)-3-fluorophenyl)-2-benzyl-3-methylpyrimidin-4(3<i>H</i>)-one (<b>24</b>)</h3><div class="NLM_p last">By using chloride <b>18</b>, we prepared compound <b>24</b> by following the procedure that was used to prepare <b>22</b>, with the following modifications: pyridine (2.5 mL) and 1,4-dioxane (1.25 mL) were both used, and the reaction was run in the microwave at 90 °C and 150 W for 10 min. Compound <b>24</b> was isolated in 3% yield as an off-white solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 8.57 (s, 1H), 8.50 (d, <i>J</i> = 5.3 Hz, 1H), 8.29 (s, 1H), 7.99 (s, 1H), 7.92 (dd, <i>J</i> = 12.5, 1.6 Hz, 1H), 7.74 (d, <i>J</i> = 8.3 Hz, 1H), 7.55 (s, 1H), 7.51 (t, <i>J</i> = 8.8 Hz, 1H), 7.41−7.25 (m, 6H), 6.52 (d, <i>J</i> = 5.3 Hz, 1H), 4.41 (t, <i>J</i> = 6.9 Hz, 2H), 4.28 (s, 2H), 4.18 (t, <i>J</i> = 6.0 Hz, 2H), 3.97 (s, 3H), 3.52 (s, 3H), 2.41−2.30 (m, 2H). MS (ES) <i>m</i>/<i>z</i>: 593 (M + H<sup>+</sup>). HRMS calcd for C<sub>33</sub>H<sub>30</sub>FN<sub>6</sub>O<sub>4</sub> (M + H<sup>+</sup>), 593.2313; found, 593.2299. Analytical HPLC: 96.8%. <i>t</i><sub>R</sub> = 5.22.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Benzyl-5-(4-(7-(3-(4-ethylpiperazin-1-yl)-propoxy)-6-methoxyquinolin-4-yloxy)-3-fluorophenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>26</b>)</h3><div class="NLM_p last">By using chloride <b>20</b>, and by following the procedure that was used to prepare <b>24</b>, we obtained <b>26</b> (10%) as a white solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 8.50 (d, <i>J</i> = 5.1 Hz, 1H), 8.29 (s, 1H), 7.92 (d, <i>J</i> = 12.6 Hz, 1H), 7.74 (d, <i>J</i> = 8.7 Hz, 1H), 7.53 (s, 1H), 7.50 (t, <i>J</i> = 12.0 Hz, 1H), 7.42−7.25 (m, 6H), 6.51 (d, <i>J</i> = 4.7 Hz, 1H), 4.28 (s, 2H), 4.19 (t, <i>J</i> = 5.8 Hz, 2H), 3.95 (s, 3H), 3.52 (s, 3H), 2.61−2.30 (m, 12H), 2.05−1.90 (m, 2H), 0.99 (t, <i>J</i> = 7.0 Hz, 3H). MS (ES) <i>m</i>/<i>z</i>: 638 (M + H<sup>+</sup>). HRMS calcd for C<sub>37</sub>H<sub>41</sub>FN<sub>5</sub>O<sub>4</sub> (M + H<sup>+</sup>), 638.3143; found, 638.3135. Analytical HPLC: 97.5%. <i>t</i><sub>R</sub> = 4.70.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Procedure for the Synthesis of <b>25</b> and <b>27</b>. 2-Benzyl-5-(3-fluoro-4-(6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinolin-4-yloxy)phenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>25</b>)</h3><div class="NLM_p last">Phenol <b>11</b> (258 mg, 0.832 mmol), chloride <b>19</b> (350 mg, 0.999 mmol), and DMAP (10 mg, 0.083 mmol) were suspended in pyridine (4.0 mL) and 1,4-dioxane (1.0 mL) and were heated in an oil bath at 110 °C over the weekend, at which time the solvent evaporated. More pyridine and 1,4-dioxane were added, and stirring was continued until about half of the starting material had been consumed, according to LCMS analysis. The reaction was cooled to room temperature, was concentrated, and was purified on silica gel (0 → 10% 2 M ammonia in MeOH/DCM). The fraction with product was collected, was concentrated, and was purified by HPLC. The fraction with product was treated with ammonium hydroxide and was extracted with 5% MeOH/DCM. The organic extracts were washed with saturated NaHCO<sub>3</sub>, were dried over sodium sulfate, were filtered, and were concentrated to afford <b>25</b> (40 mg, 8%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 8.50 (d, <i>J</i> = 5.1 Hz, 1H), 8.29 (s, 1H), 7.92 (dd, <i>J</i> = 12.5, 2.0 Hz, 1H), 7.74 (d, <i>J</i> = 12.0 Hz, 1H), 7.53 (s, 1H), 7.50 (t, <i>J</i> = 12.0 Hz, 1H), 7.41−7.27 (m, 6H), 6.51 (d, <i>J</i> = 5.3 Hz, 1H), 4.28 (s, 2H), 4.19 (t, <i>J</i> = 6.4 Hz, 2H), 3.95 (s, 3H), 3.52 (s, 3H), 2.46 (t, <i>J</i> = 7.0 Hz, 2H), 2.50−2.25 (m, 8H), 2.15 (s, 3H), 1.97 (qn, <i>J</i> = 10 Hz, 2H). MS (ES) <i>m</i>/<i>z</i>: 624 (M + H<sup>+</sup>). HRMS calcd for C<sub>36</sub>H<sub>39</sub>FN<sub>5</sub>O<sub>4</sub> (M + H<sup>+</sup>), 624.2986; found, 624.2962. Analytical HPLC: 98.8%. <i>t</i><sub>R</sub> = 4.91.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Benzyl-5-(3-fluoro-4-(7-(3-(4-hydroxy-piperidin-1-yl)propoxy)-6-methoxyquinolin-4-yloxy)phenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>27</b>)</h3><div class="NLM_p last">By using chloride <b>21</b>, we prepared compound <b>27</b> by following the procedure that was used to prepare <b>25</b>, except NMP was used instead of pyridine and was added after the mixture was stirred overnight. Compound <b>27</b> was isolated in 6% yield as an off-white solid as a TFA salt. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD, δ): 8.45 (d, <i>J</i> = 5.5 Hz, 1H), 8.23 (s, 1H), 7.81 (dd, <i>J</i> = 11.9, 2.1 Hz, 1H), 7.67 (s, 1H), 7.65 (d, <i>J</i> = 7.1 Hz, 1H), 7.43 (t, <i>J</i> = 8.4 Hz, 1H), 7.40−7.36 (m, 3H), 7.33−7.28 (m, 3H), 6.58 (d, <i>J</i> = 5.2 Hz, 1H), 4.31 (s, 2H), 4.28 (t, <i>J</i> = 5.9 Hz, 2H), 4.03 (s, 3H), 3.77 (br s, 1H), 3.56 (s, 3H), 3.14−3.05 (m, 2H), 2.93−2.86 (m, 2H), 2.65−2.55 (m, 2H), 2.22 (qn, <i>J</i> = 7.0 Hz, 2H), 1.99−1.93 (m, 2H), 1.73−1.65 (m, 2H). MS (ES) <i>m</i>/<i>z</i>: 625 (M + H<sup>+</sup>). Analytical HPLC: 98.9%. <i>t</i><sub>R</sub> = 5.32.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Procedure for the Synthesis of <b>32</b> and <b>33</b>. 2-Benzyl-5-(3-fluoro-4-hydroxy-phenyl)pyrimidin-4(3<i>H</i>)-one (<b>32</b>)</h3><div class="NLM_p">We brominated 2-benzyl-pyrimidin-4(3<i>H</i>)-one (<b>28</b>) by following the procedure that was used for the bromination of <b>9</b> to afford 2-benzyl-5-bromopyrimidin-4(3<i>H</i>)-one in 29% yield.</div><div class="NLM_p">2-Benzyl-5-bromopyrimidin-4(3<i>H</i>)-one (100 mg, 0.379 mmol), 3-fluoro-4-methoxyphenylboronic acid (128 mg, 0.756 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (22 mg, 0.019 mmol), and Na<sub>2</sub>CO<sub>3</sub> (1 M in water, 0.5 mL, 0.5 mmol) were suspended in DME (1.5 mL) and were heated in the CEM microwave to100 °C at 75 W for 10 min. The reaction was cooled to room temperature and was diluted with water and DCM. The organic layer was collected, was dried over sodium sulfate, was filtered through celite, and was concentrated. Purification via silica gel chromatography (ISCO column, 12 g, 0 → 5% MeOH/DCM) afforded <b>30</b> (86 mg, 74%) as a white solid.</div><div class="NLM_p last">Finally, we converted <b>30</b> to phenol <b>32</b> by following the demethylation procedure (HBr and HOAc) that was used to prepare <b>11</b>. Compound <b>32</b> was isolated in 65% yield as a white solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 12.88 (s, 1H), 9.98 (s, 1H), 8.09 (s, 1H), 7.58 (dd, <i>J</i> = 13.3, 2.3 Hz, 1H), 7.39−7.30 (m, 5H), 7.29−7.22 (m, 1H), 6.95 (t, <i>J</i> = 8.8 Hz, 1H), 3.89 (s, 2H). MS (ES) <i>m</i>/<i>z</i>: 297 (M + H<sup>+</sup>).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Benzyl-5-(3-fluoro-4-hydroxyphenyl)-6-methylpyrimidin-4(3<i>H</i>)-one (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared from 2-benzyl-6-methyl-pyrimidin-4(3<i>H</i>)-one (<b>29</b>) with the same three-step sequence that was used to synthesize <b>32</b>. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 12.67 (br s, 1H), 9.90 (br s, 1H), 7.39−7.31 (m, 4H), 7.28−7.23 (m, 1H), 7.03 (dd, <i>J</i> = 12.6, 2.0 Hz, 1H), 6.94 (t, <i>J</i> = 8.8 Hz, 1H), 6.85 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 3.83 (s, 2H), 2.07 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 311 (M + H<sup>+</sup>).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Benzyl-5-(4-(6,7-dimethoxyquinolin-4-yloxy)-3-fluorophenyl)pyrimidin-4(3<i>H</i>)-one (<b>34</b>)</h3><div class="NLM_p last">Compound <b>32</b> (100 mg, 0.334 mmol), 4-chloro-6,7-dimethoxyquinoline (113 mg, 0.505 mmol), and DMAP (41 mg, 0.336 mmol) were suspended in PhMe (2 mL) and CHCl<sub>3</sub> (1 mL) and were heated in the microwave to 180 °C (with variable power) for 20 min and then for an additional 10 min. The reaction was then cooled to room temperature, was concentrated, was treated with DCM, and was filtered. The white solid was collected, and the filtrate was concentrated and purified via silica gel chromatography (ISCO column, 40 g, 0 → 5% MeOH/DCM) to afford, after combining with the solid collected earlier, <b>34</b> (86 mg, 53%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 10.77 (br s, 1H), 8.52 (d, <i>J</i> = 5.3 Hz, 1H), 8.22 (s, 1H), 7.74 (dd, <i>J</i> = 11.4 Hz, 2.1 Hz, 1H), 7.59 (s, 1H), 7.60−7.55 (m, 1H), 7.45 (s, 1H), 7.43−7.30 (m, 6H), 6.51 (d, <i>J</i> = 5.3 Hz, 1H), 4.09 (s, 2H), 4.08 (s, 3H), 4.07 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 484 (M + H<sup>+</sup>). HRMS calcd for C<sub>28</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>), 484.1673; found, 484.1649. Analytical HPLC: 96.9%. <i>t</i><sub>R</sub> = 1.66.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Benzyl-5-(4-(6,7-dimethoxyquinolin-4-yl-oxy)-3-fluorophenyl)-6-methylpyrimidin-4(3<i>H</i>)-one (<b>35</b>)</h3><div class="NLM_p last">By following the procedure that was used to prepare <b>34</b>, we prepared compound <b>35</b> from phenol <b>33</b> in 24% yield as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.49 (d, <i>J</i> = 5.1 Hz, 1H), 7.60 (s, 1H), 7.45 (s, 1H), 7.42−7.26 (m, 8H), 7.19 (d, <i>J</i> = 8.2 Hz, 1H), 6.53 (d, <i>J</i> = 5.1 Hz, 1H), 4.07 (s, 3H), 4.06 (s, 3H), 3.96 (s, 2H), 2.34 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 498 (M + H<sup>+</sup>). HRMS calcd for C<sub>29</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>), 498.1829; found, 498.1812. Analytical HPLC: 95.2%. <i>t</i><sub>R</sub> = 2.36.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-Benzyl-5-(4-(6,7-dimethoxyquinolin-4-yl-oxy)-3-fluorophenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>7</b>)</h3><div class="NLM_p last">Compound <b>34</b> (25 mg, 0.052 mmol) was dissolved in DMF, and K<sub>2</sub>CO<sub>3</sub> (11 mg, 0.080 mmol) and MeI (0.004 mL, 0.06 mmol) were added. The reaction was stirred at 43 °C (oil bath temperature) for 2 h, was diluted with DCM, and was washed with water twice and with brine once. The organic layer was dried over sodium sulfate, was filtered, was concentrated, and was purified on silica gel chromatography (ISCO column, 12 g, 0 → 5% MeOH/DCM) to afford a 6:1 mixture of <b>7</b> and the undesired O-methylated isomer (11 mg, 42% total yield). This mixture was purified via HPLC (70 → 100% MeCN/water with 0.1% TFA) to afford pure <b>7</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.52 (d, <i>J</i> = 5.3 Hz, 1H), 8.16 (s, 1H), 7.73 (dd, <i>J</i> = 11.7, 2.1 Hz, 1H), 7.60 (s, 1H), 7.57 (dd, <i>J</i> = 9.4, 0.9 Hz, 1H), 7.45 (s, 1H), 7.42−7.25 (m, 6H), 6.51 (dd, <i>J</i> = 6.8, 0.8 Hz, 1H), 4.23 (s, 2H), 4.08 (s, 3H), 4.07 (s, 3H), 3.56 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 498 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>29</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>4</sub>·0.1CH<sub>2</sub>Cl<sub>2</sub>): C, H, N.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-(Bromo(phenyl)methyl)-5-(4-(6,7-dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>36</b>)</h3><div class="NLM_p last">Compound <b>7</b> (300 mg, 0.604 mmol) was diluted with CHCl<sub>3</sub>, and NBS (0.24 g, 1.3 mmol) was added. The reaction was heated at reflux for 3 h, and then more NBS (53 mg, 0.30 mmol) was added. After another 2 h, the reaction was cooled to room temperature, was concentrated, and was purified via column chromatography (0 → 5% MeOH/DCM). A second column chromatography was necessary that used EtOAc as the eluent to afford pure <b>36</b> (113 mg, 32%) as a tan solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.44 (d, <i>J</i> = 5.3 Hz, 1H), 8.09 (s, 1H), 7.65 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 7.50 (s, 1H), 7.51−7.43 (m, 3H), 7.41 (s, 1H), 7.38−7.28 (m, 3H), 7.25−7.18 (m, 1H), 6.43 (d, <i>J</i> = 5.3 Hz, 1H), 6.13 (s, 1H), 3.97 (s, 6H), 3.55 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 576 (Br79, M + H <sup>+</sup>), 578 (Br81, M + H<sup>+</sup>).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-(Amino(phenyl)methyl)-5-(4-(6,7-dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>37</b>)</h3><div class="NLM_p">Compound <b>36</b> (130 mg, 0.226 mmol) was dissolved in DMF (3 mL) and was cooled to 0° C. NaN<sub>3</sub> (18 mg, 0.28 mmol) was added, and the reaction was stirred for 1 h. It was then concentrated, treated with CHCl<sub>3</sub> and DCM, washed with water, and dried over sodium sulfate. The organic phase was decanted and concentrated and was taken directly to the next step.</div><div class="NLM_p last">The crude material was diluted with EtOAc and THF, and Pd−C (10% by weight, 24 mg) was added. The reaction was then stirred under a balloon of hydrogen for 4.5 h, was flushed with nitrogen, and was filtered through a pad of celite. The filtrate was concentrated and purified via silica gel chromatography (ISCO aminopropyl column, 40 g, 0 → 5% MeOH/DCM) to afford <b>37</b> (31 mg, 27% yield over two steps) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.51 (d, <i>J</i> = 5.0 Hz, 1H), 8.41 (s, 1H), 7.93 (dd, <i>J</i> = 12.3, 1.8 Hz, 1H), 7.76 (d, <i>J</i> = 8.5 Hz, 1H), 7.54 (s, 1H), 7.51 (t, <i>J</i> = 8.8 Hz, 1H), 7.44−7.34 (m, 5H), 7.32−7.27 (m, 1H), 6.53 (d, <i>J</i> = 5.0 Hz, 1H), 5.31 (s, 1H), 3.96 (s, 6H), 3.50 (s, 3H), 2.73 (br s, 2H). MS (ES) <i>m</i>/<i>z</i>: 513 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>29</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub>·0.5CH<sub>2</sub>Cl<sub>2</sub>): C, H, N.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> General Procedure for the Synthesis of <b>38</b>−<b>41</b>. <i>N</i>-((5-(4-(6,7-Dimethoxyquinolin-4-yl-oxy)-3-fluorophenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl)-2-(dimethylamino)acetamide) (<b>38</b>)</h3><div class="NLM_p last">Amine <b>37</b> (25 mg, 0.049 mmol) was diluted with DCM and was cooled in an ice-water bath. Et<sub>3</sub>N (0.034 mL, 0.25 mmol) and 2-(dimethylamino)acetyl chloride hydrochloride salt (9 mg, 0.06 mmol) were added, and the reaction was stirred at room temperature until TLC analysis indicated a complete reaction. More Et<sub>3</sub>N and 2-(dimethylamino)acetyl chloride hydrochloride salt were added as needed to afford a complete reaction. Upon completion, the reaction was concentrated and purified via silica gel chromatography (ISCO column, 12 g, 0 → 5% MeOH/DCM) to afford <b>38</b> (14 mg, 48% yield) as a tan solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.57 (d, <i>J</i> = 8.3 Hz, 1H), 8.52 (d, <i>J</i> = 5.3 Hz, 1H), 8.23 (s, 1H), 7.73 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 7.59 (s, 1H), 7.60−7.55 (m, 1H), 7.46 (s, 1H), 7.43−7.35 (m, 5H), 7.32 (t, <i>J</i> = 8.4 Hz, 1H), 6.51 (d, <i>J</i> = 5.3 Hz, 1H), 6.34 (d, <i>J</i> = 8.3 Hz, 1H), 4.07 (s, 3H), 4.06 (s, 3H), 3.54 (s, 3H), 3.01 (s, 2H), 2.32 (s, 6H). MS (ES) <i>m</i>/<i>z</i>: 598 (M + H<sup>+</sup>). HRMS calcd for C<sub>33</sub>H<sub>33</sub>FN<sub>5</sub>O<sub>5</sub> (M + H<sup>+</sup>), 598.2466; found, 598.2444. Analytical HPLC: 96.9%. <i>t</i><sub>R</sub> = 2.43.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-((5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl)-propionamide (<b>39</b>)</h3><div class="NLM_p last">By using propionyl chloride, and by following the procedure that was used to prepare <b>38</b>, we obtained <b>39</b> (51%) as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 8.52 (d, <i>J</i> = 5.3 Hz, 1H), 8.18 (s, 1H), 7.71 (dd, <i>J</i> = 11.6 Hz, 2.0 Hz, 1H), 7.59 (s, 1H), 7.60−7.54 (m, 1H), 7.44 (s, 1H), 7.42−7.31 (m, 6H), 7.30−7.24 (m, 1H), 6.51 (dd, <i>J</i> = 5.3, 0.7 Hz, 1H), 6.31 (d, <i>J</i> = 7.6 Hz, 1H), 4.07 (s, 3H), 4.06 (s, 3H), 3.52 (s, 3H), 2.31 (dq, <i>J</i> = 7.8, 1.5 Hz, 2H), 1.18 (t, <i>J</i> = 7.5 Hz, 3H). MS (ES) <i>m</i>/<i>z</i>: 569 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>32</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>·0.2CH<sub>2</sub>Cl<sub>2</sub>): C, H, N.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-((5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl)-3-(methylthio)propanamide (<b>40</b>)</h3><div class="NLM_p last">By using 3-(methylthio)propanoyl chloride, and by following the procedure that was used to prepare <b>38</b>, we obtained <b>40</b> (47%) as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 8.53 (d, <i>J</i> = 5.3 Hz, 1H), 8.18 (s, 1H), 7.72 (dd, <i>J</i> = 11.6 Hz, 2.1, 1H), 7.59 (s, 1H), 7.59−7.54 (m, 1H), 7.53−7.47 (m, 1H), 7.48 (s, 1H), 7.42−7.37 (m, 5H), 7.32 (t, <i>J</i> = 8.3 Hz, 1H), 6.51 (d, <i>J</i> = 5.3 Hz, 1H), 6.30 (d, <i>J</i> = 7.5 Hz, 1H), 4.07 (s, 3H), 4.06 (s, 3H), 3.52 (s, 3H), 2.84−2.77 (m, 2H), 2.61−2.55 (m, 2H), 2.09 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 615 (M + H<sup>+</sup>). HRMS calcd for C<sub>33</sub>H<sub>32</sub>FN<sub>4</sub>O<sub>5</sub>S (M + H<sup>+</sup>), 615.2077; found, 615.2067. Analytical HPLC: 96.2%. <i>t</i><sub>R</sub> = 1.87.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-((5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-1-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl)(phenyl)methyl)-1,1-dimethyl-urea (<b>41</b>)</h3><div class="NLM_p last">By using dimethylcarbamic chloride, and by following the procedure that was used to prepare <b>38</b>, we obtained <b>41</b> as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 8.53 (d, <i>J</i> = 5.1 Hz, 1H), 8.19 (s, 1H), 7.72 (dd, <i>J</i> = 11.6 Hz, 2.0, 1H), 7.59 (s, 1H), 7.60−7.55 (m, 1H), 7.45 (s, 1H), 7.42−7.36 (m, 5H), 7.31 (t, <i>J</i> = 8.3 Hz, 1H), 6.51 (d, <i>J</i> = 5.1 Hz, 1H), 6.26−6.22 (m, 1H), 6.19−6.14 (m, 1H), 4.08 (s, 3H), 4.06 (s, 3H), 3.54 (s, 3H), 2.96 (s, 6H). MS (ES) <i>m</i>/<i>z</i>: 584 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>32</sub>H<sub>30</sub>FN<sub>5</sub>O<sub>5</sub>·0.3CH<sub>2</sub>Cl<sub>2</sub>): C, H, N.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedure for the Synthesis of <b>42</b>, <b>43</b>, and <b>51</b>. 2-(4-Methylbenzyl)-5-(3-fluoro-4-(6-methoxy-7-(3-morpholinopropoxy)-quinolin-4-yloxy)phenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>42</b>)</h3><div class="NLM_p last">4-Chloro-6-methoxy-7-(3-morpholinopropoxy)quinoline (<b>16</b>, 116.7 mg, 0.346 mmol), 2-(4-methylbenzyl)-5-(3-fluoro-4-hydroxyphenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>12</b>, 120.6 mg, 0.372 mmol), copper powder (9.8 mg, 0.15 mmol), and solid KOH (56.1 mg, 1.0 mmol) were suspended in DMF (1 mL) and pyridine (1 mL) and were heated in the CEM microwave to 110 °C at 110 W for 18 min. The reaction was cooled to room temperature. We ran five more reactions in the microwave by using the same reagents in approximately the same amounts. For all six runs, the total amounts of <b>16</b> and <b>12</b> used were 1.164 g (3.457 mmol) and 1.417 g (4.370 mmol), respectively. Once completed, all six reactions were combined and were poured into 1 N NaOH (39 mL), which was then diluted with DCM. The layers were separated, and the aqueous phase was extracted repeatedly with DCM. The organic phases were combined, were dried over sodium sulfate, were filtered, were concentrated, and were purified on HPLC (1 → 70% MeCN/water with 0.1% TFA over 55 −65 min). The fractions with product were collected, were concentrated, and were repurified on HPLC (10 → 95% MeCN/water with 0.1% TFA). The fractions with product were collected, were concentrated, were diluted with DCM (∼5 mL), and were treated with polymer-supported carbonate (560 mg, MP-carbonate, Argonaut Aquatics, 2.75 mmol/g). The suspension was stirred for 75 min and was then filtered. The filtrate was concentrated and was dried under high vacuum to afford <b>42</b> (115.0 mg, 5%) as a rust-colored solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.53 (d, <i>J</i> = 5.5 Hz, 1H), 8.16 (s, 1H), 7.74 (dd, <i>J</i> = 9.6, 2.0 Hz, 1H), 7.60 (s, 1H), 7.60−7.52 (m, 2H), 7.32 (t, <i>J</i> = 8.3 Hz, 1H), 7.21−7.13 (m, 4H), 6.54 (d, <i>J</i> = 5.5 Hz, 1H), 4.30 (t, <i>J</i> = 6.5 Hz, 2H), 4.19 (s, 2H), 4.06 (s, 3H), 3.83−3.78 (m, 4H), 3.56 (s, 3H), 2.80−2.60 (m, 6H), 2.36 (s, 3H), 2.25−2.17 (m, 2H). MS (ES) <i>m</i>/<i>z</i>: 625 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>36</sub>H<sub>37</sub>FN<sub>4</sub>O<sub>5</sub>·0.6CH<sub>2</sub>Cl<sub>2</sub>): C, H, N.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-(4-Fluorobenzyl)-5-(3-fluoro-4-(6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yloxy)phenyl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>43</b>)</h3><div class="NLM_p last">By using phenol <b>13</b>, and by following the procedure that was used to prepare <b>42</b>, we obtained <b>43</b> (1%) as a rust-colored solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 8.50 (d, <i>J</i> = 5.3 Hz, 1H), 8.27 (s, 1H), 7.91 (dd, <i>J</i> = 12.5, 2.0 Hz, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (s, 1H), 7.50 (t, <i>J</i> = 8.6 Hz, 1H), 7.42 (s, 1H), 7.34 (dd, <i>J</i> = 8.5, 5.8 Hz, 2H), 7.19 (t, <i>J</i> = 8.9 Hz, 2H), 6.51 (d, <i>J</i> = 5.3 Hz, 1H), 4.27 (s, 2H), 4.21 (t, <i>J</i> = 6.5 Hz, 2H), 3.95 (s, 3H), 3.59 (t, <i>J</i> = 4.5 Hz, 4H), 3.54 (s, 3H), 2.50−2.44 (m, 2H), 2.42−2.37 (m, 4H), 1.98 (qn, <i>J</i> = 6.0 Hz, 2H). MS (ES) <i>m</i>/<i>z</i>: 629 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>35</sub>H<sub>34</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub>·0.2CH<sub>2</sub>Cl<sub>2</sub>) C, H, N: Found, 65.90; Calcd, 65.48.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-(3-Fluoro-4-(6-methoxy-7-(3-morpholino-propoxy)quinolin-4-yloxy)phenyl)-2-(4-fluorophenylamino)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>51</b>)</h3><div class="NLM_p last">By using phenol <b>47</b>, and by following the procedure that was used to prepare <b>42</b>, we obtained <b>51</b> (6%) as a tan solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 9.06 (s, 1H), 8.49 (d, <i>J</i> = 5.3 Hz, 1H), 8.09 (s, 1H), 7.87 (dd, <i>J</i> = 12.8, 1.7 Hz, 1H), 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.57−7.51 (m, 3H), 7.46−7.39 (m, 2H), 7.22 (t, <i>J</i> = 8.8 Hz, 2H), 6.49 (d, <i>J</i> = 5.1 Hz, 1H), 4.21 (t, <i>J</i> = 5.7 Hz, 2H), 3.95 (s, 3H), 3.63−3.57 (m, 4H), 3.57 (s, 3H), 2.50−2.35 (m, 6H), 2.06−1.93 (m, 2H). MS (ES) <i>m</i>/<i>z</i>: 630 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>34</sub>H<sub>33</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub>·0.4CH<sub>2</sub>Cl<sub>2</sub>): C, H, N.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-(3-Fluoro-4-hydroxyphenyl)-3-methyl-2-(methylthio)pyrimidin-4(3<i>H</i>)-one (<b>44</b>)</h3><div class="NLM_p last">Compound <b>10</b> (10.0 g, 35.8 mmol) was dissolved in HOAc (60 mL) and 48% aqueous HBr (240 mL). The flask was equipped with a reflux condenser and was placed in a preheated oil bath (115−120 °C) and was stirred for 3 h. The reaction was then cooled to room temperature and was poured into a 2 L Erlenmeyer flask. Saturated NaHCO<sub>3</sub> (1.3 L) was added in portions over 1 h, and the solution was stirred overnight at room temperature. Then, 5 N NaOH (100 mL) was added, and stirring was continued for 20 min. The suspension was filtered, and the solid was collected and dried under high vacuum at 60 °C to afford <b>44</b> (9.8 g, ∼100%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 7.95 (s, 1H) 7.51 (dd, <i>J</i> = 11.9, 2.0 Hz, 1H), 7.30−7.25 (m, 1H), 7.02 (t, <i>J</i> = 8.8 Hz, 1H), 5.33 (br s, 1H), 3.61 (s, 3H), 2.65 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 267 (M + H<sup>+</sup>).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> General Procedure for the Synthesis of <b>48</b>−<b>50</b>. 5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-3-methyl-2-(phenylamino)-pyrimidin-4(3<i>H</i>)-one (<b>48</b>)</h3><div class="NLM_p">Phenol <b>44</b> (508.1 mg, 1.908 mmol) was suspended in aniline (4.5 mL), and concentrated HCl (3 drops) was added. The suspension was sealed in a microwave vial and was heated in the CEM microwave to120 °C at 100 W for 10 min. The reaction was diluted with EtOAc (∼100 mL) and was washed with 1 N NaOH (3 × 25 mL). The aqueous washings were combined and were extracted with EtOAc (10 mL). This EtOAc extraction was washed with 1 N NaOH (20 and 10 mL). Finally, all of the aqueous extractions were combined, were washed with Et<sub>2</sub>O (3 × 15 mL), and were treated with 1 N HCl to lower the pH to about 8. The aqueous phase was extracted with EtOAc, and these organic extracts were combined and were washed with water (3 × 10 mL) and 1 N NaOH. The pH of these aqueous washings was adjusted with to be around 6 by concentrated HCl and then 1 N NaOH, and this aqueous phase was extracted with EtOAc and Et<sub>2</sub>O. These organic extracts were combined, were dried over sodium sulfate, were filtered, were concentrated, and were dried under high vacuum to afford phenol <b>45</b> (466.1 mg, 78%).</div><div class="NLM_p last">Phenol <b>45</b> (210.3 mg, 0.6756 mmol), 4-chloro-6,7-dimethoxyuinoline (247.2 mg, 1.106 mmol, and DMAP (29.8 mg, 0.244 mmol) were suspended in 1,4-dioxane (4.0 mL) and were heated in the CEM microwave to 120 °C at 300 W for 20 min. The reaction was briefly cooled and was then reheated under the same conditions for 15 min. The reaction was cooled to room temperature once more, was concentrated, and was purified via HPLC (10 → 95% MeCN/water with 0.1% TFA). The fractions with product were collected, were concentrated, and were filtered through a plug of silica gel with EtOAc and then with 5% MeOH/EtOAc. The filtrate was concentrated and was again filtered through silica gel with EtOAc. Fractions with product were collected, were concentrated, and were dried under high vacuum to afford <b>48</b> (20.9 mg, 6%). For analytical purposes, a 4 mg aliquot was purified on a pipet silica gel column (50:1 → 25:1 DCM/MeOH) to afford analytically pure material. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.50 (d, <i>J</i> = 5.3 Hz, 1H), 7.97 (s, 1H), 7.66 (dd, <i>J</i> = 11.9, 2.0 Hz, 1H), 7.60 (s, 1H), 7.52−7.38 (m, 7H), 7.25−7.20 (m, 2H), 6.51 (dd, <i>J</i> = 5.3, 1.0 Hz, 1H), 4.07 (s, 3H), 4.05 (s, 3H), 3.69 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 499 (M + H<sup>+</sup>). HRMS calcd for C<sub>28</sub>H<sub>24</sub>FN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 499.1782; found, 499.1767. Analytical HPLC: 96.6%. <i>t</i><sub>R</sub> = 1.74.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-2-(2-fluorophenylamino)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>49</b>)</h3><div class="NLM_p last">By using phenol <b>46</b> (prepared in the same manner as <b>45</b> above) and 4-chloro-6,7-dimethoxyquinoline, and by following the procedure that was used to prepare <b>48</b>, we obtained <b>49</b> (1%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 9.12 (s, 1H), 8.57 (s, 1H), 8.05 (s, 1H), 7.87 (d, <i>J</i> = 12.5 Hz, 1H), 7.73−7.22 (m, 8 H), 6.61 (s, 1H), 3.97 (s, 6H), 3.58 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 517 (M + H<sup>+</sup>). HRMS calcd for C<sub>28</sub>H<sub>23</sub>F<sub>2</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 517.1687; found, 517.1667. Analytical HPLC: 98.1%. <i>t</i><sub>R</sub> = 2.27.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenylamino)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>50</b>)</h3><div class="NLM_p last">By using phenol <b>47</b> (prepared in the same manner as <b>45</b> above) and 4-chloro-6,7-dimethoxyquinoline, and by following the procedure that was used to prepare <b>48</b>, we obtained <b>50</b> (6%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 9.06 (s, 1H), 8.66 (s, 1H), 8.12 (s, 1H), 7.92 (d, <i>J</i> = 13.1 Hz, 1H), 7.73 (d, <i>J</i> = 9.8 Hz, 1H), 7.68−7.63 (m, 1H), 7.53−7.47 (m, 3H), 7.51−7.47 (m, 1H), 7.23 (t, <i>J</i> = 8.9 Hz, 2H), 6.74 (m, 1H), 4.00 (s, 6H), 3.57 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 517 (M + H<sup>+</sup>). HRMS calcd for C<sub>28</sub>H<sub>23</sub>F<sub>2</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 517.1687; found, 517.1670. Analytical HPLC: 95.1%. <i>t</i><sub>R</sub> = 2.24.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-3-methyl-2-(methylthio)-pyrimidin-4(3<i>H</i>)-one (<b>52</b>)</h3><div class="NLM_p last">Phenol <b>44</b> (2.82 g, 10.6 mmol), 4-chloro-6,7-dimethoxyquinoline (2.10 g, 9.40 mmol), and DMAP (110.1 mg, 0.901 mmol) were suspended in pyridine (30 mL) and 1,4-dioxane (15 mL), and the reaction flask was heated in an oil bath (110 °C) while the reaction was stirred under argon overnight. The reaction was cooled to room temperature, was diluted with water (75 mL), and was filtered. The solid was washed with water and was dried under high vacuum to afford <b>52</b> (2.50 g, 59%). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 8.50 (d, <i>J</i> = 5.1 Hz, 1H), 8.29 (s, 1H), 7.90 (dd, <i>J</i> = 12.4, 1.7 Hz, 1H), 7.72 (d, <i>J</i> = 8.8 Hz, 1H), 7.54 (s, 1H), 7.50 (t, <i>J</i> = 8.6 Hz, 1H), 7.42 (s, 1H), 6.52 (d, <i>J</i> = 5.3 Hz, 1H), 3.95 (s, 6H), 3.52 (s, 3H), 2.62 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 454 (M + H<sup>+</sup>).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-2-hydroxy-3-methylpyrimidin-4(3<i>H</i>)-one (<b>53</b>)</h3><div class="NLM_p last">Compound <b>52</b> (8.90 g, 19.6 mmol) was dissolved in a solution of MeCN (288 mL) and TFA (32 mL), which was then cooled to −5 °C in a dilute dry-ice/acetone bath. Urea hydrogen peroxide (7.37 g, 78.4 mmol) was added, and the reaction was stirred for 5 min. TFAA (10.90 mL, 78.40 mmol) was added dropwise via a dropping funnel while the temperature was maintained at −5° C. The reaction was stirred at this temperature for 30 min and was then allowed to warm up to room temperature, where it was stirred for 3 h. The reaction was then diluted with DCM and H<sub>2</sub>O, and the layers were separated. The aqueous phase was extracted with DCM, and the organic phases were combined, were dried over sodium sulfate, were filtered, were concentrated, and were dried in vacuo at 100 °C over the weekend to afford <b>53</b> (10.00 g, 95% yield) as a beige solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 10.50 (d, <i>J</i> = 5.4 Hz, 1H), 8.70 (d, <i>J</i> = 6.6 Hz, 1H), 7.86 (s, 1H), 7.69 (s, 1H), 7.69−7.55 (m, 2H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 7.36 (t, <i>J</i> = 8.3 Hz, 1H), 6.80 (d, <i>J</i> = 6.1 Hz, 1H), 4.15 (s, 3H), 4.13 (s, 3H), 3.42 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 424 (M + H<sup>+</sup>).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> General Procedure for the Synthesis of <b>55</b> and <b>56</b>. 5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-2-(3-fluorophenyl-amino)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>55</b>)</h3><div class="NLM_p">Compound <b>53</b> (∼240 mg, 0.57 mmol) was dissolved in POCl<sub>3</sub> (16 mL) and <i>N</i>,<i>N</i>-dimethylaniline (1.6 mL). The reaction was heated to 125 °C for 8.5 h and was then cooled to room temperature and was stirred overnight. It was then concentrated and diluted with DCM (∼125 mL). The organic phase was washed with saturated sodium bicarbonate (25 and 17 mL), was dried over sodium sulfate, was filtered, and was concentrated. Crude chloride <b>54</b> was dissolved in 1,4-dioxane (15 mL) and was used for the next step.</div><div class="NLM_p last">This solution (5 mL) was put in a microwave vial, and 3-fluoroaniline (0.2 mL, 2 mmol) and concentrated HCl (1 drop) were added. The vial was sealed and was heated in the CEM microwave to 60 °C at 60 W for 5 min. The reaction was then cooled to room temperature, was concentrated, and was filtered through a plug of silica gel (EtOAc, 2:1 EtOAc/MeOH → 3:2 MeOH/EtOAc). The filtrate was concentrated and was purified on HPLC (10 → 95% MeCN/water with 0.1% TFA). The fractions with product were collected, were concentrated, and were purified two times on a silica gel plug (EtOAc → 1% MeOH/EtOAc the first time, EtOAc the second time) to afford <b>55</b> (14.4 mg) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 9.14 (s, 1H), 8.59 (d, <i>J</i> = 5.5 Hz, 1H), 8.17 (s, 1H), 7.91 (d, <i>J</i> = 13.6 Hz, 1H), 7.72 (d, <i>J</i> = 8.5 Hz, 1H), 7.60 (s, 1H), 7.60−7.53 (m, 1H), 7.51−7.38 (m, 4H), 7.00−6.94 (m, 1H), 6.63 (d, <i>J</i> = 5.0 Hz, 1H), 3.96 (s, 6H), 3.59 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 517 (M + H<sup>+</sup>). HRMS calcd for C<sub>28</sub>H<sub>23</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> (M + H<sup>+</sup>), 517.1687; found, 517.1672. Analytical HPLC: 95.0%. <i>t</i><sub>R</sub> = 6.37.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-3-methyl-2-(4-(trifluoro-methyl)phenylamino)pyrimidin-4(3<i>H</i>)-one (<b>56</b>)</h3><div class="NLM_p last">By using 5 mL of the same solution of crude chloride <b>54</b>, and by following the procedure that was used to prepare <b>55</b>, we obtained <b>56</b> (12.8 mg) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 9.30 (s, 1H), 8.50 (d, <i>J</i> = 5.5 Hz, 1H), 8.15 (s, 1H), 7.93−7.82 (m, 3H), 7.75−7.68 (m, 3H), 7.54 (s, 1H), 7.46 (t, <i>J</i> = 8.5 Hz, 1H), 7.42 (s, 1H), 6.52 (d, <i>J</i> = 5.0 Hz, 1H), 3.96 (s, 6H), 3.61 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 567 (M + H<sup>+</sup>). HRMS calcd for C<sub>29</sub>H<sub>23</sub>F<sub>4</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>), 567.1655; found, 567.1638. Analytical HPLC: 95.5%. <i>t</i><sub>R</sub> = 6.96.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-(Benzyloxy)-2-bromopyridine (<b>57</b>)</h3><div class="NLM_p last">A suspension of sodium hydride (3.808 g, Aldrich 60%, 95.20 mmol) and DMF (25 mL) was cooled in an ice-water bath under nitrogen, and 2-bromo-5-hydroxypyridine (14.28 g, 82.07 mmol) was added via syringe as a solution in DMF (120 mL) over 35 min. The reaction was warmed to room temperature, was stirred under nitrogen for 40 min, and was then cooled again in an ice-water bath. Benzyl bromide (12.0 mL, 98 mmol) was added via syringe, and the reaction was warmed to room temperature and was stirred for 90 min. It was then poured into 2.5% aqueous HCl (400 mL), and the pH of the aqueous layer was raised to 14 with 5 N NaOH and was then lowered to 12 with concentrated HCl, which caused precipitation. The solution was decanted, and the decanted liquid was extracted with EtOAc (3 × 300 mL). Organic extracts were combined, were dried over sodium sulfate, were filtered, and were concentrated. The concentrate and the precipitate were combined, were diluted with EtOAc (∼400 mL), and were washed with water (3 × 150 mL). The organic phase was dried over sodium sulfate, was filtered, was concentrated, and was filtered through a 2in silica gel with EtOAc. The filtrate was concentrated and was dried under high vacuum to afford <b>57</b> (22.9 g). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.14 (d, <i>J</i> = 3.1 Hz, 1H), 7,43−7.35 (m, 6H), 7.16 (dd, <i>J</i> = 8.6, 3.1 Hz, 1H), 5.10 (s, 2H). MS (ES) <i>m</i>/<i>z</i>: 264 (Br79, M + H<sup>+</sup>), 266 (Br81, M + H<sup>+</sup>).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-(5-(Benzyloxy)pyridin-2-yl)acetic Acid (<b>58</b>)</h3><div class="NLM_p"><b>57</b> (22.9 g, 86.7 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (11.3 g, 9.78 mmol) were dissolved in THF (100 mL). Argon was bubbled through for 5 min, and then 2-<i>tert</i>-butoxy-2-oxoethylzinc chloride (199 mL, 0.5 M in Et<sub>2</sub>O, 99.5 mmol) was added via syringe. The flask was equipped with a reflux condensor and was placed in a preheated oil bath (60 °C) and was stirred under argon. After 4 h, more Pd(PPh<sub>3</sub>)<sub>4</sub> (0.62 g, 0.54 mmol) was added. Stirring was continued at reflux for 1 h, and then the reaction was cooled to room temperature and was quenched with 250 mL of a 1:1 solution of saturated ammonium chloride and saturated EDTA (disodium salt). The layers were separated, and the aqueous phase was extracted with EtOAc (200 mL). The organic extracts were combined, were dried over sodium sulfate, were filtered, and were concentrated. After the mixture sat at room temperature overnight, a precipitate formed, so the suspension was refiltered, and the filtrate was concentrated and was filtered through a 2in silica gel with 5:1 → 2:1 hexanes/EtOAc → EtOAc.</div><div class="NLM_p">The filtrate was concentrated, was dissolved in DCM (250 mL), and was cooled to 0 °C in an ice-water bath under argon. TFA (30 mL, 404 mmol) was added via syringe, and the reaction was allowed to warm to room temperature while being stirring overnight.</div><div class="NLM_p last">The next morning, an additional 30 mL of TFA was added, and stirring was continued at room temperature. After 5 h, the reaction was concentrated, was poured into 10% aqueous sodium carbonate (200 mL), and was diluted with DCM (150 mL). More 10% aqueous sodium carbonate (100 mL) was added, and the layers were separated. The aqueous layer was washed with DCM (2 × 150 mL), and the organic extracts were then extracted with 10% aqueous sodium carbonate (100 mL) and 1 N NaOH (50 mL). All aqueous phases and extractions were combined, and the pH was lowered to about 8 by concentrated HCl, which caused precipitation. This suspension was filtered, and the pH of the filtrate was lowered to about 4 by concentrated HCl, which caused more precipitation. This suspension was also filtered, and the solid was allowed to dry in the air for ∼3 days and was then dried under high vacuum at 60 °C to afford <b>58</b> (11.323 g, 57% over 3 steps). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO, δ): 12.50−12.21 (br s, 1H), 8.24 (d, <i>J</i> = 3.0 Hz, 1H), 7.48−7.30 (m, 6H), 7.27 (d, <i>J</i> = 8.5 Hz, 1H), 5.17 (s, 2H), 3.66 (s, 2H). MS (ES) <i>m</i>/<i>z</i>: 244 (M + H<sup>+</sup>).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 5-(5-(Benzyloxy)pyridin-2-yl)-3-methyl-2-(methylthio)pyrimidin-4(3<i>H</i>)-one (<b>60</b>)</h3><div class="NLM_p last">Acid <b>58</b> (11.323 g, 46.55 mmol) was suspended in DCM (200 mL), and DMF (0.25 mL) was added. Then, (COCl)<sub>2</sub> (4.5 mL, 52 mmol) was added dropwise via syringe over 25 min, which caused vigorous gas evolution. The reaction was stirred at room temperature for about 10 min, and salt <b>59</b> (15.71 g, 54.74 mmol) was added. The suspension was cooled to 0 °C, triethylamine (23.0 mL, 165 mmol) was added via syringe, and DCM (3.5 mL) was added to rinse the sides of the flask. The solution was allowed to warm to room temperature and was stirred for 41 h. The reaction was then quenched with water (175 mL), and the layers were separated. The aqueous phase was extracted with DCM (2 × 150 mL), and the organic extracts and phases were combined, were dried over MgSO<sub>4</sub>, were filtered, were concentrated, and were filtered through silica gel (∼2 in) with DCM → 100:1 → 10:1 DCM/MeOH. The fractions with product were collected, were concentrated, and were filtered again through silica gel with DCM → 100:1 → 10:1 DCM/MeOH. We repeated this process one last time by using an eluent system of DCM → 100:1 → 50:1 DCM/MeoH. Fractions with product were collected and concentrated, and the solid was washed with hexanes, Et<sub>2</sub>O, and EtOAc and was filtered. The solid was collected and was set aside as batch no. 1. The filtrate was collected, concentrated, and refiltered, and the solid was washed with DCM. This filtrate was purified on silica gel (∼2 in, DCM → 50:1 → 10:1 → 5:1 DCM/MeOH), and the fractions with product were combined with the solid that was set aside earlier (batch no. 1), were concentrated, and were dried under high vacuum to afford <b>60</b> (5.21 g, 69% purity, 23% yield). For characterization purposes, a small amount of <b>60</b> (prepared separately) was washed with MeOH and acetone and was dried in vacuo. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.69 (s, 1H), 8.41 (d, <i>J</i> = 2.8 Hz, 1H), 8.32 (d, <i>J</i> = 8.9 Hz, 1H), 7.48−7.28 (m, 6H), 5.15 (s, 2H), 3.62 (s, 3H), 2.64 (s, 3H). MS (ES) <i>m</i>/<i>z</i>: 340 (M + H<sup>+</sup>).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2-(4-Fluorophenylamino)-5-(5-(6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yloxy)-pyridin-2-yl)-3-methylpyrimidin-4(3<i>H</i>)-one (<b>62</b>)</h3><div class="NLM_p">A 100 mL round-bottomed flask was charged with <b>60</b> (1.05 g, 3.09 mmol) and 1,4-dioxane (25 mL). Then, 4-fluoroaniline (1.5 mL, 16 mmol) and concentrated HCl (0.04 mL, 1 mmol) were added, and the flask was fit with a reflux condenser, was put in a preheated oil bath (120−125 °C), and was stirred under nitrogen. After 1 day, 1.5 mL of 4-fluoroaniline was added, and stirring was continued at reflux for 1 week total. The reaction was then cooled to room temperature, was concentrated, and was filtered through 2 in of silica gel with DCM → 20:1 DCM/MeOH. Fractions with product were collected, were concentrated, and were taken to the next step.</div><div class="NLM_p">The material was diluted with DCM (20 mL) and BBr<sub>3</sub> (4.0 mL, 1.0 M in DCM, 4.0 mmol) was added via syringe, which caused precipitation to occur. The flask was placed in a water bath, was stirred under argon for 45 min, and was then quenched with saturated NaHCO<sub>3</sub> (40 mL). The aqueous phase was extracted with 10:1 DCM/MeOH (4 × 100 mL, 50 mL) and 4:1 DCM/MeOH (2 × 150 mL, 50 mL, 150 mL), and the organic extracts were combined, were dried over sodium sulfate and magnesium sulfate, were filtered, and were concentrated to afford phenol <b>61</b> (1.157 g, 53% purity, 63% yield over 2 steps).</div><div class="NLM_p">Phenol <b>61</b> (574 mg, 1.84 mmol), chloride <b>16</b> (458.9 mg, 1.36 mmol), and DMAP (20.9 mg, 0.18 mmol) were dissolved in pyridine (4.6 mL) and 1,4-dioxane (2.3 mL) in a 50 mL round-bottomed flask. The flask was fit with a reflux condenser, was placed in a preheated oil bath (130−135 °C), and was stirred under nitrogen for 5 h.</div><div class="NLM_p last">The reaction was cooled to room temperature, was poured into 1 N NaOH (17 mL), and was extracted with DCM (4 × 30 mL, 2 × 50 mL). The organic extracts were combined, were dried over magnesium sulfate, were filtered, were concentrated, and were filtered through silica gel (2 in, 10:1 → 5:1 DCM/MeOH → 5:1 DCM/2 N ammonia in MeOH). The filtrate was concentrated and was purified on silica gel (20:1 → 10:1 DCM/2 N ammonia in MeOH). It was repurified on silica gel (10:1 DCM/2 N ammonia in MeOH) to afford <b>62</b> (106.8 mg, 13%) as a light-orange solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.75 (s, 1H), 8.54−8.51 (m, 2H), 8.47 (d, <i>J</i> = 8.8 Hz, 1H), 7.55 (s, 1H), 7.55−7.51 (m, 1H), 7.50−7.45 (m, 3H), 7.13 (t, <i>J</i> = 8.6 Hz, 2H), 6.54 (d, <i>J</i> = 5.3 Hz, 1H), 6.46 (s, 1H), 4.29 (t, <i>J</i> = 6.7 Hz, 2H), 4.04 (s, 3H), 3.75−3.72 (m, 4H), 3.71 (s, 3H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.53−2.47 (m, 4H), 2.15 (qn, <i>J</i> = 6.8 Hz, 2H). MS (ES) <i>m</i>/<i>z</i>: 613 (M + H<sup>+</sup>). Anal. Calcd for (C<sub>33</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>5</sub>·0.4CH<sub>2</sub>Cl<sub>2</sub>): C, H, N.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> c-Met and KDR Enzyme Assays</h3><div class="NLM_p last"><i>K</i><sub>i</sub> values for specific compounds were derived from IC<sub>50</sub> measurements versus the c-Met and KDR kinases that were determined by the use of homogeneous time-resolved fluorescence (HTRF) assays, as previously described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> We tested molecules in a 10-point serial dilution by using an ATP concentration of two-thirds the <i>K</i><sub>m</sub> value that was determined experimentally and was calculated by the use of the Eadie−Hofstee and Lineweaver−Burke methods.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Cell-Based Assays</h3><div class="NLM_p last">According to ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>, PC3 and CT26 cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD). Cells were grown as monolayers by the use of standard cell culture conditions. IC<sub>50</sub> measurements of compound activities on HGF-mediated c-Met autophosphorylation were determined in serum-starved PC3 (human) or CT26 (mouse) cells by the use of a quantitative electrochemiluminescent immunoassay. Cells were plated at a density of 20 000 cells/well in 96-well plates. After plating (24 h), cells were starved in media that contained 0.1% BSA for 18 to 20 h. Cells were then treated with a 10-point serial dilution of each tested compound for 1 h at 37 °C, followed by stimulation with optimal concentrations of recombinant human HGF for 10 min at 37 °C. Cells were washed once with PBS and were lysed (1% Triton X-100, 50 mM Tris pH 8.0, 100 mM NaCl, 300 μM Na<sub>3</sub>OV<sub>4</sub> and protease inhibitors). Cell lysates were incubated with a biotin-labeled goat-anti-c-Met antibody (BAF358 for human and c-Met and BAF527 for mouse, R&D Systems, Minneapolis, MN) for capture, followed by a mouse antiphosphotyrosine antibody 4G10 (Upstate, Charlottesville, VA) and a BV-tag-labeled antimouse IgG (BioVeris, Gaithersburg, MD) as the detection antibody. Levels of c-Met phosphorylation were then measured on a BioVeris M-series instrument. The IC<sub>50</sub> values are calculated by the use of the Xlfit4-parameter equation.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Pharmacodynamic Assay</h3><div class="NLM_p last">According to ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>, the effect of <b>22</b>, <b>51</b>, and <b>62</b> on HGF-mediated c-Met phosphorylation in vivo was evaluated in the liver of female BALB/c mice. Compounds were administered by either PO or IP at 10, 30, or 100 mg/kg. After a single dose (2 h), 12 μg human HGF was injected iv to phosphorylate c-Met in the liver. After HGF injection (5 min), the livers were harvested, and levels of phosphorylated c-Met were determined by a quantitative electrochemiluminescent assay. c-Met phosphorylation that was measured in livers from mice that were injected with BSA and were treated with vehicle served as a negative control and indicated the background level. Livers from mice that were injected with HGF and were treated with vehicle established the maximal level of c-Met phosphorylation in the liver. Statistical significance was evaluated by analysis of variance (ANOVA), followed by the Bonferroni/Dunn post hoc test by the use of StatView software v5.0.1. Data represent the mean (<i>n</i> = 3) ± standard deviation.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Crystallography</h3><div class="NLM_p last">Crystals of c-Met were grown as previously described.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Compounds were dissolved in DMSO to a final concentration of 20 mM and were then mixed with c-Met protein to a final DMSO concentration of 4% prior to crystallization. Crystals were grown from 12% PEG 6K, 1.0 M LiCl<sub>2</sub>, and 0.1 M sodium citrate, pH 5.0. Large crystals that were suitable for data collection were obtained by microseeding. Data were collected on a FRE that was equipped with an RaxisII++ and were scaled by the use of the Denzo/Scalepack programs. We solved the structures by molecular replacement by using the published c-Met structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1W">1R1W</a> as a search model and the program AMORE. The structures were built and refined by the use of COOT and REFMAC. All Figures were prepared by the use of PyMOL.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69"><a href="/doi/suppl/10.1021/jm8006189">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analyses and HPLC methods for key compounds and X-ray data for <b>7</b> and <b>50</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8006189/suppl_file/jm8006189_si_001.pdf">jm8006189_si_001.pdf (160.64 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm8006189" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noel D. D’Angelo</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#91f5f0fff6f4fdfed1f0fcf6f4ffbff2fefc"><span class="__cf_email__" data-cfemail="b0d4d1ded7d5dcdff0d1ddd7d5de9ed3dfdd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven F. Bellon</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shon K. Booker</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuan Cheng</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Coxon</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia Dominguez</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ingrid Fellows</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas Hoffman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Randall Hungate</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paula Kaplan-Lefko</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew R. Lee</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chun Li</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longbin Liu</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Rainbeau</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul J. Reider</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Rex</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron Siegmund</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yaxiong Sun</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew S. Tasker</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Xi</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shimin Xu</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yajing Yang</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihong Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teresa L. Burgess</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Dussault</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tae-Seong Kim</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jean-Christophe Harmange, Ron Hermenau, and Mark Norman for their assistance in preparing this manuscript. We also thank Howie Yu for his assistance in retrieving and compiling analytical data.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Longati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span> </span><span class="NLM_article-title">Receptor Tyrosine Kinases as Therapeutic Targets: The Model of the Met Oncogene</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.2174%2F1389450013348920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=11465538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVCqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=41-55&author=P.+Longatiauthor=P.+M.+Comoglioauthor=A.+Bardelli&title=Receptor+Tyrosine+Kinases+as+Therapeutic+Targets%3A+The+Model+of+the+Met+Oncogene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene</span></div><div class="casAuthors">Longati, Paola; Comoglio, Paolo M.; Bardelli, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-55</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 104 refs.  Control of cell growth and differentiation occurs via extracellular signals known as growth factors.  Growth factors are high affinity ligands for transmembrane receptors belonging to the family of receptor tyrosine kinases (RTKs).  A no. of genetic evidences have implicated RTKs in human diseases including developmental disorders and cancer.  For instance, germline missense mutations involving the Ret receptor are found in patients affected by multiple endocrine neoplasia types 2A and 2B (MEN2A and MEN2B) or familial medullary thyroid carcinomas.  Somatic mutations in the Kit receptor are found in mastocytomas and in gastrointestinal tumors.  Germline and sporadic mutations of the Met receptor have been described in kidney and hepatocellular carcinomas.  Overexpression of the HER-2/neu receptor in breast cancer has been assocd. with tumor progression.  The enzymic activity of RTKs is strictly regulated and is usually inhibited under basal conditions.  Receptor activation triggers a biochem. signaling cascade inside the cytoplasm, named signal transduction, which is subverted during the malignant transformation of cells.  Signal transduction by RTKs is a multistep process which includes: (i) Ligand binding and receptor dimerization, (ii) receptor phosphorylation on tyrosine residues; (iii) recruitment to the receptor and activation of cytoplasmic signaling mols. that transmit signals to the nucleus.  Each of the steps involved in this process can potentially be targeted to block the aberrant properties of tyrosine kinase receptors.  By using the MET oncogene as a model this review focuses on the strategies that can be applied to therapeutically target RTKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmKpFV7qgmVLVg90H21EOLACvtfcHk0lie0JU5TrVnIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVCqsrw%253D&md5=f83d61a5d349dad104758e87e6387ee8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1389450013348920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450013348920%26sid%3Dliteratum%253Aachs%26aulast%3DLongati%26aufirst%3DP.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DBardelli%26aufirst%3DA.%26atitle%3DReceptor%2520Tyrosine%2520Kinases%2520as%2520Therapeutic%2520Targets%253A%2520The%2520Model%2520of%2520the%2520Met%2520Oncogene%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2001%26volume%3D2%26spage%3D41%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Haddad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, C. P.</span><span> </span><span class="NLM_article-title">Hepatocyte Growth Factor Expression in Human Cancer and Therapy with Specific Inhibitors</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4243</span><span class="NLM_x">–</span> <span class="NLM_lpage">4252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=11908677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1amtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=4243-4252&author=R.+Haddadauthor=K.+E.+Lipsonauthor=C.+P.+Webb&title=Hepatocyte+Growth+Factor+Expression+in+Human+Cancer+and+Therapy+with+Specific+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors</span></div><div class="casAuthors">Haddad, Ramsi; Lipson, Kenneth E.; Webb, Craig P.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6B</span>),
    <span class="NLM_cas:pages">4243-4252</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">A review.  Hepatocyte growth factor/Scatter Factor (HGF/SF) mediated stimulation of the Met receptor tyrosine kinase results in pleiotropic cellular effects including proliferation, morphogenesis, motility and invasion.  In vivo, HGF/SF-Met activation has been shown to participate in tumorigenesis, angiogenesis and metastasis.  Coupled with accumulating evidence that aberrant HGF/SF-Met expression is frequently obsd. in a variety of human tumors, often in assocn. with progressive disease, these data present HGF/SF-Met as an attractive target for therapeutic intervention in human cancer.  In this review, we will present the most compelling evidence suggesting a key role for HGF/SF-Met signaling in tumorigenesis, and discuss several possible therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe6OmgwbFpTbVg90H21EOLACvtfcHk0ligZKc6osqs2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1amtL4%253D&md5=04bb293ee488f6371aa8dd5044cdc89b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaddad%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DWebb%26aufirst%3DC.%2BP.%26atitle%3DHepatocyte%2520Growth%2520Factor%2520Expression%2520in%2520Human%2520Cancer%2520and%2520Therapy%2520with%2520Specific%2520Inhibitors%26jtitle%3DAnticancer%2520Res.%26date%3D2001%26volume%3D21%26spage%3D4243%26epage%3D4252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Maulik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kijima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgi, R.</span><span> </span><span class="NLM_article-title">Role of the Hepatocyte Growth Factor Receptor, c-Met, in Oncogenesis and Potential for Therapeutic Inhibition</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1016%2FS1359-6101%2801%2900029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=11750879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1ahuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=41-59&author=G.+Maulikauthor=A.+Shrikhandeauthor=T.+Kijimaauthor=P.+C.+Maauthor=P.+T.+Morrisonauthor=R.+Salgi&title=Role+of+the+Hepatocyte+Growth+Factor+Receptor%2C+c-Met%2C+in+Oncogenesis+and+Potential+for+Therapeutic+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition</span></div><div class="casAuthors">Maulik, Gautam; Shrikhande, Amol; Kijima, Takashi; Ma, Patrick C.; Morrison, Paul T.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-59</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review is given.  Receptor tyrosine kinases have become important therapeutic targets for anti-neoplastic molecularly targeted therapies.  C-Met is a receptor tyrosine kinase shown to be over-expressed and mutated in a variety of malignancies.  Stimulation of c-Met via its ligand hepatocyte growth factor also known as scatter factor (HGF/SF), leads to a plethora of biol. and biochem. effects in the cell.  There has been considerable knowledge gained on the role of c-Met-HGF/SF axis in normal and malignant cells.  This review summarizes the structure of c-Met and HGF/SF and their family members.  Since there are known mutations of c-Met in solid tumors, particularly in papillary renal cell carcinoma, we have summarized the various mutations and over-expression of c-Met known thus far.  Stimulation of c-Met can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventual metastasis.  The biol. functions altered by c-Met are quite unique and described in detail.  Along with biol. functions, various signal transduction pathways, including the cytoskeleton are altered with the activation of c-Met-HGF/SF loop.  We have recently shown the phosphorylation of focal adhesion proteins, such as paxillin and p125FAK in response to c-Met stimulation in lung cancer cells, and this is detailed here.  Finally, c-Met when mutated or over-expressed in malignant cells serves as an important therapeutic target and the most recent data in terms of inhibition of c-Met and downstream signal transduction pathways is summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2mu2QMKr_7Vg90H21EOLACvtfcHk0ligZKc6osqs2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1ahuro%253D&md5=aead14efa103c522ef374b0a16e51b35</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1359-6101%2801%2900029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6101%252801%252900029-6%26sid%3Dliteratum%253Aachs%26aulast%3DMaulik%26aufirst%3DG.%26aulast%3DShrikhande%26aufirst%3DA.%26aulast%3DKijima%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DMorrison%26aufirst%3DP.%2BT.%26aulast%3DSalgi%26aufirst%3DR.%26atitle%3DRole%2520of%2520the%2520Hepatocyte%2520Growth%2520Factor%2520Receptor%252C%2520c-Met%252C%2520in%2520Oncogenesis%2520and%2520Potential%2520for%2520Therapeutic%2520Inhibition%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2002%26volume%3D13%26spage%3D41%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Date, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">Acquisition of Invasive Phenotype in Gallbladder Cancer Cells Via Mutual Interaction of Stromal Fibroblasts and Cancer Cells as Mediated by Hepatocyte Growth Factor</span> <span class="citation_source-journal">Jpn. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1111%2Fj.1349-7006.1996.tb00281.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=8698619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK28Xks1ejt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=702-710&author=K.+Matsumotoauthor=K.+Dateauthor=H.+Shimuraauthor=T.+Nakamura&title=Acquisition+of+Invasive+Phenotype+in+Gallbladder+Cancer+Cells+Via+Mutual+Interaction+of+Stromal+Fibroblasts+and+Cancer+Cells+as+Mediated+by+Hepatocyte+Growth+Factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor</span></div><div class="casAuthors">Matsumoto, Kunio; Date, Kazuhiko; Shimura, Hideo; Nakamura, Toshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-710</span>CODEN:
                <span class="NLM_cas:coden">JJCREP</span>;
        ISSN:<span class="NLM_cas:issn">0910-5050</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">Growth and motility of carcinoma cells are regulated through their interactions with host stromal cells, i.e., tumor-stromal interactions.  Hepatocyte growth factor (HGF), a ligand for c-Met tyrosine kinase, is a stromal-derived regulator of growth, motility, and morphogenesis.  HGF stimulated proliferation and motility of GB-d1 gallbladder carcinoma cells from a patient with gallbladder cancer.  HGF induced in vitro invasion of GB-d1 cells into a collagen gel matrix, and this potent, invasive effect was not seen with epidermal growth factor, transforming growth factor-β1, basic fibroblast growth factor, or platelet-derived growth factor.  Although GB-d1 did not produce HGF, the cells did not produce a factor which enhances HGF prodn. in human skin fibroblasts, and this factor proved to be interleukin-1β (IL-1β).  When GB-d1 cells were co-cultured with fibroblasts such that a collagen gel matrix was layered between the GB-d1 cells and fibroblasts, GB-d1 cells invaded the gel, but invasion of the cells in the co-culture system was inhibited by antibodies against HGF and partially inhibited by antibodies against IL-1β.  Thus, GB-d1 cell-derived IL-1β stimulates HGF prodn. in stromal fibroblasts and HGF up-regulated in the fibroblasts induces invasion of GB-d1 cells.  The looped interaction of carcinoma cells and stromal fibroblasts mediated by HGF and a HGF-inducer such as IL-1β may be one mechanism which would explain the acquisition of malignant phenotype through tumor-stromal interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZBGl7W8WPybVg90H21EOLACvtfcHk0ligZKc6osqs2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1ejt74%253D&md5=16a94e67d95b86d35983d5db4be98ab0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.1996.tb00281.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.1996.tb00281.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DDate%26aufirst%3DK.%26aulast%3DShimura%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DAcquisition%2520of%2520Invasive%2520Phenotype%2520in%2520Gallbladder%2520Cancer%2520Cells%2520Via%2520Mutual%2520Interaction%2520of%2520Stromal%2520Fibroblasts%2520and%2520Cancer%2520Cells%2520as%2520Mediated%2520by%2520Hepatocyte%2520Growth%2520Factor%26jtitle%3DJpn.%2520J.%2520Cancer%2520Res.%26date%3D1996%26volume%3D87%26spage%3D702%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Jeffers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Enhanced Tumorigenicity and Invasion-Metastasis by Hepatocyte Growth Factor/Scatter Factor-Met Signaling in Human Cells Concomitant with Induction of the Urokinase Proteolysis Network</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=8622656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK28XhtFOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=1115-1125&author=M.+Jeffersauthor=S.+Rongauthor=G.+F.+Vande+Woude&title=Enhanced+Tumorigenicity+and+Invasion-Metastasis+by+Hepatocyte+Growth+Factor%2FScatter+Factor-Met+Signaling+in+Human+Cells+Concomitant+with+Induction+of+the+Urokinase+Proteolysis+Network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signaling in human cells concomitant with induction of the urokinase proteolysis network</span></div><div class="casAuthors">Jeffers, Michael; Rong, Sing; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1115-25</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatocyte growth factor/scatter factor (HGF/SF) is a pleiotropic effector of cells expressing the Met tyrosine kinase receptor.  Although HGF/SF is synthesized by mesenchymal cells and acts predominantly on epithelial cells, the authors have recently demonstrated that human sarcoma cell lines often inappropriately express high levels of Met and respond mitogenically to HGF/SF.  In the present report, the authors show that HGF/SF-Met signaling in the human leiomyosarcoma cell line SK-LMS-1 enhances its in vivo tumorigenicity, an effect for which the mitogenicity of this signaling pathway is likely to play a role.  In addn., the authors found that HGF/SF-Met signaling dramatically induces the in vitro invasiveness and in vivo metastatic potential of these cells.  The authors have studied the mol. basis by which HGF/SF-Met signaling mediates the invasive phenotype.  A strong correlation has previously been demonstrated between the activation of the urokinase plasminogen activator (uPA) proteolysis network and the acquisition of the invasive-metastatic phenotype, and the authors show here that HGF/SF-Met signaling significantly increases the protein levels of both uPA and its cellular receptor in SK-LMS-1 cells.  This results in elevated levels of cell-assocd. uPA and enhanced plasmin-generating ability by these cells.  These studies couple HGF/SF-Met signaling to the activation of proteases that mediate dissoln. of the extracellular matrix-basement membrane, an important property for cellular invasion-metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZbXnGjTq6LVg90H21EOLACvtfcHk0lh1l4SE3Fnw2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFOls7k%253D&md5=1c663d7eead27a58e362e459860aecb7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeffers%26aufirst%3DM.%26aulast%3DRong%26aufirst%3DS.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DEnhanced%2520Tumorigenicity%2520and%2520Invasion-Metastasis%2520by%2520Hepatocyte%2520Growth%2520Factor%252FScatter%2520Factor-Met%2520Signaling%2520in%2520Human%2520Cells%2520Concomitant%2520with%2520Induction%2520of%2520the%2520Urokinase%2520Proteolysis%2520Network%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D1115%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Met, Metastasis, Motility and More</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1038%2Fnrm1261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=14685170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=915-925&author=C.+Birchmeierauthor=W.+Birchmeierauthor=E.+Gherardiauthor=G.+F.+Vande+Woude&title=Met%2C+Metastasis%2C+Motility+and+More"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Met, metastasis, motility and more</span></div><div class="casAuthors">Birchmeier, Carmen; Birhcmeier, Walter; Gherardi, Ermanno; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocyte growth factor. scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates.  In spite of this, Met uses mols. such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster - for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG_-6XRpZ-sLVg90H21EOLACvtfcHk0lh1l4SE3Fnw2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D&md5=ff5a02c73415784480c628fe65299a81</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1261%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DMet%252C%2520Metastasis%252C%2520Motility%2520and%2520More%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D915%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Corso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">Cancer Therapy: Can the Challenge Be MET?</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=284-292&author=S.+Corsoauthor=P.+M.+Comoglioauthor=S.+Giordano&title=Cancer+Therapy%3A+Can+the+Challenge+Be+MET%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorso%26aufirst%3DS.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DCancer%2520Therapy%253A%2520Can%2520the%2520Challenge%2520Be%2520MET%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D284%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maulik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">C-Met: Structure, Functions, and Potential for Therapeutic Inhibition</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1023%2FA%3A1023768811842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=12884908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslyiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=309-325&author=P.+C.+Maauthor=G.+Maulikauthor=J.+Christensenauthor=R.+Salgia&title=C-Met%3A+Structure%2C+Functions%2C+and+Potential+for+Therapeutic+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met: Structure, functions and potential for therapeutic inhibition</span></div><div class="casAuthors">Ma, Patrick C.; Maulik, Gautam; Christensen, James; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-325</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Studies on signal transduction pathways have generated various promising mol. targets for therapeutic inhibition in cancer therapy.  Receptor tyrosine kinases represent an important class of such therapeutic targets.  C-Met is a receptor tyrosine kinase that has been shown to be overexpressed and/or mutated in a variety of malignancies.  A no. of c-Met activating mutations, many of which are located in the tyrosine kinase domain, have been detected in various solid tumors and have been implicated in invasion and metastasis of tumor cells.  It is known that stimulation of c-Met via its natural ligand, hepatocyte growth factor (also known as scatter factor, HGF/SF) results in a plethora of biol. and biochem. effects in the cell.  Activation of c-Met signaling can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventual metastasis.  In this review, the role of c-Met dysregulation in tumor progression and metastasis is discussed in detail with particular emphasis on c-Met mutations.  Moreover, we summarize current knowledge on various pathways of c-Met signal transduction, highlighting the central role in the cytoskeletal functions.  In this summary is included recent data in our lab. indicating that phosphorylation of focal adhesion proteins, such as paxillin, p125FAK, and PYK2, occurs in response to c-Met stimulation in lung cancer cells.  Most importantly, current data on c-Met suggest that when mutated or overexpressed in malignant cells, c-Met would serve as an important therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9rIdb5Ao4a7Vg90H21EOLACvtfcHk0lh1l4SE3Fnw2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslyiurY%253D&md5=7b7bf60da872071a39ce313efd32fd1f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023768811842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023768811842%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DMaulik%26aufirst%3DG.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DC-Met%253A%2520Structure%252C%2520Functions%252C%2520and%2520Potential%2520for%2520Therapeutic%2520Inhibition%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2003%26volume%3D22%26spage%3D309%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met as a Target for Human Cancer and Characterization of Inhibitors for Therapeutic Intervention</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1016%2Fj.canlet.2004.09.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=15922853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2005&pages=1-26&author=J.+G.+Christensenauthor=J.+Burrowsauthor=R.+Salgia&title=c-Met+as+a+Target+for+Human+Cancer+and+Characterization+of+Inhibitors+for+Therapeutic+Intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span></div><div class="casAuthors">Christensen, James G.; Burrows, Jon; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinase (RTK) targeted agents such as trastuzumab, Imatinib, bevacizumab, and gefitinib inhibitors have illustrated the utility of targeting this protein class for treatment of selected cancers.  A unique member of the RTK family, c-Met, also represents an intriguing target for cancer therapy that is yet to be explored in a clin. setting.  The proto-oncogene, c-Met, encodes the high-affinity receptor for hepatocyte growth factor (HGF) or scatter factor (SF).  C-Met and HGF are each required for normal mammalian development and have been shown to be particularly important in cell migration, morphogenic differentiation, and organization of three-dimensional tubular structures (e.g. renal tubular cells, gland formation, etc.) as well as cell growth and angiogenesis.  Both c-Met and HGF have been shown to be deregulated in and to correlate with poor prognosis in a no. of major human cancers.  New data describing the constitutive phosphorylation of c-Met in a no. of human tumors is presented here along with a variety of mechanisms by which c-Met can become activated, including mutation and gene amplification.  In support of the clin. data implicating c-Met activation in the pathogenesis of human cancers, introduction of c-Met and HGF (or mutant c-Met) into cells conferred the properties of motility, invasiveness, and tumorigenicity to the transformed cells.  Conversely, the inhibition of c-Met with a variety of receptor antagonists inhibited the motility, invasiveness, and tumorigenicity of human tumor cell lines.  Consistent with this observation, small-mol. inhibitors of c-Met were developed that antagonized c-Met/HGF-dependent phenotypes and tumor growth in mouse models.  This review will address the potential for development of c-Met inhibitors for treatment of human cancers with particular emphasis on recent findings with small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTbSn0ouMILVg90H21EOLACvtfcHk0ljnHMLBapJKpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D&md5=106b145cbf442e9fec9667817697658d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.044%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%2520as%2520a%2520Target%2520for%2520Human%2520Cancer%2520and%2520Characterization%2520of%2520Inhibitors%2520for%2520Therapeutic%2520Intervention%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D225%26spage%3D1%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span> </span><span class="NLM_article-title">HGF- and c-Met-Targeted Drugs: Hopes, Challenges, and their Future in Cancer Therapy</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1358%2Fdof.2006.031.09.1026670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=819-825&author=I.+Dussaultauthor=P.+Kaplan-Lefkoauthor=T.+Junauthor=A.+Coxonauthor=T.+L.+Burgess&title=HGF-+and+c-Met-Targeted+Drugs%3A+Hopes%2C+Challenges%2C+and+their+Future+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HGF- and c-Met-targeted drugs: hopes, challenges and their future in cancer therapy</span></div><div class="casAuthors">Dussault, Isabelle; Kaplan-Lefko, Paula; Jun, Tani; Coxon, Angela; Burgess, Teresa L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">819-825</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Cancer remains a formidable disease, with 1,372,910 new cases and 570,280 deaths in the United States alone in 2005 (http://www.cancer.org/docroot/stt/stt_0.asp).  Many types of cancers are still difficult to treat using conventional therapies.  For example, chemotherapeutic drugs are widely used, but their side effects can be devastating to the quality of life of patients and their efficacy is limited in late-stage cancers.  Therefore, efforts have been undertaken for the past several years to develop targeted drugs in the hope of improving efficacy and tolerability.  As these new drugs are starting to make their mark in the clinic, what can we expect in the future with anticancer drugs.  Already we are seeing the benefits of targeted therapies, different drug modalities, including antibodies, and more convenient forms of drug delivery.  Moreover, much attention is now being placed not only on attacking the cancer cells themselves, but also on intervening in the microenvironment in which they reside.  In this review, we will discuss the promise behind novel targeted therapies under development to inhibit signaling via the oncogenic HGF/c-Met pathway.  HGF and c-Met are exciting therapeutic targets that play important roles both directly in tumor cells and in the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1H3RCrcur7Vg90H21EOLACvtfcHk0ljnHMLBapJKpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKnuw%253D%253D&md5=014dca5910768abf2478b0c7a6a29169</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.09.1026670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.09.1026670%26sid%3Dliteratum%253Aachs%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DJun%26aufirst%3DT.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26atitle%3DHGF-%2520and%2520c-Met-Targeted%2520Drugs%253A%2520Hopes%252C%2520Challenges%252C%2520and%2520their%2520Future%2520in%2520Cancer%2520Therapy%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D819%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Cao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oskarsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kort, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woude, G. F. V.</span><span> </span><span class="NLM_article-title">Neutralizing Monoclonal Antibodies to Hepatocyte Growth Factor/Scatter Factor (HGF/SF) Display Antitumor Activity in Animal Models</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">7443</span><span class="NLM_x">–</span> <span class="NLM_lpage">7448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=7443-7448&author=B.+Caoauthor=Y.+Suauthor=M.+Oskarssonauthor=P.+Zhaoauthor=E.+J.+Kortauthor=R.+J.+Fisherauthor=L.+M.+Wangauthor=G.+F.+V.+Woude&title=Neutralizing+Monoclonal+Antibodies+to+Hepatocyte+Growth+Factor%2FScatter+Factor+%28HGF%2FSF%29+Display+Antitumor+Activity+in+Animal+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DOskarsson%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DKort%26aufirst%3DE.%2BJ.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DWoude%26aufirst%3DG.%2BF.%2BV.%26atitle%3DNeutralizing%2520Monoclonal%2520Antibodies%2520to%2520Hepatocyte%2520Growth%2520Factor%252FScatter%2520Factor%2520%2528HGF%252FSF%2529%2520Display%2520Antitumor%2520Activity%2520in%2520Animal%2520Models%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D7443%26epage%3D7448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kim, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salhotra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laterra, J.</span><span> </span><span class="NLM_article-title">Systemic Anti-Hepatocyte Growth Factor Monoclonal Antibody Therapy Induces the Regression of Intracranial Glioma Xenografts</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1158%2F1078-0432.CCR-05-1793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=16489086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFaltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1292-1298&author=K.+J.+Kimauthor=L.+Wangauthor=Y.+C.+Suauthor=G.+Y.+Gillespieauthor=A.+Salhotraauthor=B.+Lalauthor=J.+Laterra&title=Systemic+Anti-Hepatocyte+Growth+Factor+Monoclonal+Antibody+Therapy+Induces+the+Regression+of+Intracranial+Glioma+Xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic Anti-Hepatocyte Growth Factor Monoclonal Antibody Therapy Induces the Regression of Intracranial Glioma Xenografts</span></div><div class="casAuthors">Kim, K. Jin; Wang, Lihong; Su, Yi-Chi; Gillespie, G. Yancey; Salhotra, Amandeep; Lal, Bachchu; Laterra, John</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1292-1298</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Hepatocyte growth factor (HGF) and its receptor Met are involved in the initiation, progression, and metastasis of numerous systemic and central nervous system tumors.  Thus, an anti-HGF monoclonal antibody (mAb) capable of blocking the HGF-Met interaction could have broad applicability in cancer therapy.  Exptl. Design: An anti-HGF mAb L2G7 that blocks binding of HGF to Met was generated by hybridoma technol., and its ability to inhibit the various biol. activities of HGF was measured by in vitro assays.  The ability of L2G7 to inhibit the growth of tumors was detd. by establishing s.c. and intracranial xenografts of human U87 and U118 glioma cell lines in nude mice, and treatment with 100 μg of L2G7 or control given i.p. twice per wk.  RESULTS: MAb L2G7 strongly inhibited all biol. activities of HGF measured in vitro, including cell proliferation, cell scattering, and endothelial tubule formation.  Treatment with L2G7 completely inhibited the growth of established s.c. xenografts in nude mice.  Moreover, systemic administration of L2G7 from day 5 induced the regression of intracranial U87 xenografts and dramatically prolonged the survival of tumor-bearing mice from a median of 39 to >90 days.  L2G7 treatment of large intracranial tumors (av. tumor size, 26.7 mm3) from day 18 induced substantial tumor regression (control group, 134.3 mm3; L2G7 treated group, 11.7 mm3) by day 29 and again prolonged animal survival.  CONCLUSIONS: These findings show that blocking the HGF-Met interaction with systemically given anti-HGF mAb can have profound antitumor effects even within the central nervous system, a site previously believed to be resistant to systemic antibody-based therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyA1OCh4M04bVg90H21EOLACvtfcHk0ljnHMLBapJKpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFaltbs%253D&md5=4e1157723ff017d2f51f5864c5eb06ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1793%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DY.%2BC.%26aulast%3DGillespie%26aufirst%3DG.%2BY.%26aulast%3DSalhotra%26aufirst%3DA.%26aulast%3DLal%26aufirst%3DB.%26aulast%3DLaterra%26aufirst%3DJ.%26atitle%3DSystemic%2520Anti-Hepatocyte%2520Growth%2520Factor%2520Monoclonal%2520Antibody%2520Therapy%2520Induces%2520the%2520Regression%2520of%2520Intracranial%2520Glioma%2520Xenografts%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1292%26epage%3D1298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDorman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R.</span><span> </span><span class="NLM_article-title">Fully Human Monoclonal Antibodies to Hepatocyte Growth Factor with Therapeutic Potential Against Hepatocyte Growth Factor/c-Met-Dependent Human Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1729</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1721-1729&author=T.+Burgessauthor=A.+Coxonauthor=S.+Meyerauthor=J.+Sunauthor=K.+Rexauthor=T.+Tsurudaauthor=Q.+Chenauthor=S.+Y.+Hoauthor=L.+Liauthor=S.+Kaufmanauthor=K.+McDormanauthor=R.+C.+Cattleyauthor=J.+Sunauthor=G.+Elliotauthor=K.+Zhangauthor=X.+Fengauthor=X.+C.+Jiaauthor=L.+Greenauthor=R.+Radinskyauthor=R.+Kendall&title=Fully+Human+Monoclonal+Antibodies+to+Hepatocyte+Growth+Factor+with+Therapeutic+Potential+Against+Hepatocyte+Growth+Factor%2Fc-Met-Dependent+Human+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DTsuruda%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DMcDorman%26aufirst%3DK.%26aulast%3DCattley%26aufirst%3DR.%2BC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DElliot%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DX.%2BC.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DRadinsky%26aufirst%3DR.%26aulast%3DKendall%26aufirst%3DR.%26atitle%3DFully%2520Human%2520Monoclonal%2520Antibodies%2520to%2520Hepatocyte%2520Growth%2520Factor%2520with%2520Therapeutic%2520Potential%2520Against%2520Hepatocyte%2520Growth%2520Factor%252Fc-Met-Dependent%2520Human%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1721%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Martens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckerich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillbrandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwall, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamszus, K.</span><span> </span><span class="NLM_article-title">A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In Vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6144</span><span class="NLM_x">–</span> <span class="NLM_lpage">6152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1158%2F1078-0432.CCR-05-1418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=17062691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWhsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=6144-6152&author=T.+Martensauthor=N.+O.+Schmidtauthor=C.+Eckerichauthor=R.+Fillbrandtauthor=M.+Merchantauthor=R.+Schwallauthor=M.+Westphalauthor=K.+Lamszus&title=A+Novel+One-Armed+Anti-c-Met+Antibody+Inhibits+Glioblastoma+Growth+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth in vivo</span></div><div class="casAuthors">Martens, Tobias; Schmidt, Nils-Ole; Eckerich, Carmen; Fillbrandt, Regina; Merchant, Mark; Schwall, Ralph; Westphal, Manfred; Lamszus, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20, Pt. 1</span>),
    <span class="NLM_cas:pages">6144-6152</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Expression of the receptor tyrosine kinase c-Met and its ligand scatter factor/hepatocyte growth factor (SF/HGF) are strongly increased in glioblastomas, where they promote tumor proliferation, migration, invasion, and angiogenesis.  We used a novel one-armed anti-c-Met antibody to inhibit glioblastoma growth in vivo.  Exptl. Design: U87 glioblastoma cells (c-Met and SF/HGF pos.) or G55 glioblastoma cells (c-Met pos. and SF/HGF neg.) were used to generate intracranial orthotopic xenografts in nude mice.  The one-armed 5D5 (OA-5D5) anti-c-Met antibody was infused intratumorally using osmotic minipumps.  Following treatment, tumor vols. were measured and tumors were analyzed histol. for extracellular matrix (ECM) components and proteases relevant to tumor invasion.  Microarray analyses were done to det. the effect of the antibody on invasion-related genes.  Results: U87 tumor growth, strongly driven by SF/HGF, was inhibited >95% with OA-5D5 treatment.  In contrast, G55 tumors, which are not SF/HGF driven, did not respond to OA-5D5, suggesting that the antibody can have efficacy in SF/HGF-activated tumors.  In OA-5D5-treated U87 tumors, cell proliferation was reduced >75%, microvessel d. was reduced >90%, and apoptosis was increased >60%.  Furthermore, OA-5D5 treatment decreased tumor cell d. >2-fold, with a consequent increase in ECM deposition and increased immunoreactivity for laminin, fibronectin, and tenascin.  Microarray studies showed no increase in these ECM factors, rather down-regulation of urokinase-type plasminogen activator and matrix metalloproteinase 16 in glioblastoma cells treated with OA-5D5.  Conclusions: Local treatment with OA-5D5 can almost completely inhibit intracerebral glioblastoma growth when SF/HGF is driving tumor growth.  The mechanisms of tumor inhibition include antiproliferative, antiangiogenic, and proapoptotic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoClBrUgwIdRbVg90H21EOLACvtfcHk0lhUGEFyllXlzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWhsbbN&md5=18744a40c4a89eb8a721191887adc03a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1418%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DN.%2BO.%26aulast%3DEckerich%26aufirst%3DC.%26aulast%3DFillbrandt%26aufirst%3DR.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DSchwall%26aufirst%3DR.%26aulast%3DWestphal%26aufirst%3DM.%26aulast%3DLamszus%26aufirst%3DK.%26atitle%3DA%2520Novel%2520One-Armed%2520Anti-c-Met%2520Antibody%2520Inhibits%2520Glioblastoma%2520Growth%2520In%2520Vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D6144%26epage%3D6152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Date, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">HGF/NK4 is a Specific Antagonist for Pleiotrophic Actions of Hepatocyte Growth Factor</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=1997&pages=1-6&author=K.+Dateauthor=K.+Matsumotoauthor=H.+Shimuraauthor=M.+Tanakaauthor=T.+Nakamura&title=HGF%2FNK4+is+a+Specific+Antagonist+for+Pleiotrophic+Actions+of+Hepatocyte+Growth+Factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDate%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DShimura%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DHGF%252FNK4%2520is%2520a%2520Specific%2520Antagonist%2520for%2520Pleiotrophic%2520Actions%2520of%2520Hepatocyte%2520Growth%2520Factor%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D420%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tomioka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maehara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">Inhibition of Growth, Invasion, and Metastasis of Human Pancreatic Carcinoma Cells by NK4 in an Orthotopic Mouse Model</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7518</span><span class="NLM_x">–</span> <span class="NLM_lpage">7524</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7518-7524&author=D.+Tomiokaauthor=N.+Maeharaauthor=K.+Kubaauthor=K.+Mizumotoauthor=M.+Tanakaauthor=K.+Matsumotoauthor=T.+Nakamura&title=Inhibition+of+Growth%2C+Invasion%2C+and+Metastasis+of+Human+Pancreatic+Carcinoma+Cells+by+NK4+in+an+Orthotopic+Mouse+Model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomioka%26aufirst%3DD.%26aulast%3DMaehara%26aufirst%3DN.%26aulast%3DKuba%26aufirst%3DK.%26aulast%3DMizumoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520Growth%252C%2520Invasion%252C%2520and%2520Metastasis%2520of%2520Human%2520Pancreatic%2520Carcinoma%2520Cells%2520by%2520NK4%2520in%2520an%2520Orthotopic%2520Mouse%2520Model%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7518%26epage%3D7524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Brockmann, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadimitriou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillbrandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamszus, K.</span><span> </span><span class="NLM_article-title">Inhibition of Intracerebral Glioblastoma Growth by Local Treatment with the Scatter Factor/Hepatocyte Growth Factor-Antagonist NK4</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4578</span><span class="NLM_x">–</span> <span class="NLM_lpage">4585</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotVSht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=4578-4585&author=M.+A.+Brockmannauthor=A.+Papadimitriouauthor=M.+Brandtauthor=R.+Fillbrandtauthor=M.+Westphalauthor=K.+Lamszus&title=Inhibition+of+Intracerebral+Glioblastoma+Growth+by+Local+Treatment+with+the+Scatter+Factor%2FHepatocyte+Growth+Factor-Antagonist+NK4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Intracerebral Glioblastoma Growth by Local Treatment with the Scatter Factor/Hepatocyte Growth Factor-Antagonist NK4</span></div><div class="casAuthors">Brockmann, Marc A.; Papadimitriou, Apollon; Brandt, Michael; Fillbrandt, Regina; Westphal, Manfred; Lamszus, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4578-4585</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Scatter factor/hepatocyte growth factor (SF/HGF) and its tyrosine kinase receptor MET are strongly up-regulated in malignant gliomas.  The SF/HGF-MET system contributes to glioma invasion and angiogenesis via autocrine and paracrine mechanisms.  We analyzed whether local treatment with NK4, an antagonistic fragment of SF/HGF, could inhibit glioma growth in vivo.  A guide-screw system was used to implant tumor cells intra-cerebrally and to perform therapeutic injections.  Mice received daily intratumoral injections of NK4 or buffer as of day 1 or 7 after tumor cell injection until day 20.  Functional effects of NK4 on glioma and endothelial cells were analyzed in vitro.  Tumor vol. was reduced by 61.1% in mice treated with NK4 compared with controls when treatment was initiated on day 1 (P < 0.05) and by 61.4% when treatment was initiated on day 7 (P < 0.001).  Intratumoral microvessel d. was reduced by 64.9% when treatment started on day 1 and by 36.7% when it started on day 7.  The proliferative activity of the tumor cells was reduced by >30% regardless of when NK4-treatment was initiated.  The apoptotic fraction of tumor cells was increased 2-fold and 1.5-fold when animals were treated with NK4 as of day 1 or day 7, resp.  In vitro, NK4 inhibited SF/HGF-induced glioblastoma, and endothelial cell migration and proliferation in a dose-dependent fashion.  Thus, NK4 inhibits glioblastoma growth in vivo, most likely via anti-mitogenic, anti-motogenic, pro-apoptotic, and anti-angiogenic mechanisms.  Given the strong up-regulation of SF/HGF and MET in human malignant gliomas, NK4 holds promise as a direct interstitial therapeutic agent for these fatal tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeY5ANkMJPSbVg90H21EOLACvtfcHk0lhUGEFyllXlzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotVSht7o%253D&md5=e4f0c001dac94d5d054d70a4543ca620</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrockmann%26aufirst%3DM.%2BA.%26aulast%3DPapadimitriou%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DFillbrandt%26aufirst%3DR.%26aulast%3DWestphal%26aufirst%3DM.%26aulast%3DLamszus%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520Intracerebral%2520Glioblastoma%2520Growth%2520by%2520Local%2520Treatment%2520with%2520the%2520Scatter%2520Factor%252FHepatocyte%2520Growth%2520Factor-Antagonist%2520NK4%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D4578%26epage%3D4585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Michieli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basilico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavassa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sottile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Targeting the Tumor and its Microenvironment by a Dual-Function Decoy Met Receptor</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=61-73&author=P.+Michieliauthor=M.+Mazzoneauthor=C.+Basilicoauthor=S.+Cavassaauthor=A.+Sottileauthor=L.+Naldiniauthor=P.+M.+Comoglio&title=Targeting+the+Tumor+and+its+Microenvironment+by+a+Dual-Function+Decoy+Met+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMichieli%26aufirst%3DP.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DBasilico%26aufirst%3DC.%26aulast%3DCavassa%26aufirst%3DS.%26aulast%3DSottile%26aufirst%3DA.%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DTargeting%2520the%2520Tumor%2520and%2520its%2520Microenvironment%2520by%2520a%2520Dual-Function%2520Decoy%2520Met%2520Receptor%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D61%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kong-Beltran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, D.</span><span> </span><span class="NLM_article-title">The Sema Domain of Met Is Necessary for Receptor Dimerization and Activation</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=75-84&author=M.+Kong-Beltranauthor=J.+Stamosauthor=D.+Wickramasinghe&title=The+Sema+Domain+of+Met+Is+Necessary+for+Receptor+Dimerization+and+Activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKong-Beltran%26aufirst%3DM.%26aulast%3DStamos%26aufirst%3DJ.%26aulast%3DWickramasinghe%26aufirst%3DD.%26atitle%3DThe%2520Sema%2520Domain%2520of%2520Met%2520Is%2520Necessary%2520for%2520Receptor%2520Dimerization%2520and%2520Activation%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D75%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Abounader, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fielding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Book, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laterra, J.</span><span> </span><span class="NLM_article-title">Reversion of Human Glioblastoma Malignancy by U1 Small Nuclear RNA/Ribozyme Targeting of Scatter Factor/Hepatocyte Growth Factor and c-Met Expression</span> <span class="citation_source-journal">J. Natl. Cancer. Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1548</span><span class="NLM_x">–</span> <span class="NLM_lpage">1556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1548-1556&author=R.+Abounaderauthor=S.+Ranganathanauthor=B.+Lalauthor=K.+Fieldingauthor=A.+Bookauthor=H.+Dietzauthor=P.+Burgerauthor=J.+Laterra&title=Reversion+of+Human+Glioblastoma+Malignancy+by+U1+Small+Nuclear+RNA%2FRibozyme+Targeting+of+Scatter+Factor%2FHepatocyte+Growth+Factor+and+c-Met+Expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression</span></div><div class="casAuthors">Abounader, Roger; Ranganathan, Srikanth; Lal, Bachchu; Fielding, Kevin; Book, Adam; Dietz, Hal; Burger, Peter; Laterra, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1548-1556</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Expression of scatter factor (SF), also known as hepatocyte growth factor (HGF), and its receptor, c-met, is often assocd. with malignant progression of human tumors, including gliomas.  Overexpression of SF/HGF in exptl. gliomas enhances tumorigenicity and tumor-assocd. angiogenesis (i.e., growth of new blood vessels).  However, the role of endogenous SF/HGF or c-met expression in the malignant progression of gliomas has not been examd. directly.  In this study, we tested the hypothesis that human glioblastomas can be SF/HGF-c-met dependent and that a redn. in endogenous SF/HGF or c-met expression can lead to inhibition of tumor growth and tumorigenicity.  Expression of the SF/HGF and c-met genes was inhibited by transfecting glioblastoma cells with chimeric transgenes consisting of U1 small nuclear RNA, a hammerhead ribozyme, and antisense sequences.  The effects of reduced SF/HGF and c-met expression on (1) SF/HGF-dependent induction of immediate early genes (c-fos and c-jun), indicative of signal transduction; (2) anchorage-independent colony formation (clonogenicity), an in vitro correlate of solid tumor malignancy; and () intracranial tumor formation were quantified in immunodeficient mice.  Statistical tests were two-sided.  Introduction of the transgenes into glioblastoma cells reduced expression of the SF/HGF and c-met genes to as little as 2% of control cell levels.  Redn. in c-met expression specifically inhibited SF/HGF-dependent signal transduction (P<.01).  Inhibition of SF/HGF or c-met expression in glioblastoma cells possessing an SF/HGF-c-met autocrine loop reduced tumor cell clonogenicity (P = .005 for SF/HGF and P=.009 for c-met) and substantially inhibited tumorigenicity (P<.0001) and tumor growth in vivo (P<.0001).  To our knowledge, this is the first successful inhibition of SF/HGF and c-met expression in a tumor model directly demonstrating a role for endogenous SF/HGF and c-met in human glioblastoma.  Our results suggest that targeting the SF/HGF-c-met signaling pathway may be an important approach in controlling tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YkaYtwUd4rVg90H21EOLACvtfcHk0liqNJGFwVWIYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVCrt7o%253D&md5=d1eecd126806ca198930b4b3c8fe2f04</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbounader%26aufirst%3DR.%26aulast%3DRanganathan%26aufirst%3DS.%26aulast%3DLal%26aufirst%3DB.%26aulast%3DFielding%26aufirst%3DK.%26aulast%3DBook%26aufirst%3DA.%26aulast%3DDietz%26aufirst%3DH.%26aulast%3DBurger%26aufirst%3DP.%26aulast%3DLaterra%26aufirst%3DJ.%26atitle%3DReversion%2520of%2520Human%2520Glioblastoma%2520Malignancy%2520by%2520U1%2520Small%2520Nuclear%2520RNA%252FRibozyme%2520Targeting%2520of%2520Scatter%2520Factor%252FHepatocyte%2520Growth%2520Factor%2520and%2520c-Met%2520Expression%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1548%26epage%3D1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koterba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herynk, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallick, G. E.</span><span> </span><span class="NLM_article-title">Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">5161</span><span class="NLM_x">–</span> <span class="NLM_lpage">5170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVOgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=5161-5170&author=S.+J.+Kimauthor=M.+Johnsonauthor=K.+Koterbaauthor=M.+H.+Herynkauthor=H.+Ueharaauthor=G.+E.+Gallick&title=Reduced+c-Met+Expression+by+an+Adenovirus+Expressing+a+c-Met+Ribozyme+Inhibits+Tumorigenic+Growth+and+Lymph+Node+Metastases+of+PC3-LN4+Prostate+Tumor+Cells+in+an+Orthotopic+Nude+Mouse+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model</span></div><div class="casAuthors">Kim, Sun Jin; Johnson, Marjorie; Koterba, Kristen; Herynk, Matthew H.; Uehara, Hisanori; Gallick, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5161-5170</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The expression of c-Met, the receptor protein tyrosine kinase for hepatocyte growth factor/scatter factor, frequently increases during prostate tumor progression.  However, whether reduced c-Met expression inhibits tumor growth and metastasis has not been ascertained.  C-Met expression was reduced by infection of an adenovirus expressing a c-Met ribozyme into the highly metastatic human prostate cancer cell line PC3-LN4.  In vitro, effects on c-Met, Akt, and extracellular signal-regulated kinase 1/2 expression and phosphorylation, Src expression and activity, and vascular endothelial growth factor expression were detd., as were effects on cell migration and invasion.  Prostate tumor formation and metastasis to regional lymph nodes in nude mice were examd. after both ex vivo and in vivo infection of cells.  Infection of PC3-LN4 cells with the Ad-c-Met-expressing ribozyme decreased steady-state c-Met levels, decreased Src kinase activity, decreased vascular endothelial growth factor expression, and decreased migration and invasion vs. the pU1 (control) virus.  Significant inhibition of tumorigenicity (histol. confirmed tumors in only 1 of 10 mice) and consequent lymph node metastasis were obsd. upon ex vivo infection of Ad-c-Met.  Similarly, gene therapy expts. led to complete inhibition of tumor growth in 7 of 8 mice.  Redn. in c-Met expression substantially inhibits both tumor growth and lymph node metastasis of PC3-LN4 cells in orthotopic nude mouse models.  Therefore, targeting the c-Met signaling pathways may be important in controlling tumor growth and metastasis in human prostate cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjS2eXDUC1l7Vg90H21EOLACvtfcHk0liqNJGFwVWIYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVOgur8%253D&md5=fa4e48e3a4034972f5e34602f0d05f36</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DKoterba%26aufirst%3DK.%26aulast%3DHerynk%26aufirst%3DM.%2BH.%26aulast%3DUehara%26aufirst%3DH.%26aulast%3DGallick%26aufirst%3DG.%2BE.%26atitle%3DReduced%2520c-Met%2520Expression%2520by%2520an%2520Adenovirus%2520Expressing%2520a%2520c-Met%2520Ribozyme%2520Inhibits%2520Tumorigenic%2520Growth%2520and%2520Lymph%2520Node%2520Metastases%2520of%2520PC3-LN4%2520Prostate%2520Tumor%2520Cells%2520in%2520an%2520Orthotopic%2520Nude%2520Mouse%2520Model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D5161%26epage%3D5170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pride, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinnan, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">A Novel Small Molecule Met Inhibitor Induces Apoptosis in Cells Transformed by the Oncogenic TPR-MET Tyrosine Kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">5462</span><span class="NLM_x">–</span> <span class="NLM_lpage">5469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=14500382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntleku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5462-5469&author=M.+Sattlerauthor=Y.+B.+Prideauthor=P.+Maauthor=J.+L.+Gramlichauthor=S.+C.+Chuauthor=L.+A.+Quinnanauthor=S.+Shirazianauthor=C.+Liangauthor=K.+Podarauthor=J.+G.+Christensenauthor=R.+Salgia&title=A+Novel+Small+Molecule+Met+Inhibitor+Induces+Apoptosis+in+Cells+Transformed+by+the+Oncogenic+TPR-MET+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Small Molecule Met Inhibitor Induces Apoptosis in Cells Transformed by the Oncogenic TPR-MET Tyrosine Kinase</span></div><div class="casAuthors">Sattler, Martin; Pride, Yuri B.; Ma, Patrick; Gramlich, Jessica L.; Chu, Stephanie C.; Quinnan, Laura A.; Shirazian, Sheri; Liang, Congxin; Podar, Klaus; Christensen, James G.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5462-5469</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Met receptor tyrosine kinase has been shown to be overexpressed or mutated in a variety of solid tumors and has, therefore, been identified as a good candidate for molecularly targeted therapy.  Activation of the Met tyrosine kinase by the TPR gene was originally described in vitro through carcinogen-induced rearrangement.  The TPR-MET fusion protein contains constitutively elevated Met tyrosine kinase activity and constitutes an ideal model to study the transforming activity of the Met kinase.  We found, when introduced into an interleukin 3-dependent cell line, TPR-MET induces factor independence and constitutive tyrosine phosphorylation of several cellular proteins.  One major tyrosine phosphorylated protein was identified as the TPR-MET oncoprotein itself.  Inhibition of the Met kinase activity by the novel small mol. drug SU11274 [(3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide] led to time- and dose-dependent reduced cell growth.  The inhibitor did not affect other tyrosine kinase oncoproteins, including BCR-ABL, TEL-JAK2, TEL-PDGFβR, or TEL-ABL.  The Met inhibitor induced G1 cell cycle arrest and apoptosis with increased Annexin V staining and caspase 3 activity.  The autophosphorylation of the Met kinase was reduced on sites that have been shown previously to be important for activation of pathways involved in cell growth and survival, esp. the phosphatidylinositol-3'-kinase and the Ras pathway.  In particular, we found that the inhibitor blocked phosphorylation of AKT, GSK-3β, and the pro-apoptotic transcription factor FKHR.  The characterization of SU11274 as an effective inhibitor of Met tyrosine kinase activity illustrates the potential of targeting for Met therapeutic use in cancers assocd. with activated forms of this kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvIwRT4z1IbVg90H21EOLACvtfcHk0lhTpXdlYxHy7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntleku7s%253D&md5=3223841b665e6b95f3dab0f18ce64dbe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DPride%26aufirst%3DY.%2BB.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DGramlich%26aufirst%3DJ.%2BL.%26aulast%3DChu%26aufirst%3DS.%2BC.%26aulast%3DQuinnan%26aufirst%3DL.%2BA.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DA%2520Novel%2520Small%2520Molecule%2520Met%2520Inhibitor%2520Induces%2520Apoptosis%2520in%2520Cells%2520Transformed%2520by%2520the%2520Oncogenic%2520TPR-MET%2520Tyrosine%2520Kinase%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5462%26epage%3D5469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiewlich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasile, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span> </span><span class="NLM_article-title">Potent and Selective Inhibitors of the Met [Hepatocyte Growth Factor/Scatter Factor (HGF/SF) Receptor] Tyrosine Kinase Block HGF/SF-Induced Tumor Cell Growth and Invasion</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=14617781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1085-1092&author=X.+Wangauthor=P.+Leauthor=C.+Liangauthor=J.+Chanauthor=D.+Kiewlichauthor=T.+Millerauthor=D.+Harrisauthor=L.+Sunauthor=A.+Riceauthor=S.+Vasileauthor=R.+A.+Blakeauthor=A.+R.+Howlettauthor=N.+Patelauthor=G.+McMahonauthor=K.+E.+Lipson&title=Potent+and+Selective+Inhibitors+of+the+Met+%5BHepatocyte+Growth+Factor%2FScatter+Factor+%28HGF%2FSF%29+Receptor%5D+Tyrosine+Kinase+Block+HGF%2FSF-Induced+Tumor+Cell+Growth+and+Invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion</span></div><div class="casAuthors">Wang, Xueyan; Le, Phuong; Liang, Congxin; Chan, Julie; Kiewlich, David; Miller, Todd; Harris, Dave; Sun, Li; Rice, Audie; Vasile, Stefan; Blake, Robert A.; Howlett, Anthony R.; Patel, Neela; McMahon, Gerald; Lipson, Kenneth E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1085-1092</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The hepatocyte growth factor/scatter factor (HGF/SF) receptor, Met, mediates various cellular responses on activation with its ligand, including proliferation, survival, motility, invasion, and tubular morphogenesis.  Met expression is frequently up-regulated in sarcomas and carcinomas.  Exptl. evidence suggests that Met activation correlates with poor clin. outcome and the likelihood of metastasis.  Therefore, inhibitors of Met tyrosine kinase may be useful for the treatment of a wide variety of cancers that have spread from the primary site.  We have discovered potent and selective pyrrole-indolinone Met kinase inhibitors and characterized them for their ability to inhibit HGF/SF-induced cellular responses in vitro.  These compds. inhibit HGF/SF-induced receptor phosphorylation in a dose-dependent manner.  They also inhibit the HGF/SF-induced motility and invasion of epithelial and carcinoma cells.  Therefore, these compds. represent a class of prototype small mols. that selectively inhibit the Met kinase and could lead to identification of compds. with potential therapeutic utility in treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVAQRRxT_J1rVg90H21EOLACvtfcHk0lhTpXdlYxHy7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCqtL8%253D&md5=3b3141600b15ed4f9c97d86fb7ade81d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DKiewlich%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DRice%26aufirst%3DA.%26aulast%3DVasile%26aufirst%3DS.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DHowlett%26aufirst%3DA.%2BR.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26atitle%3DPotent%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Met%2520%255BHepatocyte%2520Growth%2520Factor%252FScatter%2520Factor%2520%2528HGF%252FSF%2529%2520Receptor%255D%2520Tyrosine%2520Kinase%2520Block%2520HGF%252FSF-Induced%2520Tumor%2520Cell%2520Growth%2520and%2520Invasion%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D1085%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruganti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramphal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D. B.</span><span> </span><span class="NLM_article-title">A Selective Small Molecule Inhibitor of c-Met Kinase Inhibits c-Met-Dependent Phenotypes In Vitro and Exhibits Cytoreductive Antitumor Activity In Vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7345</span><span class="NLM_x">–</span> <span class="NLM_lpage">7355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7345-7355&author=J.+G.+Christensenauthor=R.+Schreckauthor=J.+Burrowsauthor=P.+Kurugantiauthor=E.+Chanauthor=P.+Leauthor=J.+Chenauthor=X.+Wangauthor=L.+Ruslimauthor=R.+Blakeauthor=K.+E.+Lipsonauthor=J.+Ramphalauthor=S.+Doauthor=J.+J.+Cuiauthor=J.+M.+Cherringtonauthor=D.+B.+Mendel&title=A+Selective+Small+Molecule+Inhibitor+of+c-Met+Kinase+Inhibits+c-Met-Dependent+Phenotypes+In+Vitro+and+Exhibits+Cytoreductive+Antitumor+Activity+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DKuruganti%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DRamphal%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DA%2520Selective%2520Small%2520Molecule%2520Inhibitor%2520of%2520c-Met%2520Kinase%2520Inhibits%2520c-Met-Dependent%2520Phenotypes%2520In%2520Vitro%2520and%2520Exhibits%2520Cytoreductive%2520Antitumor%2520Activity%2520In%2520Vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7345%26epage%3D7355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cui, J. J.</span><span> </span><span class="NLM_article-title">Inhibitors Targeting Hepatocyte Growth Factor Receptor and their Potential Therapeutic Applications</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1517%2F13543776.17.9.1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1035-1045&author=J.+J.+Cui&title=Inhibitors+Targeting+Hepatocyte+Growth+Factor+Receptor+and+their+Potential+Therapeutic+Applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications</span></div><div class="casAuthors">Cui, Jingrong Jean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1035-1045</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The hepatocyte growth factor (HGF)/c-Met signaling pathway is important in mediating a wide range of biol. activities, including embryol. development, wound healing, tissue regeneration, angiogenesis, proliferation, survival, scattering, motility, invasion and morphogenic differentiation.  HGF and/or c-Met are expressed at abnormally high levels in a large variety of solid tumors.  Various c-Met mutations have been described in many solid tumors and some hematol. malignancies.  Therefore, inhibition of the HGF/c-Met signaling pathway has great potential in mol. targeted cancer therapy.  Many patent applications assocd. with inhibition of the HGF/c-Met axis have been published in the past few years.  There are four small mol. c-Met inhibitors presently in clin. trials.  This review focuses on recent patent applications for small mol. c-Met inhibitors and their potential applications in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwCxL0QxmH-LVg90H21EOLACvtfcHk0lizf8m5l0BGEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7P&md5=11d01e76a70de95edd486293fd94b62d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.9.1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.9.1035%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DInhibitors%2520Targeting%2520Hepatocyte%2520Growth%2520Factor%2520Receptor%2520and%2520their%2520Potential%2520Therapeutic%2520Applications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D1035%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.+P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+Orally+Available+Small-Molecule+Inhibitor+of+c-Met%2C+PF-2341066%2C+Exhibits+Cytoreductive+Antitumor+Efficacy+through+Antiproliferative+and+Antiangiogenic+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0lizf8m5l0BGEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520Orally%2520Available%2520Small-Molecule%2520Inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520Exhibits%2520Cytoreductive%2520Antitumor%2520Efficacy%2520through%2520Antiproliferative%2520and%2520Antiangiogenic%2520Mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-Related Mutations</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">2675</span><span class="NLM_x">–</span> <span class="NLM_lpage">2683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=2675-2683&author=S.+F.+Bellonauthor=P.+Kaplan-Lefkoauthor=Y.+Yangauthor=Y.+Zhangauthor=J.+Moriguchiauthor=K.+Rexauthor=C.+W.+Johnsonauthor=P.+E.+Roseauthor=A.+M.+Longauthor=A.+B.+O%E2%80%99Connorauthor=Y.+Guauthor=A.+Coxonauthor=T.+S.+Kimauthor=A.+Taskerauthor=T.+L.+Burgessauthor=I.+Dussault&title=c-Met+Inhibitors+with+Novel+Binding+Mode+Show+Activity+against+Several+Hereditary+Papillary+Renal+Cell+Carcinoma-Related+Mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DC.%2BW.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DT.%2BS.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3Dc-Met%2520Inhibitors%2520with%2520Novel%2520Binding%2520Mode%2520Show%2520Activity%2520against%2520Several%2520Hereditary%2520Papillary%2520Renal%2520Cell%2520Carcinoma-Related%2520Mutations%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D2675%26epage%3D2683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridrich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span> </span><span class="NLM_article-title">Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2879</span><span class="NLM_x">–</span> <span class="NLM_lpage">2882</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800043g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFShtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2879-2882&author=B.+K.+Albrechtauthor=J.-C.+Harmangeauthor=D.+Bauerauthor=L.+Berryauthor=C.+Bodeauthor=A.+A.+Boezioauthor=A.+Chenauthor=D.+Choquetteauthor=I.+Dussaultauthor=C.+Fridrichauthor=S.+Hiraiauthor=D.+Hoffmanauthor=J.+F.+Larrowauthor=P.+Kaplan-Lefkoauthor=J.+Linauthor=J.+Lohmanauthor=A.+M.+Longauthor=J.+Moriguchiauthor=A.+O%E2%80%99Connorauthor=M.+H.+Potashmanauthor=M.+Reeseauthor=K.+Rexauthor=A.+Siegmundauthor=K.+Shahauthor=R.+Shimanovichauthor=S.+K.+Springerauthor=Y.+Tefferaauthor=Y.+Yangauthor=Y.+Zhangauthor=S.+F.+Bellon&title=Discovery+and+Optimization+of+Triazolopyridazines+as+Potent+and+Selective+Inhibitors+of+the+c-Met+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase</span></div><div class="casAuthors">Albrecht, Brian K.; Harmange, Jean-Christophe; Bauer, David; Berry, Loren; Bode, Christiane; Boezio, Alessandro A.; Chen, April; Choquette, Deborah; Dussault, Isabelle; Fridrich, Cary; Hirai, Satoko; Hoffman, Doug; Larrow, Jay F.; Kaplan-Lefko, Paula; Lin, Jasmine; Lohman, Julia; Long, Alexander M.; Moriguchi, Jodi; O'Connor, Anne; Potashman, Michele H.; Reese, Monica; Rex, Karen; Siegmund, Aaron; Shah, Kavita; Shimanovich, Roman; Springer, Stephanie K.; Teffera, Yohannes; Yang, Yajing; Zhang, Yihong; Bellon, Steven F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2879-2882</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumorigenesis is a multistep process in which oncogenes play a key role in tumor formation, growth, and maintenance.  MET was discovered as an oncogene that is activated by its ligand, hepatocyte growth factor.  Deregulated signaling in the c-Met pathway has been obsd. in multiple tumor types.  Herein we report the discovery of potent and selective triazolopyridazine small mols. that inhibit c-Met activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVeQ8sYpasHLVg90H21EOLACvtfcHk0lidGPMHvOPvQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFShtLk%253D&md5=c0aec3ca102d90869884c139372f60a0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm800043g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800043g%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DHoffman%26aufirst%3DD.%26aulast%3DLarrow%26aufirst%3DJ.%2BF.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DReese%26aufirst%3DM.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSpringer%26aufirst%3DS.%2BK.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Triazolopyridazines%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520c-Met%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2879%26epage%3D2882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fujiwara, Y.; Senga, T.; Nishitoba, T.; Osawa, T.; Miwa, A.; Nakamura, K.</span><div class="note"><p class="first last">Quinoline Derivative and Quinazoline Derivative Inhibiting Self-Phosphorylation of Hepatocytus Proliferator Receptor, and Medicinal Composition Containing the Same. PCT Int. Appl. WO03000660A1</p></div>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fujiwara%2C+Y.%3B+Senga%2C+T.%3B+Nishitoba%2C+T.%3B+Osawa%2C+T.%3B+Miwa%2C+A.%3B+Nakamura%2C+K.Quinoline+Derivative+and+Quinazoline+Derivative+Inhibiting+Self-Phosphorylation+of+Hepatocytus+Proliferator+Receptor%2C+and+Medicinal+Composition+Containing+the+Same.+PCT+Int.+Appl.+WO03000660A1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DFujiwara%26aufirst%3DY.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">Compound <b>4</b> exhibited a <i>K</i><sub>i</sub> of 219 nM against KDR, a <i>K</i><sub>i</sub> of 65 nM against RON, and a <i>K</i><sub>i</sub> of 211 nM against IGFR.</p></div><span class="NLM_contrib-group">Harmange, J. C.; Booker, S.; Bauer, D.; Kim, T. S.; Cheng, Y.; Xu, S.; Xi, N.; Kim, J. L.; Tasker, A.</span> Preparation of Heteroaryloxy Substituted Quinolines for Treating or Preventing HGF Mediated Diseases. PCT Int. Appl. WO05073224A2,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+4+exhibited+a+Ki+of+219+nM+against+KDR%2C+a+Ki+of+65+nM+against+RON%2C+and+a+Ki+of+211+nM+against+IGFR.Harmange%2C+J.+C.%3B+Booker%2C+S.%3B+Bauer%2C+D.%3B+Kim%2C+T.+S.%3B+Cheng%2C+Y.%3B+Xu%2C+S.%3B+Xi%2C+N.%3B+Kim%2C+J.+L.%3B+Tasker%2C+A.+Preparation+of+Heteroaryloxy+Substituted+Quinolines+for+Treating+or+Preventing+HGF+Mediated+Diseases.+PCT+Int.+Appl.+WO05073224A2%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Spychala, J.</span><span> </span><span class="NLM_article-title">A Facile Preparation of N2-Arylisocytosines</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1080%2F00397919708006796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK2sXjtF2iu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1997&pages=1943-1949&author=J.+Spychala&title=A+Facile+Preparation+of+N2-Arylisocytosines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A facile preparation of N2-arylisocytosines</span></div><div class="casAuthors">Spychala, Jaroslaw</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1943-1949</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">N2-Arylisocytosines I (R = H, 2-, 3-, 4-Me, 2-, 3-, 4-Cl, 4-CN, 4-CH2CN) were obtained in good yields varying from 59 to 96% by a simple two-step process starting from 2-thiouracil via readily accessible 2-(methylthio)pyrimidin-4(3H)-one and RC6H4NH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYlGY1jYicDrVg90H21EOLACvtfcHk0lidGPMHvOPvQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtF2iu70%253D&md5=172ee28bd7f77754445cd8480b0fd3ac</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1080%2F00397919708006796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919708006796%26sid%3Dliteratum%253Aachs%26aulast%3DSpychala%26aufirst%3DJ.%26atitle%3DA%2520Facile%2520Preparation%2520of%2520N2-Arylisocytosines%26jtitle%3DSynth.%2520Commun.%26date%3D1997%26volume%3D27%26spage%3D1943%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Walker, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barder, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martilelli, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">A Rationally Designed Universal Catalyst for Suzuki-Miyaura Coupling Processes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1002%2Fanie.200353615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFSisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=1871-1876&author=S.+D.+Walkerauthor=T.+E.+Barderauthor=J.+R.+Martilelliauthor=S.+L.+Buchwald&title=A+Rationally+Designed+Universal+Catalyst+for+Suzuki-Miyaura+Coupling+Processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A rationally designed universal catalyst for Suzuki-Miyaura coupling processes</span></div><div class="casAuthors">Walker, Shawn D.; Barder, Timothy E.; Martinelli, Joseph R.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1871-1876</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Scope, reactivity, and stability of a catalyst system, contg. a palladium catalyst and phosphine ligand I, in the Suzuki-Miyaura coupling reaction, is reported.  Sterically hindered biaryls, e.g., II, were prepd., in high yields, by coupling of arylboronic acids with aryl bromides and chlorides.  Furthermore, coupling of aryl chlorides with n-hexyl-9-BBN or alkylboronic acids afforded the corresponding alkylarenes in excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf9KouyAWdILVg90H21EOLACvtfcHk0lhfsBTW5Wu33g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFSisr0%253D&md5=779716e7fdafd2419346173a558ec8c9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fanie.200353615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200353615%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DS.%2BD.%26aulast%3DBarder%26aufirst%3DT.%2BE.%26aulast%3DMartilelli%26aufirst%3DJ.%2BR.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520Rationally%2520Designed%2520Universal%2520Catalyst%2520for%2520Suzuki-Miyaura%2520Coupling%2520Processes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D1871%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Angiolelli, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalnuovo, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, T. P.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling of Benzylzinc Reagents with Methylthio N-Heterocycles: A New Coupling Reaction with Unusual Selectivity</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=905-907&author=M.+E.+Angiolelliauthor=A.+L.+Casalnuovoauthor=T.+P.+Selby&title=Palladium-Catalyzed+Cross-Coupling+of+Benzylzinc+Reagents+with+Methylthio+N-Heterocycles%3A+A+New+Coupling+Reaction+with+Unusual+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngiolelli%26aufirst%3DM.%2BE.%26aulast%3DCasalnuovo%26aufirst%3DA.%2BL.%26aulast%3DSelby%26aufirst%3DT.%2BP.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520of%2520Benzylzinc%2520Reagents%2520with%2520Methylthio%2520N-Heterocycles%253A%2520A%2520New%2520Coupling%2520Reaction%2520with%2520Unusual%2520Selectivity%26jtitle%3DSynlett%26date%3D2000%26volume%3D6%26spage%3D905%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Thomas, A. P.; Hennequin, L. F. A.; Ple, P. A.</span><div class="note"><p class="first last">Qinoline Derivatives Inhibiting the Effect of Growth Factors such as VEGF. PCT Int. Appl. WO9813350A1, 1998.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Ple%2C+P.+A.Qinoline+Derivatives+Inhibiting+the+Effect+of+Growth+Factors+such+as+VEGF.+PCT+Int.+Appl.+WO9813350A1%2C+1998."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BP." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ife, R. J.; Leach, C. A.</span><div class="note"><p class="first last">Amidine Derivatives as Gastric Acid Secretion Inhibitors. PCT Int. Appl. WO9426715A1</p></div>, 1994.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ife%2C+R.+J.%3B+Leach%2C+C.+A.Amidine+Derivatives+as+Gastric+Acid+Secretion+Inhibitors.+PCT+Int.+Appl.+WO9426715A1%2C+1994."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DIfe%26aufirst%3DR.%2BJ." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Brown, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardo, G.</span><span> </span><span class="NLM_article-title">Heterocyclic Amplifiers of Phleomycin. VII. Phenyl-, Tolyl-, Phenoxy- and Benzylpyrimidines: Also Some Carbocyclic Analogs</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1985&pages=825-833&author=D.+J.+Brownauthor=B.+J.+Croninauthor=S.+B.+Lanauthor=G.+Nardo&title=Heterocyclic+Amplifiers+of+Phleomycin.+VII.+Phenyl-%2C+Tolyl-%2C+Phenoxy-+and+Benzylpyrimidines%3A+Also+Some+Carbocyclic+Analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BJ.%26aulast%3DCronin%26aufirst%3DB.%2BJ.%26aulast%3DLan%26aufirst%3DS.%2BB.%26aulast%3DNardo%26aufirst%3DG.%26atitle%3DHeterocyclic%2520Amplifiers%2520of%2520Phleomycin.%2520VII.%2520Phenyl-%252C%2520Tolyl-%252C%2520Phenoxy-%2520and%2520Benzylpyrimidines%253A%2520Also%2520Some%2520Carbocyclic%2520Analogs%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D1985%26volume%3D38%26spage%3D825%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lokensgard, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartz, W. J.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-(α-Methoxyalkyl) Amides from Imidates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5609</span><span class="NLM_x">–</span> <span class="NLM_lpage">5611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00350a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=5609-5611&author=J.+P.+Lokensgardauthor=J.+W.+Fischerauthor=W.+J.+Bartz&title=Synthesis+of+N-%28%CE%B1-Methoxyalkyl%29+Amides+from+Imidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo00350a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00350a035%26sid%3Dliteratum%253Aachs%26aulast%3DLokensgard%26aufirst%3DJ.%2BP.%26aulast%3DFischer%26aufirst%3DJ.%2BW.%26aulast%3DBartz%26aufirst%3DW.%2BJ.%26atitle%3DSynthesis%2520of%2520N-%2528%25CE%25B1-Methoxyalkyl%2529%2520Amides%2520from%2520Imidates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1985%26volume%3D50%26spage%3D5609%26epage%3D5611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Recent Advances in the Cross-Coupling Reactions of Organoboron Derivatives with Organic Electrophiles, 1995−1998</span> <span class="citation_source-journal">J. Organomet. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">576</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1016%2FS0022-328X%2898%2901055-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=1999&pages=147-168&author=A.+Suzuki&title=Recent+Advances+in+the+Cross-Coupling+Reactions+of+Organoboron+Derivatives+with+Organic+Electrophiles%2C+1995%E2%88%921998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995-1998</span></div><div class="casAuthors">Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">147-168</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">The Pd-catalyzed cross-coupling reaction between organoboron compds. and org. halides or triflates provides a powerful and general methodol. for the formation of C-C bonds.  Recently, this reaction was called the Suzuki coupling, Suzuki reaction, or Suzuki-Miyaura coupling, although the authors never referred to it as such previously.  In this review, this name will be used with hesitation, simply to express the coupling reaction.  The availability of the reagents and the mild reaction conditions all contribute to the versatility of this reaction.  The coupling reaction offers several addnl. advantages, such as being largely unaffected by the presence of H2O, tolerating a broad range of functional groups, and proceeding generally regio- and stereoselectively.  Also, the inorg. byproduct of the reaction is nontoxic and easily removed from the reaction mixt. thereby making the Suzuki coupling suitable not only for labs. but also for industrial processes.  The authors published previously a comprehensive review of the reaction which covered mainly the refs. until the end of 1994.  Thereafter, a large no. of papers related to the coupling reaction are reported.  Consequently, such new results presented from 1995 to May 1998 are summarized in this review, with 139 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCbrdm1cvkLVg90H21EOLACvtfcHk0lhfsBTW5Wu33g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D&md5=be2fdd114211afa4abdf106008dd9845</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2898%2901055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252898%252901055-9%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Derivatives%2520with%2520Organic%2520Electrophiles%252C%25201995%25E2%2588%25921998%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1999%26volume%3D576%26spage%3D147%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Negishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okukado, N. J.</span><span> </span><span class="NLM_article-title">Selective Carbon−Carbon Bond Formation via Transition Metal Catalysis. 3. A Highly Selective Synthesis of Unsymmetrical Biaryls and Diarylmethanes by the Nickel- or Palladium-Catalyzed Reaction of Aryl- and Benzylzinc Derivatives with Aryl Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1821</span><span class="NLM_x">–</span> <span class="NLM_lpage">1823</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00430a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1977&pages=1821-1823&author=E.+Negishiauthor=A.+O.+Kingauthor=N.+J.+Okukado&title=Selective+Carbon%E2%88%92Carbon+Bond+Formation+via+Transition+Metal+Catalysis.+3.+A+Highly+Selective+Synthesis+of+Unsymmetrical+Biaryls+and+Diarylmethanes+by+the+Nickel-+or+Palladium-Catalyzed+Reaction+of+Aryl-+and+Benzylzinc+Derivatives+with+Aryl+Halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo00430a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00430a041%26sid%3Dliteratum%253Aachs%26aulast%3DNegishi%26aufirst%3DE.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DOkukado%26aufirst%3DN.%2BJ.%26atitle%3DSelective%2520Carbon%25E2%2588%2592Carbon%2520Bond%2520Formation%2520via%2520Transition%2520Metal%2520Catalysis.%25203.%2520A%2520Highly%2520Selective%2520Synthesis%2520of%2520Unsymmetrical%2520Biaryls%2520and%2520Diarylmethanes%2520by%2520the%2520Nickel-%2520or%2520Palladium-Catalyzed%2520Reaction%2520of%2520Aryl-%2520and%2520Benzylzinc%2520Derivatives%2520with%2520Aryl%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1977%26volume%3D42%26spage%3D1821%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Potashman, M.; Kim, T. S.; Bellon, S.; Booker, S.; Cheng, Y.; Kim, J. L.; Tasker, A.; Xi, N.; Xu, S.; Harmange, J. C.; Borg, G.; Weiss, M.; Hodous, B. L.; Graceffa, R.; Buckner, W. H.; Masse, C. E.; Choquette, D.; Martin, M. W.; Germain, J.; Dipietro, L. V.; Chaffee, S. C.; Nunes, J. J.; Buchanan, J. L.; Habgood, G. J.; McGowan, D. C.; Whittington, D. A.</span><div class="note"><p class="first last">Preparation of Heteroaryl Substituted Napthalenes as Inhibitors of Lck, VEGFR, and/or HGF Related Activity. PCT Int. Appl. WO05070891A2</p></div>, 2005.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Potashman%2C+M.%3B+Kim%2C+T.+S.%3B+Bellon%2C+S.%3B+Booker%2C+S.%3B+Cheng%2C+Y.%3B+Kim%2C+J.+L.%3B+Tasker%2C+A.%3B+Xi%2C+N.%3B+Xu%2C+S.%3B+Harmange%2C+J.+C.%3B+Borg%2C+G.%3B+Weiss%2C+M.%3B+Hodous%2C+B.+L.%3B+Graceffa%2C+R.%3B+Buckner%2C+W.+H.%3B+Masse%2C+C.+E.%3B+Choquette%2C+D.%3B+Martin%2C+M.+W.%3B+Germain%2C+J.%3B+Dipietro%2C+L.+V.%3B+Chaffee%2C+S.+C.%3B+Nunes%2C+J.+J.%3B+Buchanan%2C+J.+L.%3B+Habgood%2C+G.+J.%3B+McGowan%2C+D.+C.%3B+Whittington%2C+D.+A.Preparation+of+Heteroaryl+Substituted+Napthalenes+as+Inhibitors+of+Lck%2C+VEGFR%2C+and%2For+HGF+Related+Activity.+PCT+Int.+Appl.+WO05070891A2%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPotashman%26aufirst%3DM." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Harmange, J. C.; Booker, S.; Bauer, D.; Kim, T. S.; Cheng, Y.; Xu, S.; Xi, N.; Kim, J. L.; Tasker, A.</span><div class="note"><p class="first last">Preparation of Heteroaryloxy Substituted Quinolines for Treating or Preventing HGF Mediated Diseases. PCT Int. Appl. WO05073224A2</p></div>, 2005.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Harmange%2C+J.+C.%3B+Booker%2C+S.%3B+Bauer%2C+D.%3B+Kim%2C+T.+S.%3B+Cheng%2C+Y.%3B+Xu%2C+S.%3B+Xi%2C+N.%3B+Kim%2C+J.+L.%3B+Tasker%2C+A.Preparation+of+Heteroaryloxy+Substituted+Quinolines+for+Treating+or+Preventing+HGF+Mediated+Diseases.+PCT+Int.+Appl.+WO05073224A2%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHarmange%26aufirst%3DJ.%2BC." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><div class="note"><p class="first last">A table of the studied kinases is presented in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+table+of+the+studied+kinases+is+presented+in+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Still, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, A.</span><span> </span><span class="NLM_article-title">Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2923</span><span class="NLM_x">–</span> <span class="NLM_lpage">2925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00408a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=2923-2925&author=W.+C.+Stillauthor=M.+Kahnauthor=A.+Mitra&title=Rapid+Chromatographic+Technique+for+Preparative+Separations+with+Moderate+Resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid chromatographic technique for preparative separations with moderate resolution</span></div><div class="casAuthors">Still, W. Clark; Kahn, Michael; Mitra, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2923-5</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A simple adsorption chromatog. technique has been developed for rapid (<15 min) sepns.  The technique uses a short (e.g., 5 in.) column of 40-63-μm silica gel and operates at high flow rates (2.0 vertical in./min) to allow the sepn. of multigram quantities of compds. which are resolved on anal. TLC by as little as ΔRf 0.15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsgCIAoC4VbVg90H21EOLACvtfcHk0lhyck2WCjRDIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D&md5=34e721c237babee0665e2f9c6f6a3999</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo00408a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00408a041%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DW.%2BC.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DA.%26atitle%3DRapid%2520Chromatographic%2520Technique%2520for%2520Preparative%2520Separations%2520with%2520Moderate%2520Resolution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D2923%26epage%3D2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Polverino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMelfi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bready, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neervannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talvenheimo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montestruque, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R.</span><span> </span><span class="NLM_article-title">AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor Xenografts</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8715</span><span class="NLM_x">–</span> <span class="NLM_lpage">8721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8715-8721&author=A.+Polverinoauthor=A.+Coxonauthor=C.+Starnesauthor=Z.+Diazauthor=T.+DeMelfiauthor=L.+Wangauthor=J.+Breadyauthor=J.+Estradaauthor=R.+Cattleyauthor=S.+Kaufmanauthor=D.+Chenauthor=Y.+Ganauthor=G.+Kumarauthor=J.+Meyerauthor=S.+Neervannanauthor=G.+Alvaauthor=J.+Talvenheimoauthor=S.+Montestruqueauthor=A.+Taskerauthor=V.+Patelauthor=R.+Radinskyauthor=R.+Kendall&title=AMG+706%2C+an+Oral%2C+Multikinase+Inhibitor+that+Selectively+Targets+Vascular+Endothelial+Growth+Factor%2C+Platelet-Derived+Growth+Factor%2C+and+Kit+Receptors%2C+Potently+Inhibits+Angiogenesis+and+Induces+Regression+in+Tumor+Xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolverino%26aufirst%3DA.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DStarnes%26aufirst%3DC.%26aulast%3DDiaz%26aufirst%3DZ.%26aulast%3DDeMelfi%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBready%26aufirst%3DJ.%26aulast%3DEstrada%26aufirst%3DJ.%26aulast%3DCattley%26aufirst%3DR.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DGan%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DNeervannan%26aufirst%3DS.%26aulast%3DAlva%26aufirst%3DG.%26aulast%3DTalvenheimo%26aufirst%3DJ.%26aulast%3DMontestruque%26aufirst%3DS.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DRadinsky%26aufirst%3DR.%26aulast%3DKendall%26aufirst%3DR.%26atitle%3DAMG%2520706%252C%2520an%2520Oral%252C%2520Multikinase%2520Inhibitor%2520that%2520Selectively%2520Targets%2520Vascular%2520Endothelial%2520Growth%2520Factor%252C%2520Platelet-Derived%2520Growth%2520Factor%252C%2520and%2520Kit%2520Receptors%252C%2520Potently%2520Inhibits%2520Angiogenesis%2520and%2520Induces%2520Regression%2520in%2520Tumor%2520Xenografts%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8715%26epage%3D8721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 71 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gavin W. Collie, Iacovos N. Michaelides, Kevin Embrey, Christopher J. Stubbs, Ulf Börjesson, Ian L. Dale, Arjan Snijder, Louise Barlind, Kun Song, Puneet Khurana, Christopher Phillips, <span class="NLM_string-name hlFld-ContribAuthor">R. Ian Storer</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis for Targeting the Folded P-Loop Conformation of c-MET. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 162-167. <a href="https://doi.org/10.1021/acsmedchemlett.0c00392" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00392%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252BBasis%252Bfor%252BTargeting%252Bthe%252BFolded%252BP-Loop%252BConformation%252Bof%252Bc-MET%26aulast%3DCollie%26aufirst%3DGavin%2BW.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13072020%26date%3D30112020%26date%3D08122020%26volume%3D12%26issue%3D1%26spage%3D162%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bálint  Szokol</span>, <span class="hlFld-ContribAuthor ">Pál  Gyulavári</span>, <span class="hlFld-ContribAuthor ">Ibolya  Kurkó</span>, <span class="hlFld-ContribAuthor ">Ferenc  Baska</span>, <span class="hlFld-ContribAuthor ">Csaba  Szántai-Kis</span>, <span class="hlFld-ContribAuthor ">Zoltán  Greff</span>, <span class="hlFld-ContribAuthor ">Zoltán  Őrfi</span>, <span class="hlFld-ContribAuthor ">István  Peták</span>, <span class="hlFld-ContribAuthor ">Kinga  Pénzes</span>, <span class="hlFld-ContribAuthor ">Robert  Torka</span>, <span class="hlFld-ContribAuthor ">Axel  Ullrich</span>, <span class="hlFld-ContribAuthor ">László  Őrfi</span>, <span class="hlFld-ContribAuthor ">Tibor  Vántus</span>, and <span class="hlFld-ContribAuthor ">György  Kéri</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (4)
                                     , 298-303. <a href="https://doi.org/10.1021/ml4003309" title="DOI URL">https://doi.org/10.1021/ml4003309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4003309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4003309%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BDual%252BEGFR%25252Fc-Met%252BInhibitors%26aulast%3DSzokol%26aufirst%3DB%25C3%25A1lint%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D25082013%26date%3D30012014%26date%3D04022014%26date%3D10042014%26date%3D30012014%26volume%3D5%26issue%3D4%26spage%3D298%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar P. J.  van Linden</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (2)
                                     , 249-277. <a href="https://doi.org/10.1021/jm400378w" title="DOI URL">https://doi.org/10.1021/jm400378w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400378w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400378w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKLIFS%25253A%252BA%252BKnowledge-Based%252BStructural%252BDatabase%252BTo%252BNavigate%252BKinase%2525E2%252580%252593Ligand%252BInteraction%252BSpace%26aulast%3Dvan%2BLinden%26aufirst%3DOscar%2BP.%2BJ.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D14032013%26date%3D20092013%26date%3D23012014%26date%3D13082013%26volume%3D57%26issue%3D2%26spage%3D249%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Matthew  Lee</span>, <span class="hlFld-ContribAuthor ">Ning  Xi</span>, <span class="hlFld-ContribAuthor ">Ingrid  Fellows</span>, <span class="hlFld-ContribAuthor ">Noel D.  D’Angelo</span>, <span class="hlFld-ContribAuthor ">Celia  Dominguez</span>, <span class="hlFld-ContribAuthor ">Karen  Rex</span>, <span class="hlFld-ContribAuthor ">Steven F.  Bellon</span>, <span class="hlFld-ContribAuthor ">Tae-Seong  Kim</span>, and <span class="hlFld-ContribAuthor ">Isabelle  Dussault</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 1858-1867. <a href="https://doi.org/10.1021/jm201330u" title="DOI URL">https://doi.org/10.1021/jm201330u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201330u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201330u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BNovel%252BClass%252BII%252Bc-Met%252BInhibitors%25253A%252B1.%252BIdentification%252Bof%252BPyrazolone-Based%252BDerivatives%26aulast%3DNorman%26aufirst%3DMark%2BH.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D06102011%26date%3D24022012%26date%3D08032012%26date%3D09022012%26volume%3D55%26issue%3D5%26spage%3D1858%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason D.  Katz</span>, <span class="hlFld-ContribAuthor ">James P.  Jewell</span>, <span class="hlFld-ContribAuthor ">David J.  Guerin</span>, <span class="hlFld-ContribAuthor ">Jongwon  Lim</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Dinsmore</span>, <span class="hlFld-ContribAuthor ">Sujal V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Bo-Sheng  Pan</span>, <span class="hlFld-ContribAuthor ">C. Gary  Marshall</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">William K.  Dahlberg</span>, <span class="hlFld-ContribAuthor ">Lenora  Davis</span>, <span class="hlFld-ContribAuthor ">Danielle  Falcone</span>, <span class="hlFld-ContribAuthor ">Ana E.  Gabarda</span>, <span class="hlFld-ContribAuthor ">Gaozhen  Hang</span>, <span class="hlFld-ContribAuthor ">Harold  Hatch</span>, <span class="hlFld-ContribAuthor ">Rachael  Holmes</span>, <span class="hlFld-ContribAuthor ">Kaiko  Kunii</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Lumb</span>, <span class="hlFld-ContribAuthor ">Bart  Lutterbach</span>, <span class="hlFld-ContribAuthor ">Robert  Mathvink</span>, <span class="hlFld-ContribAuthor ">Naim  Nazef</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">Xianlu  Qu</span>, <span class="hlFld-ContribAuthor ">John F.  Reilly</span>, <span class="hlFld-ContribAuthor ">Keith W.  Rickert</span>, <span class="hlFld-ContribAuthor ">Craig  Rosenstein</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Soisson</span>, <span class="hlFld-ContribAuthor ">Kerrie B.  Spencer</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Szewczak</span>, <span class="hlFld-ContribAuthor ">Deborah  Walker</span>, <span class="hlFld-ContribAuthor ">Wenxian  Wang</span>, <span class="hlFld-ContribAuthor ">Jonathan  Young</span>, and <span class="hlFld-ContribAuthor ">Qinwen  Zeng</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a 5H-Benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (12)
                                     , 4092-4108. <a href="https://doi.org/10.1021/jm200112k" title="DOI URL">https://doi.org/10.1021/jm200112k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200112k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200112k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252B5H-Benzo%25255B4%25252C5%25255Dcyclohepta%25255B1%25252C2-b%25255Dpyridin-5-one%252B%252528MK-2461%252529%252BInhibitor%252Bof%252Bc-Met%252BKinase%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DKatz%26aufirst%3DJason%2BD.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D31012011%26date%3D24052011%26date%3D23062011%26volume%3D54%26issue%3D12%26spage%3D4092%26epage%3D4108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Ao  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and c-Met Kinase Inhibition of 3,5-Disubstituted and 3,5,7-Trisubstituted Quinolines: Identification of 3-(4-Acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a Novel Anticancer Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (7)
                                     , 2127-2142. <a href="https://doi.org/10.1021/jm101340q" title="DOI URL">https://doi.org/10.1021/jm101340q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101340q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101340q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bc-Met%252BKinase%252BInhibition%252Bof%252B3%25252C5-Disubstituted%252Band%252B3%25252C5%25252C7-Trisubstituted%252BQuinolines%25253A%252BIdentification%252Bof%252B3-%2525284-Acetylpiperazin-1-yl%252529-5-%2525283-nitrobenzylamino%252529-7-%252B%252528trifluoromethyl%252529quinoline%252Bas%252Ba%252BNovel%252BAnticancer%252BAgent%26aulast%3DWang%26aufirst%3DYuanxiang%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D16102010%26date%3D15032011%26date%3D14042011%26volume%3D54%26issue%3D7%26spage%3D2127%26epage%3D2142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongjie  Liang</span>, <span class="hlFld-ContribAuthor ">Ting  Shi</span>, <span class="hlFld-ContribAuthor ">Sisheng  Ouyang</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>, <span class="hlFld-ContribAuthor ">Kunqian  Yu</span>, <span class="hlFld-ContribAuthor ">Weiliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span> and <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Investigation of the Catalytic Mechanism of Sir2 Enzyme with QM/MM Approach: SN1 vs SN2?. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2010,</strong> <em>114 </em>
                                    (36)
                                     , 11927-11933. <a href="https://doi.org/10.1021/jp1054183" title="DOI URL">https://doi.org/10.1021/jp1054183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jp1054183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjp1054183%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DInvestigation%252Bof%252Bthe%252BCatalytic%252BMechanism%252Bof%252BSir2%252BEnzyme%252Bwith%252BQM%25252FMM%252BApproach%25253A%252BSN1%252Bvs%252BSN2%25253F%26aulast%3DLiang%26aufirst%3DZhongjie%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D13%252006%25202010%26date%3D22%252007%25202010%26date%3D20082010%26date%3D16092010%26volume%3D114%26issue%3D36%26spage%3D11927%26epage%3D11933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu‐juan  Feng</span>, <span class="hlFld-ContribAuthor ">Yu‐Lin  Ren</span>, <span class="hlFld-ContribAuthor ">Li‐Ming  Zhao</span>, <span class="hlFld-ContribAuthor ">Guo‐Qiang  Xue</span>, <span class="hlFld-ContribAuthor ">Wen‐Hao  Yu</span>, <span class="hlFld-ContribAuthor ">Jia‐Qi  Yang</span>, <span class="hlFld-ContribAuthor ">Jun‐Wei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Novel
              α‐Acyloxycarboxamide‐Based
              Derivatives as
              c‐Met
              Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2021,</strong> <em>39 </em>
                                    (8)
                                     , 2241-2250. <a href="https://doi.org/10.1002/cjoc.202100106" title="DOI URL">https://doi.org/10.1002/cjoc.202100106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202100106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202100106%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B%2525CE%2525B1%2525E2%252580%252590Acyloxycarboxamide%2525E2%252580%252590Based%252BDerivatives%252Bas%252Bc%2525E2%252580%252590Met%252BInhibitors%26aulast%3DFeng%26aufirst%3DYu%25E2%2580%2590juan%26date%3D2021%26date%3D2021%26volume%3D39%26issue%3D8%26spage%3D2241%26epage%3D2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tahereh  Damghani</span>, <span class="hlFld-ContribAuthor ">Maryam  Elyasi</span>, <span class="hlFld-ContribAuthor ">Somayeh  Pirhadi</span>, <span class="hlFld-ContribAuthor ">Zahra  Haghighijoo</span>, <span class="hlFld-ContribAuthor ">Somayeh  Ghazi</span>. </span><span class="cited-content_cbyCitation_article-title">Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibition. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>66 </em><a href="https://doi.org/10.1007/s11030-021-10267-7" title="DOI URL">https://doi.org/10.1007/s11030-021-10267-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-021-10267-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-021-10267-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DType%252BII%252Bc-Met%252Binhibitors%25253A%252Bmolecular%252Binsight%252Binto%252Bcrucial%252Binteractions%252Bfor%252Beffective%252Binhibition%26aulast%3DDamghani%26aufirst%3DTahereh%26date%3D2021%26date%3D2021%26volume%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuhong  Dong</span>, <span class="hlFld-ContribAuthor ">Hao  Hu</span>, <span class="hlFld-ContribAuthor ">Yuwei  Sun</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yunlei  Hou</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (23)
                                     , 127610. <a href="https://doi.org/10.1016/j.bmcl.2020.127610" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127610%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bc-Met%25252FHDAC%252Bdual%252Binhibitors%26aulast%3DDong%26aufirst%3DYuhong%26date%3D2020%26volume%3D30%26issue%3D23%26spage%3D127610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Nan</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Wu</span>, <span class="hlFld-ContribAuthor ">Sen-Biao  Fang</span>, <span class="hlFld-ContribAuthor ">Zhi-Zhou  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Chao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112470. <a href="https://doi.org/10.1016/j.ejmech.2020.112470" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112470%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252BN-sulfonylamidine-based%252Bderivatives%252Bas%252Bc-Met%252Binhibitors%252Bvia%252BCu-catalyzed%252Bthree-component%252Breaction%26aulast%3DNan%26aufirst%3DXiang%26date%3D2020%26volume%3D200%26spage%3D112470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elsa M.  Arce</span>, <span class="hlFld-ContribAuthor ">Scott G.  Lamont</span>, <span class="hlFld-ContribAuthor ">Paul W.  Davies</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfenyl Ynamides in Gold Catalysis: Synthesis of Oxo‐functionalised 4‐aminoimidazolyl Fused Compounds by Intermolecular Annulation Reactions. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (12)
                                     , 2503-2509. <a href="https://doi.org/10.1002/adsc.202000134" title="DOI URL">https://doi.org/10.1002/adsc.202000134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000134%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSulfenyl%252BYnamides%252Bin%252BGold%252BCatalysis%25253A%252BSynthesis%252Bof%252BOxo%2525E2%252580%252590functionalised%252B4%2525E2%252580%252590aminoimidazolyl%252BFused%252BCompounds%252Bby%252BIntermolecular%252BAnnulation%252BReactions%26aulast%3DArce%26aufirst%3DElsa%2BM.%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D12%26spage%3D2503%26epage%3D2509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongchuang  Xu</span>, <span class="hlFld-ContribAuthor ">Minshu  Wang</span>, <span class="hlFld-ContribAuthor ">Fengxu  Wu</span>, <span class="hlFld-ContribAuthor ">Linsheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Nengfang  She</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-substituted-3-phenyl-1,6-naphthyridinone derivatives bearing quinoline moiety as selective type II c-Met kinase inhibitors against VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (12)
                                     , 115555. <a href="https://doi.org/10.1016/j.bmc.2020.115555" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115555%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-substituted-3-phenyl-1%25252C6-naphthyridinone%252Bderivatives%252Bbearing%252Bquinoline%252Bmoiety%252Bas%252Bselective%252Btype%252BII%252Bc-Met%252Bkinase%252Binhibitors%252Bagainst%252BVEGFR-2%26aulast%3DXu%26aufirst%3DHongchuang%26date%3D2020%26volume%3D28%26issue%3D12%26spage%3D115555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Nan</span>, <span class="hlFld-ContribAuthor ">Hui-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Sen-Biao  Fang</span>, <span class="hlFld-ContribAuthor ">Qin-Ying  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Chao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>193 </em>, 112241. <a href="https://doi.org/10.1016/j.ejmech.2020.112241" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112241%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bnovel%252B4-%2525282-fluorophenoxy%252529quinoline%252Bderivatives%252Bas%252Bc-Met%252Binhibitors%252Busing%252Bisocyanide-involved%252Bmulticomponent%252Breactions%26aulast%3DNan%26aufirst%3DXiang%26date%3D2020%26volume%3D193%26spage%3D112241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Lin-Sheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Fan-Peng  Yang</span>, <span class="hlFld-ContribAuthor ">Wen-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new MET inhibitors with 1,6-naphthyridinone scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111803. <a href="https://doi.org/10.1016/j.ejmech.2019.111803" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111803%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252BMET%252Binhibitors%252Bwith%252B1%25252C6-naphthyridinone%252Bscaffold%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26volume%3D185%26spage%3D111803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifeng  Yang</span>, <span class="hlFld-ContribAuthor ">Yingxiu  Li</span>, <span class="hlFld-ContribAuthor ">Yunlei  Hou</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Ju  Liu</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 4-phenoxyquinoline derivatives as potent c-Met kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (23)
                                     , 126666. <a href="https://doi.org/10.1016/j.bmcl.2019.126666" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126666%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B4-phenoxyquinoline%252Bderivatives%252Bas%252Bpotent%252Bc-Met%252Bkinase%252Binhibitor%26aulast%3DYang%26aufirst%3DYifeng%26date%3D2019%26volume%3D29%26issue%3D23%26spage%3D126666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng-Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Yu-Shun  Yang</span>, <span class="hlFld-ContribAuthor ">Zhong-Chang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Development of Small Molecule c-Met Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (15)
                                     , 1276-1288. <a href="https://doi.org/10.2174/1568026619666190712205353" title="DOI URL">https://doi.org/10.2174/1568026619666190712205353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712205353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712205353%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BSmall%252BMolecule%252Bc-Met%252BInhibitors%26aulast%3DLv%26aufirst%3DPeng-Cheng%26date%3D2019%26volume%3D19%26issue%3D15%26spage%3D1276%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Nan</span>, <span class="hlFld-ContribAuthor ">Yi-Fan  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Jun-Hu  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-Chao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of sulfonylurea-containing 4-phenoxyquinolines as highly selective c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (13)
                                     , 2801-2812. <a href="https://doi.org/10.1016/j.bmc.2019.05.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bsulfonylurea-containing%252B4-phenoxyquinolines%252Bas%252Bhighly%252Bselective%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DNan%26aufirst%3DXiang%26date%3D2019%26volume%3D27%26issue%3D13%26spage%3D2801%26epage%3D2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You-Lu  Pan</span>, <span class="hlFld-ContribAuthor ">Yan-Ling  Liu</span>, <span class="hlFld-ContribAuthor ">Jian-Zhong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular simulation studies on the binding activity and selectivity of 3-amino-phenyl-5-chloro-pyrimidine-2, 4-diamine derivatives in complexes with kinases
              c
              -Met and ALK. </span><span class="cited-content_cbyCitation_journal-name">Molecular Simulation</span><span> <strong>2019,</strong> <em>45 </em>
                                    (1)
                                     , 1-14. <a href="https://doi.org/10.1080/08927022.2018.1515486" title="DOI URL">https://doi.org/10.1080/08927022.2018.1515486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08927022.2018.1515486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08927022.2018.1515486%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Simulation%26atitle%3DMolecular%252Bsimulation%252Bstudies%252Bon%252Bthe%252Bbinding%252Bactivity%252Band%252Bselectivity%252Bof%252B3-amino-phenyl-5-chloro-pyrimidine-2%25252C%252B4-diamine%252Bderivatives%252Bin%252Bcomplexes%252Bwith%252Bkinases%252Bc%252B-Met%252Band%252BALK%26aulast%3DPan%26aufirst%3DYou-Lu%26date%3D2019%26date%3D2018%26volume%3D45%26issue%3D1%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Hao  Qiang</span>, <span class="hlFld-ContribAuthor ">Dandan  Huang</span>, <span class="hlFld-ContribAuthor ">Xinzhou  Bi</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 814-831. <a href="https://doi.org/10.1016/j.ejmech.2018.09.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bnovel%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252Bderivatives%252Bwith%252Bimproved%252Banticancer%252Befficacy%252Bas%252Bdual%252Binhibitors%252Bof%252Bc-Met%25252FVEGFR-2%26aulast%3DShi%26aufirst%3DWei%26date%3D2018%26volume%3D158%26spage%3D814%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongli  Duan</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Hehua  Xiong</span>, <span class="hlFld-ContribAuthor ">Linxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Bingbing  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Caolin  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Peng</span>, <span class="hlFld-ContribAuthor ">Shifan  Cai</span>, <span class="hlFld-ContribAuthor ">Rong  Luo</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Qidong  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 2-substituted-4-phenoxypyridine derivatives as potential antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 254-259. <a href="https://doi.org/10.1016/j.bmcl.2017.12.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252B2-substituted-4-phenoxypyridine%252Bderivatives%252Bas%252Bpotential%252Bantitumor%252Bagents%26aulast%3DDuan%26aufirst%3DYongli%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D254%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baohui  Qi</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Huan  He</span>, <span class="hlFld-ContribAuthor ">Xupeng  Yue</span>, <span class="hlFld-ContribAuthor ">Yuting  Zhou</span>, <span class="hlFld-ContribAuthor ">Xing  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuying  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Anmian  Zhang</span>, <span class="hlFld-ContribAuthor ">Fachang  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel N-(2-aryl-1, 3-thiazolidin-4-one)-N-aryl ureas showing potent multi-tyrosine kinase inhibitory activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>146 </em>, 368-380. <a href="https://doi.org/10.1016/j.ejmech.2018.01.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnovel%252BN-%2525282-aryl-1%25252C%252B3-thiazolidin-4-one%252529-N-aryl%252Bureas%252Bshowing%252Bpotent%252Bmulti-tyrosine%252Bkinase%252Binhibitory%252Bactivities%26aulast%3DQi%26aufirst%3DBaohui%26date%3D2018%26volume%3D146%26spage%3D368%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qidong  Tang</span>, <span class="hlFld-ContribAuthor ">Yongli  Duan</span>, <span class="hlFld-ContribAuthor ">Linxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqiang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Caolin  Wang</span>, <span class="hlFld-ContribAuthor ">Han  Mei</span>, <span class="hlFld-ContribAuthor ">Sheng  Tang</span>, <span class="hlFld-ContribAuthor ">Yinhua  Xiong</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 266-275. <a href="https://doi.org/10.1016/j.ejmech.2017.11.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantiproliferative%252Bactivity%252Bof%252Bpyrrolo%25255B2%25252C3-b%25255Dpyridine%252Bderivatives%252Bbearing%252Bthe%252B1%25252C8-naphthyridin-2-one%252Bmoiety%26aulast%3DTang%26aufirst%3DQidong%26date%3D2018%26volume%3D143%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dilip  Narayanan</span>, <span class="hlFld-ContribAuthor ">Osman A. B. S. M.  Gani</span>, <span class="hlFld-ContribAuthor ">Franz X. E.  Gruber</span>, <span class="hlFld-ContribAuthor ">Richard A.  Engh</span>. </span><span class="cited-content_cbyCitation_article-title">Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cheminformatics</span><span> <strong>2017,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13321-017-0229-8" title="DOI URL">https://doi.org/10.1186/s13321-017-0229-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13321-017-0229-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13321-017-0229-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cheminformatics%26atitle%3DData%252Bdriven%252Bpolypharmacological%252Bdrug%252Bdesign%252Bfor%252Blung%252Bcancer%25253A%252Banalyses%252Bfor%252Btargeting%252BALK%25252C%252BMET%25252C%252Band%252BEGFR%26aulast%3DNarayanan%26aufirst%3DDilip%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Lijun  Xie</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Shuancheng  Xi</span>, <span class="hlFld-ContribAuthor ">Tianfang  Zeng</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel 4-Phenoxyquinolines Bearing 3-Hydrosulfonylacrylamido or 1
              H
              -Imidazole-4-carboxamido Scaffolds as c-Met Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (2)
                                     , 1600307. <a href="https://doi.org/10.1002/ardp.201600307" title="DOI URL">https://doi.org/10.1002/ardp.201600307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201600307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201600307%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252B4-Phenoxyquinolines%252BBearing%252B3-Hydrosulfonylacrylamido%252Bor%252B1%252BH%252B-Imidazole-4-carboxamido%252BScaffolds%252Bas%252Bc-Met%252BKinase%252BInhibitors%26aulast%3DWang%26aufirst%3DJiao%26date%3D2017%26date%3D2017%26volume%3D350%26issue%3D2%26spage%3D1600307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Sijia  Zhao</span>, <span class="hlFld-ContribAuthor ">Shuancheng  Xi</span>, <span class="hlFld-ContribAuthor ">Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Tongfei  Jing</span>, <span class="hlFld-ContribAuthor ">Wenyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives as selective c-Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (3)
                                     , 886-896. <a href="https://doi.org/10.1016/j.bmc.2016.12.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.12.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.12.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-%2525282-fluorophenoxy%252529quinoline%252Bderivatives%252Bas%252Bselective%252Bc-Met%252Binhibitors%26aulast%3DWang%26aufirst%3DXiaoqiang%26date%3D2017%26volume%3D25%26issue%3D3%26spage%3D886%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mansoura I.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Nadia G.  Kandile</span>, <span class="hlFld-ContribAuthor ">Howida T.  Zaky</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antimicrobial Activity of 1,3,4-Oxadiazole-2(3H)-thione and Azidomethanone Derivatives Based on Quinoline-4-carbohydrazide Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2017,</strong> <em>54 </em>
                                    (1)
                                     , 35-43. <a href="https://doi.org/10.1002/jhet.2529" title="DOI URL">https://doi.org/10.1002/jhet.2529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2529%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252BAntimicrobial%252BActivity%252Bof%252B1%25252C3%25252C4-Oxadiazole-2%2525283H%252529-thione%252Band%252BAzidomethanone%252BDerivatives%252BBased%252Bon%252BQuinoline-4-carbohydrazide%252BDerivatives%26aulast%3DMohamed%26aufirst%3DMansoura%2BI.%26date%3D2017%26date%3D2015%26volume%3D54%26issue%3D1%26spage%3D35%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueyi  Lu</span>, <span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Jiapei  Yang</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Fabao  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (18)
                                     , 4424-4433. <a href="https://doi.org/10.1016/j.bmc.2016.07.041" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.07.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.07.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.07.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DArylazolyl%252528azinyl%252529thioacetanilides.%252BPart%252B20%25253A%252BDiscovery%252Bof%252Bnovel%252Bpurinylthioacetanilides%252Bderivatives%252Bas%252Bpotent%252BHIV-1%252BNNRTIs%252Bvia%252Ba%252Bstructure-based%252Bbioisosterism%252Bapproach%26aulast%3DLu%26aufirst%3DXueyi%26date%3D2016%26volume%3D24%26issue%3D18%26spage%3D4424%26epage%3D4433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sijia  Zhao</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Shuancheng  Xi</span>, <span class="hlFld-ContribAuthor ">Bin  Zou</span>, <span class="hlFld-ContribAuthor ">Guanglong  Bao</span>, <span class="hlFld-ContribAuthor ">Limei  Wang</span>, <span class="hlFld-ContribAuthor ">Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Tianfang  Zeng</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 4-(2-fluorophenoxy)-3,3′-bipyridine derivatives as potential c-met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>120 </em>, 37-50. <a href="https://doi.org/10.1016/j.ejmech.2016.04.062" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.062%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-%2525282-fluorophenoxy%252529-3%25252C3%2525E2%252580%2525B2-bipyridine%252Bderivatives%252Bas%252Bpotential%252Bc-met%252Binhibitors%26aulast%3DZhao%26aufirst%3DSijia%26date%3D2016%26volume%3D120%26spage%3D37%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed M.  Mohyeldin</span>, <span class="hlFld-ContribAuthor ">Belnaser A.  Busnena</span>, <span class="hlFld-ContribAuthor ">Mohamed R.  Akl</span>, <span class="hlFld-ContribAuthor ">Ana Maria  Dragoi</span>, <span class="hlFld-ContribAuthor ">James A.  Cardelli</span>, <span class="hlFld-ContribAuthor ">Khalid A.  El Sayed</span>. </span><span class="cited-content_cbyCitation_article-title">Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>118 </em>, 299-315. <a href="https://doi.org/10.1016/j.ejmech.2016.04.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bc-Met%252Binhibitory%252Bolive%252Bsecoiridoid%252Bsemisynthetic%252Banalogs%252Bfor%252Bthe%252Bcontrol%252Bof%252Binvasive%252Bbreast%252Bcancer%26aulast%3DMohyeldin%26aufirst%3DMohamed%2BM.%26date%3D2016%26volume%3D118%26spage%3D299%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism Approach. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>88 </em>
                                    (2)
                                     , 241-253. <a href="https://doi.org/10.1111/cbdd.12751" title="DOI URL">https://doi.org/10.1111/cbdd.12751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12751%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DArylazolyl%252528azinyl%252529thioacetanilides%25253A%252BPart%252B19%25253A%252BDiscovery%252Bof%252BNovel%252BSubstituted%252BImidazo%25255B4%25252C5-b%25255Dpyridin-2-ylthioacetanilides%252Bas%252BPotent%252BHIV%252BNNRTIs%252BVia%252Ba%252BStructure-based%252BBioisosterism%252BApproach%26aulast%3DLi%26aufirst%3DXiao%26date%3D2016%26date%3D2016%26volume%3D88%26issue%3D2%26spage%3D241%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Aijun  Shen</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Weiqiang  Xing</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel benzo[d]oxazol-2(3H)-one derivatives bearing 7-substituted-4-enthoxyquinoline moieties as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 191-200. <a href="https://doi.org/10.1016/j.ejmech.2016.03.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bbenzo%25255Bd%25255Doxazol-2%2525283H%252529-one%252Bderivatives%252Bbearing%252B7-substituted-4-enthoxyquinoline%252Bmoieties%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DLu%26aufirst%3DDong%26date%3D2016%26volume%3D115%26spage%3D191%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Guanglong  Bao</span>, <span class="hlFld-ContribAuthor ">Limei  Wang</span>, <span class="hlFld-ContribAuthor ">Mingke  Cheng</span>, <span class="hlFld-ContribAuthor ">Meng  Zhao</span>, <span class="hlFld-ContribAuthor ">Sijia  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (6)
                                     , 1331-1345. <a href="https://doi.org/10.1016/j.bmc.2016.02.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-phenoxy-6%25252C7-disubstituted%252Bquinolines%252Bpossessing%252B%252528thio%252529semicarbazones%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DZhai%26aufirst%3DXin%26date%3D2016%26volume%3D24%26issue%3D6%26spage%3D1331%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel 2-(Pyridin-3-yloxy)acetamide Derivatives as Potential Anti-HIV-1 Agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>87 </em>
                                    (2)
                                     , 283-289. <a href="https://doi.org/10.1111/cbdd.12657" title="DOI URL">https://doi.org/10.1111/cbdd.12657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12657%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B2-%252528Pyridin-3-yloxy%252529acetamide%252BDerivatives%252Bas%252BPotential%252BAnti-HIV-1%252BAgents%26aulast%3DHuang%26aufirst%3DBoshi%26date%3D2016%26date%3D2015%26volume%3D87%26issue%3D2%26spage%3D283%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Shiyu  Jin</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Limin  Zeng</span>, <span class="hlFld-ContribAuthor ">Yiming  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 322-333. <a href="https://doi.org/10.1016/j.ejmech.2015.11.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.11.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.11.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyridazinone%252Bderivatives%252Bdisplaying%252Bhighly%252Bpotent%252Band%252Bselective%252Binhibitory%252Bactivities%252Bagainst%252Bc-Met%252Btyrosine%252Bkinase%26aulast%3DLiu%26aufirst%3DYang%26date%3D2016%26volume%3D108%26spage%3D322%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xixi  Hou</span>, <span class="hlFld-ContribAuthor ">Jianxue  Yang</span>, <span class="hlFld-ContribAuthor ">Linlin  Mao</span>, <span class="hlFld-ContribAuthor ">Caoxuan  Lou</span>, <span class="hlFld-ContribAuthor ">Longfei  Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5,6,7,8-tetrahydroimidazo[2′,1′:2,3]thiazolo[5,4-c]pyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2016,</strong> <em>22 </em>
                                    (5)
                                     <a href="https://doi.org/10.1515/hc-2016-0137" title="DOI URL">https://doi.org/10.1515/hc-2016-0137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2016-0137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2016-0137%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3DNovel%252B5%25252C6%25252C7%25252C8-tetrahydroimidazo%25255B2%2525E2%252580%2525B2%25252C1%2525E2%252580%2525B2%25253A2%25252C3%25255Dthiazolo%25255B5%25252C4-c%25255Dpyridine%252Bderivatives%26aulast%3DHou%26aufirst%3DXixi%26date%3D2016%26volume%3D22%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiqiang  Xing</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Shiyu  Jin</span>, <span class="hlFld-ContribAuthor ">Zhangxing  Shi</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Lang  Wang</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing the cellular anti-proliferation activity of pyridazinones as c-met inhibitors using docking analysis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 302-312. <a href="https://doi.org/10.1016/j.ejmech.2015.03.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnhancing%252Bthe%252Bcellular%252Banti-proliferation%252Bactivity%252Bof%252Bpyridazinones%252Bas%252Bc-met%252Binhibitors%252Busing%252Bdocking%252Banalysis%26aulast%3DXing%26aufirst%3DWeiqiang%26date%3D2015%26volume%3D95%26spage%3D302%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunguang  Zhou</span>, <span class="hlFld-ContribAuthor ">Huimin  Liao</span>, <span class="hlFld-ContribAuthor ">Mingmei  Liu</span>, <span class="hlFld-ContribAuthor ">Guobing  Feng</span>, <span class="hlFld-ContribAuthor ">Baolin  Fu</span>, <span class="hlFld-ContribAuthor ">Ruijuan  Li</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery andw biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (22)
                                     , 6438-6452. <a href="https://doi.org/10.1016/j.bmc.2014.09.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.09.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.09.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bandw%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B6%25252C7-disubstituted-4-%2525282-fluorophenoxy%252529quinoline%252Bderivatives%252Bpossessing%252B1%25252C2%25252C3-triazole-4-carboxamide%252Bmoiety%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DZhou%26aufirst%3DShunguang%26date%3D2014%26volume%3D22%26issue%3D22%26spage%3D6438%26epage%3D6452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Xueyi  Lu</span>, <span class="hlFld-ContribAuthor ">Wenmin  Chen</span>, <span class="hlFld-ContribAuthor ">Huiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Jan  Balzarini</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (19)
                                     , 5290-5297. <a href="https://doi.org/10.1016/j.bmc.2014.08.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DArylazolyl%252528azinyl%252529thioacetanilides.%252BPart%252B16%25253A%252BStructure-based%252Bbioisosterism%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrimidinylthioacetanilides%252Bas%252Bpotent%252BHIV-1%252Binhibitors%26aulast%3DLi%26aufirst%3DXiao%26date%3D2014%26volume%3D22%26issue%3D19%26spage%3D5290%26epage%3D5297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunguang  Zhou</span>, <span class="hlFld-ContribAuthor ">Huimin  Liao</span>, <span class="hlFld-ContribAuthor ">Chao  He</span>, <span class="hlFld-ContribAuthor ">Yanan  Dou</span>, <span class="hlFld-ContribAuthor ">Mingyan  Jiang</span>, <span class="hlFld-ContribAuthor ">Lixiang  Ren</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure–activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>83 </em>, 581-593. <a href="https://doi.org/10.1016/j.ejmech.2014.06.068" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.06.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.06.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.06.068%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnovel%252B4-phenoxyquinoline%252Bderivatives%252Bcontaining%252Bpyridazinone%252Bmoiety%252Bas%252Bpotential%252Bantitumor%252Bagents%26aulast%3DZhou%26aufirst%3DShunguang%26date%3D2014%26volume%3D83%26spage%3D581%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijian  Liu</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Ruiming  Guo</span>, <span class="hlFld-ContribAuthor ">Jinxing  Hu</span>, <span class="hlFld-ContribAuthor ">Ruijuan  Li</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (14)
                                     , 3642-3653. <a href="https://doi.org/10.1016/j.bmc.2014.05.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B6%25252C7-disubstituted-4-phenoxyquinoline%252Bderivatives%252Bbearing%252B4-oxo-3%25252C4-dihydrophthalazine-1-carboxamide%252Bmoieties%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DLiu%26aufirst%3DZijian%26date%3D2014%26volume%3D22%26issue%3D14%26spage%3D3642%26epage%3D3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qidong  Tang</span>, <span class="hlFld-ContribAuthor ">Guogang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xinming  Du</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>, <span class="hlFld-ContribAuthor ">Ruijuan  Li</span>, <span class="hlFld-ContribAuthor ">Huafang  Lin</span>, <span class="hlFld-ContribAuthor ">Pengcheng  Li</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 5-(aminomethylene)pyrimidine-2,4,6-trione moiety as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (4)
                                     , 1236-1249. <a href="https://doi.org/10.1016/j.bmc.2014.01.014" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.01.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.01.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B6%25252C7-disubstituted-4-phenoxyquinoline%252Bderivatives%252Bbearing%252B5-%252528aminomethylene%252529pyrimidine-2%25252C4%25252C6-trione%252Bmoiety%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DTang%26aufirst%3DQidong%26date%3D2014%26volume%3D22%26issue%3D4%26spage%3D1236%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Dakuo  Shi</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Yingxia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel c-Met Inhibitors Bearing a 3-Carboxyl Piperidin-2-one Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (2)
                                     , 2655-2673. <a href="https://doi.org/10.3390/molecules19022655" title="DOI URL">https://doi.org/10.3390/molecules19022655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules19022655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules19022655%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BNovel%252Bc-Met%252BInhibitors%252BBearing%252Ba%252B3-Carboxyl%252BPiperidin-2-one%252BScaffold%26aulast%3DZhang%26aufirst%3DWei%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D2%26spage%3D2655%26epage%3D2673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dengyou  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Yun  Zhai</span>, <span class="hlFld-ContribAuthor ">Zhongjie  Liang</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Chunpu  Li</span>, <span class="hlFld-ContribAuthor ">Fei  Zhao</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2-amino-5-aryl-3-benzylthiopyridine scaffold based potent c-Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (21)
                                     , 6804-6820. <a href="https://doi.org/10.1016/j.bmc.2013.07.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.07.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.07.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-amino-5-aryl-3-benzylthiopyridine%252Bscaffold%252Bbased%252Bpotent%252Bc-Met%252Binhibitors%26aulast%3DZhang%26aufirst%3DDengyou%26date%3D2013%26volume%3D21%26issue%3D21%26spage%3D6804%26epage%3D6820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qidong  Tang</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinming  Du</span>, <span class="hlFld-ContribAuthor ">Lian'e  Chong</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Chun  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and structure–activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>69 </em>, 77-89. <a href="https://doi.org/10.1016/j.ejmech.2013.08.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.08.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.08.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnovel%252B6%25252C7-disubstituted-4-phenoxyquinoline%252Bderivatives%252Bas%252Bpotential%252Bantitumor%252Bagents%26aulast%3DTang%26aufirst%3DQidong%26date%3D2013%26volume%3D69%26spage%3D77%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baohui  Qi</span>, <span class="hlFld-ContribAuthor ">Bin  Mi</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Ziyi  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zeru  Tian</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of novel 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazones as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (17)
                                     , 5246-5260. <a href="https://doi.org/10.1016/j.bmc.2013.06.026" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.06.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.06.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bnovel%252B4-phenoxy-6%25252C7-disubstituted%252Bquinolines%252Bpossessing%252Bsemicarbazones%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DQi%26aufirst%3DBaohui%26date%3D2013%26volume%3D21%26issue%3D17%26spage%3D5246%26epage%3D5260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baohui  Qi</span>, <span class="hlFld-ContribAuthor ">Haiyan  Tao</span>, <span class="hlFld-ContribAuthor ">Di  Wu</span>, <span class="hlFld-ContribAuthor ">Jinying  Bai</span>, <span class="hlFld-ContribAuthor ">Yandan  Shi</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of 4-Phenoxy-6,7-disubstituted Quinolines Possessing Semicarbazone Scaffolds as Selective c-Met Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2013,</strong> <em>346 </em>
                                    (8)
                                     , 596-609. <a href="https://doi.org/10.1002/ardp.201300087" title="DOI URL">https://doi.org/10.1002/ardp.201300087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201300087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201300087%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252B4-Phenoxy-6%25252C7-disubstituted%252BQuinolines%252BPossessing%252BSemicarbazone%252BScaffolds%252Bas%252BSelective%252Bc-Met%252BInhibitors%26aulast%3DQi%26aufirst%3DBaohui%26date%3D2013%26date%3D2013%26volume%3D346%26issue%3D8%26spage%3D596%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Jiang</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Haicheng  Liu</span>, <span class="hlFld-ContribAuthor ">Guangyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antitumor Activity of Novel 4-(2-Fluorophenoxy)quinoline Derivatives Bearing the 4-Oxo-1,4-dihydroquinoline-3-carboxamide Moiety. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2013,</strong> <em>346 </em>
                                    (7)
                                     , 521-533. <a href="https://doi.org/10.1002/ardp.201300029" title="DOI URL">https://doi.org/10.1002/ardp.201300029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201300029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201300029%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BAntitumor%252BActivity%252Bof%252BNovel%252B4-%2525282-Fluorophenoxy%252529quinoline%252BDerivatives%252BBearing%252Bthe%252B4-Oxo-1%25252C4-dihydroquinoline-3-carboxamide%252BMoiety%26aulast%3DLi%26aufirst%3DSai%26date%3D2013%26date%3D2013%26volume%3D346%26issue%3D7%26spage%3D521%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lianbao  Ye</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Ou</span>, <span class="hlFld-ContribAuthor ">Yuanxin  Tian</span>, <span class="hlFld-ContribAuthor ">Bangwei  Yu</span>, <span class="hlFld-ContribAuthor ">Yan  Luo</span>, <span class="hlFld-ContribAuthor ">Binghong  Feng</span>, <span class="hlFld-ContribAuthor ">Hansen  Lin</span>, <span class="hlFld-ContribAuthor ">Jiajie  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuguang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Indazoles as potential c-met inhibitors: Design, synthesis and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>65 </em>, 112-118. <a href="https://doi.org/10.1016/j.ejmech.2013.04.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndazoles%252Bas%252Bpotential%252Bc-met%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%252Band%2525C2%2525A0molecular%252Bdocking%252Bstudies%26aulast%3DYe%26aufirst%3DLianbao%26date%3D2013%26volume%3D65%26spage%3D112%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai  Li</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Kewen  Wang</span>, <span class="hlFld-ContribAuthor ">Yali  Gao</span>, <span class="hlFld-ContribAuthor ">Jianming  Han</span>, <span class="hlFld-ContribAuthor ">Bingbing  Cui</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (11)
                                     , 2843-2855. <a href="https://doi.org/10.1016/j.bmc.2013.04.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.04.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.04.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B4-%2525282-fluorophenoxy%252529quinoline%252Bderivatives%252Bbearing%252B4-oxo-1%25252C4-dihydrocinnoline-3-carboxamide%252Bmoiety%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DLi%26aufirst%3DSai%26date%3D2013%26volume%3D21%26issue%3D11%26spage%3D2843%26epage%3D2855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Huang</span>, <span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuang  Liu</span>, <span class="hlFld-ContribAuthor ">Chao  He</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>64 </em>, 62-73. <a href="https://doi.org/10.1016/j.ejmech.2013.04.001" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantitumour%252Bactivity%252Bof%252Bbisquinoline%252Bderivatives%252Bconnected%252Bby%252B4-oxy-3-fluoroaniline%252Bmoiety%26aulast%3DLi%26aufirst%3DSai%26date%3D2013%26volume%3D64%26spage%3D62%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorenzo  Palmieri</span>, <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>. </span><span class="cited-content_cbyCitation_article-title">αC helix displacement as a general approach for allosteric modulation of protein kinases. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2013,</strong> <em>18 </em>
                                    (7-8)
                                     , 407-414. <a href="https://doi.org/10.1016/j.drudis.2012.11.009" title="DOI URL">https://doi.org/10.1016/j.drudis.2012.11.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2012.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2012.11.009%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3D%2525CE%2525B1C%252Bhelix%252Bdisplacement%252Bas%252Ba%252Bgeneral%252Bapproach%252Bfor%252Ballosteric%252Bmodulation%252Bof%252Bprotein%252Bkinases%26aulast%3DPalmieri%26aufirst%3DLorenzo%26date%3D2013%26volume%3D18%26issue%3D7-8%26spage%3D407%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dengyou  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Zhongjie  Liang</span>, <span class="hlFld-ContribAuthor ">Chunpu  Li</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">YinChun  Ji</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (17)
                                     , 5169-5180. <a href="https://doi.org/10.1016/j.bmc.2012.07.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B2-aminopyridine-3-carboxamides%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DZhang%26aufirst%3DDengyou%26date%3D2012%26volume%3D20%26issue%3D17%26spage%3D5169%26epage%3D5180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita  Azevedo</span>, <span class="hlFld-ContribAuthor ">Mario  van Zeeland</span>, <span class="hlFld-ContribAuthor ">Hans  Raaijmakers</span>, <span class="hlFld-ContribAuthor ">Bert  Kazemier</span>, <span class="hlFld-ContribAuthor ">Jacob  de Vlieg</span>, <span class="hlFld-ContribAuthor ">Arthur  Oubrie</span>. </span><span class="cited-content_cbyCitation_article-title">X-ray structure of p38α bound to TAK-715: comparison with three classic inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Biological Crystallography</span><span> <strong>2012,</strong> <em>68 </em>
                                    (8)
                                     , 1041-1050. <a href="https://doi.org/10.1107/S090744491201997X" title="DOI URL">https://doi.org/10.1107/S090744491201997X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S090744491201997X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS090744491201997X%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Biological%2520Crystallography%26atitle%3DX-ray%252Bstructure%252Bof%252Bp38%2525CE%2525B1%252Bbound%252Bto%252BTAK-715%25253A%252Bcomparison%252Bwith%252Bthree%252Bclassic%252Binhibitors%26aulast%3DAzevedo%26aufirst%3DRita%26date%3D2012%26date%3D2012%26volume%3D68%26issue%3D8%26spage%3D1041%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiane M.  Bode</span>, <span class="hlFld-ContribAuthor ">Alessandro A.  Boezio</span>, <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, <span class="hlFld-ContribAuthor ">Steven F.  Bellon</span>, <span class="hlFld-ContribAuthor ">Loren  Berry</span>, <span class="hlFld-ContribAuthor ">Martin A.  Broome</span>, <span class="hlFld-ContribAuthor ">Deborah  Choquette</span>, <span class="hlFld-ContribAuthor ">Isabelle  Dussault</span>, <span class="hlFld-ContribAuthor ">Richard T.  Lewis</span>, <span class="hlFld-ContribAuthor ">Min-Hwa Jasmine  Lin</span>, <span class="hlFld-ContribAuthor ">Karen  Rex</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Yajing  Yang</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (12)
                                     , 4089-4093. <a href="https://doi.org/10.1016/j.bmcl.2012.04.072" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Ba%252Bpotent%252Band%252Bselective%252Btriazolopyridinone%252Bseries%252Bof%252Bc-Met%252Binhibitors%26aulast%3DBode%26aufirst%3DChristiane%2BM.%26date%3D2012%26volume%3D22%26issue%3D12%26spage%3D4089%26epage%3D4093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibrahim  Petekkaya</span>, <span class="hlFld-ContribAuthor ">Veysel  Ayyildiz</span>, <span class="hlFld-ContribAuthor ">Muhammet C.  Kizilarslanoglu</span>, <span class="hlFld-ContribAuthor ">Ugur  Sahin</span>, <span class="hlFld-ContribAuthor ">Gamze  Gezgen</span>, <span class="hlFld-ContribAuthor ">Emir C.  Roach</span>, <span class="hlFld-ContribAuthor ">Musturay  Karcaaltincaba</span>, <span class="hlFld-ContribAuthor ">Kadri  Altundag</span>. </span><span class="cited-content_cbyCitation_article-title">Prognosis of breast cancer in patients with peritoneal metastasis. </span><span class="cited-content_cbyCitation_journal-name">The Breast</span><span> <strong>2012,</strong> <em>21 </em>
                                    (3)
                                     , 420-421. <a href="https://doi.org/10.1016/j.breast.2012.02.008" title="DOI URL">https://doi.org/10.1016/j.breast.2012.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.breast.2012.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.breast.2012.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Breast%26atitle%3DPrognosis%252Bof%252Bbreast%252Bcancer%252Bin%252Bpatients%252Bwith%252Bperitoneal%252Bmetastasis%26aulast%3DPetekkaya%26aufirst%3DIbrahim%26date%3D2012%26volume%3D21%26issue%3D3%26spage%3D420%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ermanno  Gherardi</span>, <span class="hlFld-ContribAuthor ">Walter  Birchmeier</span>, <span class="hlFld-ContribAuthor ">Carmen  Birchmeier</span>, <span class="hlFld-ContribAuthor ">George Vande  Woude</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting MET in cancer: rationale and progress. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Cancer</span><span> <strong>2012,</strong> <em>12 </em>
                                    (2)
                                     , 89-103. <a href="https://doi.org/10.1038/nrc3205" title="DOI URL">https://doi.org/10.1038/nrc3205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrc3205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrc3205%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Cancer%26atitle%3DTargeting%252BMET%252Bin%252Bcancer%25253A%252Brationale%252Band%252Bprogress%26aulast%3DGherardi%26aufirst%3DErmanno%26date%3D2012%26date%3D2012%26volume%3D12%26issue%3D2%26spage%3D89%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Furlan</span>, <span class="hlFld-ContribAuthor ">Francesco  Colombo</span>, <span class="hlFld-ContribAuthor ">Andrea  Kover</span>, <span class="hlFld-ContribAuthor ">Nathalie  Issaly</span>, <span class="hlFld-ContribAuthor ">Cristina  Tintori</span>, <span class="hlFld-ContribAuthor ">Lucilla  Angeli</span>, <span class="hlFld-ContribAuthor ">Vincent  Leroux</span>, <span class="hlFld-ContribAuthor ">Sébastien  Letard</span>, <span class="hlFld-ContribAuthor ">Mercedes  Amat</span>, <span class="hlFld-ContribAuthor ">Yasmine  Asses</span>, <span class="hlFld-ContribAuthor ">Bernard  Maigret</span>, <span class="hlFld-ContribAuthor ">Patrice  Dubreuil</span>, <span class="hlFld-ContribAuthor ">Maurizio  Botta</span>, <span class="hlFld-ContribAuthor ">Rosanna  Dono</span>, <span class="hlFld-ContribAuthor ">Joan  Bosch</span>, <span class="hlFld-ContribAuthor ">Oreste  Piccolo</span>, <span class="hlFld-ContribAuthor ">Daniele  Passarella</span>, <span class="hlFld-ContribAuthor ">Flavio  Maina</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of new aminoacid amides containing the imidazo[2,1-b]benzothiazol-2-ylphenyl moiety as inhibitors of tumorigenesis by oncogenic Met signaling. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>47 </em>, 239-254. <a href="https://doi.org/10.1016/j.ejmech.2011.10.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.10.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.10.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.10.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnew%252Baminoacid%252Bamides%252Bcontaining%252Bthe%252Bimidazo%25255B2%25252C1-b%25255Dbenzothiazol-2-ylphenyl%252Bmoiety%252Bas%252Binhibitors%252Bof%252Btumorigenesis%252Bby%252Boncogenic%252BMet%252Bsignaling%26aulast%3DFurlan%26aufirst%3DAlessandro%26date%3D2012%26volume%3D47%26spage%3D239%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongjie  Liang</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Xiangqian  Kong</span>, <span class="hlFld-ContribAuthor ">Limin  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovering potent inhibitors against c-Met kinase: molecular design, organic synthesis and bioassay. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2012,</strong> <em>10 </em>
                                    (2)
                                     , 421-430. <a href="https://doi.org/10.1039/C1OB06186K" title="DOI URL">https://doi.org/10.1039/C1OB06186K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C1OB06186K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC1OB06186K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DDiscovering%252Bpotent%252Binhibitors%252Bagainst%252Bc-Met%252Bkinase%25253A%252Bmolecular%252Bdesign%25252C%252Borganic%252Bsynthesis%252Band%252Bbioassay%26aulast%3DLiang%26aufirst%3DZhongjie%26date%3D2012%26date%3D2012%26volume%3D10%26issue%3D2%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Qing  Xie</span>, <span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">You-Li  Pan</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Ping  Zhou</span>, <span class="hlFld-ContribAuthor ">Lei  Di-wu</span>, <span class="hlFld-ContribAuthor ">Qi  Huang</span>, <span class="hlFld-ContribAuthor ">Yu-Lan  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Huan-Zhang  Xie</span>, <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Combined SVM-based and docking-based virtual screening for retrieving novel inhibitors of c-Met. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (9)
                                     , 3675-3680. <a href="https://doi.org/10.1016/j.ejmech.2011.05.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.05.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.05.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.05.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCombined%252BSVM-based%252Band%252Bdocking-based%252Bvirtual%252Bscreening%252Bfor%252Bretrieving%252Bnovel%252Binhibitors%252Bof%252Bc-Met%26aulast%3DXie%26aufirst%3DQing-Qing%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D3675%26epage%3D3680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ailing  Zhao</span>, <span class="hlFld-ContribAuthor ">Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Yuanxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (13)
                                     , 3906-3918. <a href="https://doi.org/10.1016/j.bmc.2011.05.038" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.05.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.05.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bc-Met%252Bkinase%252Binhibitors%252Bbearing%252Ba%252Bthieno%25255B2%25252C3-d%25255Dpyrimidine%252Bor%252Bfuro%25255B2%25252C3-d%25255Dpyrimidine%252Bscaffold%26aulast%3DZhao%26aufirst%3DAiling%26date%3D2011%26volume%3D19%26issue%3D13%26spage%3D3906%26epage%3D3918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongjie  Liang</span>, <span class="hlFld-ContribAuthor ">Dengyou  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Limin  Chen</span>, <span class="hlFld-ContribAuthor ">Hengshuai  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangqian  Kong</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and synthesis of N′-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (12)
                                     , 3749-3754. <a href="https://doi.org/10.1016/j.bmcl.2011.04.064" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.04.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.04.064%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Band%252Bsynthesis%252Bof%252BN%2525E2%252580%2525B2-%2525282-oxoindolin-3-ylidene%252529hydrazide%252Bderivatives%252Bagainst%252Bc-Met%252Bkinase%26aulast%3DLiang%26aufirst%3DZhongjie%26date%3D2011%26volume%3D21%26issue%3D12%26spage%3D3749%26epage%3D3754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julio  Caballero</span>, <span class="hlFld-ContribAuthor ">Miguel  Quiliano</span>, <span class="hlFld-ContribAuthor ">Jans H.  Alzate-Morales</span>, <span class="hlFld-ContribAuthor ">Mirko  Zimic</span>, <span class="hlFld-ContribAuthor ">Eric  Deharo</span>. </span><span class="cited-content_cbyCitation_article-title">Docking and quantitative structure–activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2011,</strong> <em>25 </em>
                                    (4)
                                     , 349-369. <a href="https://doi.org/10.1007/s10822-011-9425-1" title="DOI URL">https://doi.org/10.1007/s10822-011-9425-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-011-9425-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-011-9425-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DDocking%252Band%252Bquantitative%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bfor%252B3-fluoro-4-%252528pyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-4-yloxy%252529aniline%25252C%252B3-fluoro-4-%2525281H-pyrrolo%25255B2%25252C3-b%25255Dpyridin-4-yloxy%252529aniline%25252C%252Band%252B4-%2525284-amino-2-fluorophenoxy%252529-2-pyridinylamine%252Bderivatives%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DCaballero%26aufirst%3DJulio%26date%3D2011%26date%3D2011%26volume%3D25%26issue%3D4%26spage%3D349%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith W.  Rickert</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Allison</span>, <span class="hlFld-ContribAuthor ">Noel J.  Byrne</span>, <span class="hlFld-ContribAuthor ">Paul L.  Darke</span>, <span class="hlFld-ContribAuthor ">Rachael E.  Ford</span>, <span class="hlFld-ContribAuthor ">David J.  Guerin</span>, <span class="hlFld-ContribAuthor ">Dawn L.  Hall</span>, <span class="hlFld-ContribAuthor ">Maria  Kornienko</span>, <span class="hlFld-ContribAuthor ">Jun  Lu</span>, <span class="hlFld-ContribAuthor ">Sanjeev K.  Munshi</span>, <span class="hlFld-ContribAuthor ">John C.  Reid</span>, <span class="hlFld-ContribAuthor ">Jennifer M.  Shipman</span>, <span class="hlFld-ContribAuthor ">Elizabeth F.  Stanton</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jonathon R.  Young</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Soisson</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Lumb</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2011,</strong> <em>286 </em>
                                    (13)
                                     , 11218-11225. <a href="https://doi.org/10.1074/jbc.M110.204404" title="DOI URL">https://doi.org/10.1074/jbc.M110.204404</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M110.204404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M110.204404%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DStructural%252BBasis%252Bfor%252BSelective%252BSmall%252BMolecule%252BKinase%252BInhibition%252Bof%252BActivated%252Bc-Met%26aulast%3DRickert%26aufirst%3DKeith%2BW.%26date%3D2011%26volume%3D286%26issue%3D13%26spage%3D11218%26epage%3D11225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Porter</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule c-Met kinase inhibitors: a review of recent patents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2010,</strong> <em>20 </em>
                                    (2)
                                     , 159-177. <a href="https://doi.org/10.1517/13543770903514137" title="DOI URL">https://doi.org/10.1517/13543770903514137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543770903514137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543770903514137%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall%252Bmolecule%252Bc-Met%252Bkinase%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Brecent%252Bpatents%26aulast%3DPorter%26aufirst%3DJohn%26date%3D2010%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D159%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Mannion</span>, <span class="hlFld-ContribAuthor ">Stéphane  Raeppel</span>, <span class="hlFld-ContribAuthor ">Stephen  Claridge</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhou</span>, <span class="hlFld-ContribAuthor ">Oscar  Saavedra</span>, <span class="hlFld-ContribAuthor ">Ljubomir  Isakovic</span>, <span class="hlFld-ContribAuthor ">Lijie  Zhan</span>, <span class="hlFld-ContribAuthor ">Frédéric  Gaudette</span>, <span class="hlFld-ContribAuthor ">Franck  Raeppel</span>, <span class="hlFld-ContribAuthor ">Robert  Déziel</span>, <span class="hlFld-ContribAuthor ">Normand  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Hannah  Nguyen</span>, <span class="hlFld-ContribAuthor ">Ian  Chute</span>, <span class="hlFld-ContribAuthor ">Carole  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Isabelle  Dupont</span>, <span class="hlFld-ContribAuthor ">Marie-France  Robert</span>, <span class="hlFld-ContribAuthor ">Sylvain  Lefebvre</span>, <span class="hlFld-ContribAuthor ">Marja  Dubay</span>, <span class="hlFld-ContribAuthor ">Jubrail  Rahil</span>, <span class="hlFld-ContribAuthor ">James  Wang</span>, <span class="hlFld-ContribAuthor ">Hélène  Ste-Croix</span>, <span class="hlFld-ContribAuthor ">A.  Robert Macleod</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Besterman</span>, <span class="hlFld-ContribAuthor ">Arkadii  Vaisburg</span>. </span><span class="cited-content_cbyCitation_article-title">N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (23)
                                     , 6552-6556. <a href="https://doi.org/10.1016/j.bmcl.2009.10.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.10.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.10.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DN-%2525284-%2525286%25252C7-Disubstituted-quinolin-4-yloxy%252529-3-fluorophenyl%252529-2-oxo-3-phenylimidazolidine-1-carboxamides%25253A%252BA%252Bnovel%252Bseries%252Bof%252Bdual%252Bc-Met%25252FVEGFR2%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DMannion%26aufirst%3DMichael%26date%3D2009%26volume%3D19%26issue%3D23%26spage%3D6552%26epage%3D6556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Saavedra</span>, <span class="hlFld-ContribAuthor ">Stephen  Claridge</span>, <span class="hlFld-ContribAuthor ">Lijie  Zhan</span>, <span class="hlFld-ContribAuthor ">Franck  Raeppel</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Granger</span>, <span class="hlFld-ContribAuthor ">Stéphane  Raeppel</span>, <span class="hlFld-ContribAuthor ">Michael  Mannion</span>, <span class="hlFld-ContribAuthor ">Frédéric  Gaudette</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhou</span>, <span class="hlFld-ContribAuthor ">Ljubomir  Isakovic</span>, <span class="hlFld-ContribAuthor ">Naomy  Bernstein</span>, <span class="hlFld-ContribAuthor ">Robert  Déziel</span>, <span class="hlFld-ContribAuthor ">Hannah  Nguyen</span>, <span class="hlFld-ContribAuthor ">Normand  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Carole  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Isabelle  Dupont</span>, <span class="hlFld-ContribAuthor ">James  Wang</span>, <span class="hlFld-ContribAuthor ">A. Robert  Macleod</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Besterman</span>, <span class="hlFld-ContribAuthor ">Arkadii  Vaisburg</span>. </span><span class="cited-content_cbyCitation_article-title">N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (24)
                                     , 6836-6839. <a href="https://doi.org/10.1016/j.bmcl.2009.10.095" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.10.095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.10.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.10.095%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DN3-Arylmalonamides%25253A%252BA%252Bnew%252Bseries%252Bof%252Bthieno%25255B3%25252C2-b%25255Dpyridine%252Bbased%252Binhibitors%252Bof%252Bc-Met%252Band%252BVEGFR2%252Btyrosine%252Bkinases%26aulast%3DSaavedra%26aufirst%3DOscar%26date%3D2009%26volume%3D19%26issue%3D24%26spage%3D6836%26epage%3D6839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian T.  Grimberg</span>, <span class="hlFld-ContribAuthor ">Maria M.  Jaworska</span>, <span class="hlFld-ContribAuthor ">Lindsay B.  Hough</span>, <span class="hlFld-ContribAuthor ">Peter A.  Zimmerman</span>, <span class="hlFld-ContribAuthor ">James G.  Phillips</span>. </span><span class="cited-content_cbyCitation_article-title">Addressing the malaria drug resistance challenge using flow cytometry to discover new antimalarials. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (18)
                                     , 5452-5457. <a href="https://doi.org/10.1016/j.bmcl.2009.07.095" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.07.095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.07.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.07.095%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAddressing%252Bthe%252Bmalaria%252Bdrug%252Bresistance%252Bchallenge%252Busing%252Bflow%252Bcytometry%252Bto%252Bdiscover%252Bnew%252Bantimalarials%26aulast%3DGrimberg%26aufirst%3DBrian%2BT.%26date%3D2009%26volume%3D19%26issue%3D18%26spage%3D5452%26epage%3D5457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Tuthill</span>, <span class="hlFld-ContribAuthor ">Robert  Pell</span>, <span class="hlFld-ContribAuthor ">Rosa  Guiliani</span>, <span class="hlFld-ContribAuthor ">Adrian  Lim</span>, <span class="hlFld-ContribAuthor ">Mihir  Gudi</span>, <span class="hlFld-ContribAuthor ">Kaiyumars B.  Contractor</span>, <span class="hlFld-ContribAuthor ">Jacqueline S.  Lewis</span>, <span class="hlFld-ContribAuthor ">R. Charles  Coombes</span>, <span class="hlFld-ContribAuthor ">Justin  Stebbing</span>. </span><span class="cited-content_cbyCitation_article-title">Peritoneal disease in breast cancer: A specific entity with an extremely poor prognosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2009,</strong> <em>45 </em>
                                    (12)
                                     , 2146-2149. <a href="https://doi.org/10.1016/j.ejca.2009.04.027" title="DOI URL">https://doi.org/10.1016/j.ejca.2009.04.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2009.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2009.04.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DPeritoneal%252Bdisease%252Bin%252Bbreast%252Bcancer%25253A%252BA%252Bspecific%252Bentity%252Bwith%252Ban%252Bextremely%252Bpoor%252Bprognosis%26aulast%3DTuthill%26aufirst%3DMark%26date%3D2009%26volume%3D45%26issue%3D12%26spage%3D2146%26epage%3D2149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra W  Cowan-Jacob</span>, <span class="hlFld-ContribAuthor ">Henrik  Möbitz</span>, <span class="hlFld-ContribAuthor ">Doriano  Fabbro</span>. </span><span class="cited-content_cbyCitation_article-title">Structural biology contributions to tyrosine kinase drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Cell Biology</span><span> <strong>2009,</strong> <em>21 </em>
                                    (2)
                                     , 280-287. <a href="https://doi.org/10.1016/j.ceb.2009.01.012" title="DOI URL">https://doi.org/10.1016/j.ceb.2009.01.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ceb.2009.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ceb.2009.01.012%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Cell%2520Biology%26atitle%3DStructural%252Bbiology%252Bcontributions%252Bto%252Btyrosine%252Bkinase%252Bdrug%252Bdiscovery%26aulast%3DCowan-Jacob%26aufirst%3DSandra%2BW%26date%3D2009%26volume%3D21%26issue%3D2%26spage%3D280%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stéphane  Raeppel</span>, <span class="hlFld-ContribAuthor ">Stephen  Claridge</span>, <span class="hlFld-ContribAuthor ">Oscar  Saavedra</span>, <span class="hlFld-ContribAuthor ">Frédéric  Gaudette</span>, <span class="hlFld-ContribAuthor ">Lijie  Zhan</span>, <span class="hlFld-ContribAuthor ">Michael  Mannion</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhou</span>, <span class="hlFld-ContribAuthor ">Franck  Raeppel</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Granger</span>, <span class="hlFld-ContribAuthor ">Ljubomir  Isakovic</span>, <span class="hlFld-ContribAuthor ">Robert  Déziel</span>, <span class="hlFld-ContribAuthor ">Hannah  Nguyen</span>, <span class="hlFld-ContribAuthor ">Normand  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Carole  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Isabelle  Dupont</span>, <span class="hlFld-ContribAuthor ">Marie-France  Robert</span>, <span class="hlFld-ContribAuthor ">Sylvain  Lefebvre</span>, <span class="hlFld-ContribAuthor ">Marja  Dubay</span>, <span class="hlFld-ContribAuthor ">Jubrail  Rahil</span>, <span class="hlFld-ContribAuthor ">James  Wang</span>, <span class="hlFld-ContribAuthor ">Hélène  Ste-Croix</span>, <span class="hlFld-ContribAuthor ">A.  Robert Macleod</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Besterman</span>, <span class="hlFld-ContribAuthor ">Arkadii  Vaisburg</span>. </span><span class="cited-content_cbyCitation_article-title">N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (5)
                                     , 1323-1328. <a href="https://doi.org/10.1016/j.bmcl.2009.01.068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.01.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.01.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DN-%2525283-fluoro-4-%2525282-arylthieno%25255B3%25252C2-b%25255Dpyridin-7-yloxy%252529phenyl%252529-2-oxo-3-phenylimidazolidine-1-carboxamides%25253A%252BA%252Bnovel%252Bseries%252Bof%252Bdual%252Bc-Met%25252FVEGFR2%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DRaeppel%26aufirst%3DSt%25C3%25A9phane%26date%3D2009%26volume%3D19%26issue%3D5%26spage%3D1323%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0001.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Small-molecule c-Met inhibitors and the design of the pyrimidone series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0003.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LiHMDS, DMF, MeI, 0 °C to rt; (ii) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C; (iii) 3-fluoro-4-methoxyphenylboronic acid, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>S</i>-Phos, K<sub>3</sub>PO<sub>4</sub>, PhMe, 100 °C; (iv) ArylZnCl, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, 60 °C; (v) HOAc, HBr, 120 °C; (vi) MeSO<sub>3</sub>H, TFA, reflux; (vii) Cl(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF; (viii) amine, NaI, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (ix) DMAP, 1,4-dioxane, 110 °C; (x) pyridine, 1,4-dioxane, 110 °C; (xi) DMAP, 1,4-dioxane, 120 °C, μW; and (xii) DMAP, pyridine, 1,4-dioxane, 90 °C, μW.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0004.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C; (ii) 3-fluoro-4-methoxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, 100 °C, μW; (iii) HOAc, HBr, 120 °C; (iv) 4-chloro-6,7-dimethoxyquinoline, DMAP, PhMe, CHCl<sub>3</sub>, 180 °C; and (v) 2 N NaOH, MeI, 1,4-dioxane, 40 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0005.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NBS, CHCl<sub>3</sub>; (ii) NaN<sub>3</sub>, DMF, 0 °C; (iii) H<sub>2</sub>, Pd/C, EtOAc, THF; and (iv) RCOCl, Et<sub>3</sub>N, DCM, 0 °C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0006.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Cu, KOH, DMF, pyridine, 110 °C, μW.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0007.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HOAc, HBr, 120 °C; (ii) RNH<sub>2</sub>, concd HCl, 120 °C, μW; (iii) 4-chloro-6,7-dimethoxyquinoline, DMAP, 1,4-dioxane, 120 °C, μW; and (iv) <b>16</b>, Cu, KOH, DMF, pyridine, 110 °C, μW.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0008.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4-chloro-6,7-dimethoxyquinoline, DMAP, pyridine, 1,4-dioxane, 110 °C; (ii) urea hydrogen peroxide, TFA, MeCN, 0 °C; TFAA, 0 °C to rt; (iii) POCl<sub>3</sub>, <i>N</i>,<i>N</i>-dimethylaniline, 125 °C to rt; and (iv) RNH<sub>2</sub>, concd HCl, 1,4-dioxane, 60 °C, μW.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0009.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, BnBr, DMF, 0 °C to rt; (ii) Pd(PPh<sub>3</sub>)<sub>4</sub>, <i>t</i>-BuOC(O)CH<sub>2</sub>ZnCl, THF, 60 °C; (iii) TFA, DCM, 0 °C to rt; (iv) (COCl)<sub>2</sub>, DCM, DMF; <b>59</b>, Et<sub>3</sub>N, 0 °C to greater than rt; (v) 4-fluoroaniline, concd HCl, 1,4-dioxane, 125 °C; (vi) BBr<sub>3</sub>, DCM; and (vii) <b>16</b>, DMAP, pyridine, 1,4-dioxane, 130 °C.</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal of <b>7</b> bound to c-Met.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal of <b>50</b> bound to c-Met.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Torsional profiles of 5-phenyl pyrimidone (top) and pyridin-2-yl pyrimidone (bottom) for the dihedral angle highlighted in red. The coplanar structures shown are defined with a dihedral angle of 0°. Energy profiles were calculated on the basis of gas-phase quantum mechanic calculations by the use of density functional theory.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>22</b> and <b>51</b> on HGF-mediated c-Met phosphorylation at 2 h postdose. Asterisk denotes <i>p</i> < 0.0001 compared with the HGF group (black bar). Bars represent the mean ± standard deviation (<i>n</i> = 3). Circles represent mean plasma concentration ± standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/medium/jm-2008-006189_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of <b>62</b> on HGF-mediated c-Met phosphorylation at 2 h postdose. Asterisk denotes <i>p</i> < 0.0001 compared with the HGF group (black bar). Bars represent the mean ± standard deviation (<i>n</i> = 3). Circles represent mean plasma concentration ± standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-18/jm8006189/production/images/large/jm-2008-006189_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8006189&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Longati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span> </span><span class="NLM_article-title">Receptor Tyrosine Kinases as Therapeutic Targets: The Model of the Met Oncogene</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.2174%2F1389450013348920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=11465538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVCqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=41-55&author=P.+Longatiauthor=P.+M.+Comoglioauthor=A.+Bardelli&title=Receptor+Tyrosine+Kinases+as+Therapeutic+Targets%3A+The+Model+of+the+Met+Oncogene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene</span></div><div class="casAuthors">Longati, Paola; Comoglio, Paolo M.; Bardelli, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-55</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 104 refs.  Control of cell growth and differentiation occurs via extracellular signals known as growth factors.  Growth factors are high affinity ligands for transmembrane receptors belonging to the family of receptor tyrosine kinases (RTKs).  A no. of genetic evidences have implicated RTKs in human diseases including developmental disorders and cancer.  For instance, germline missense mutations involving the Ret receptor are found in patients affected by multiple endocrine neoplasia types 2A and 2B (MEN2A and MEN2B) or familial medullary thyroid carcinomas.  Somatic mutations in the Kit receptor are found in mastocytomas and in gastrointestinal tumors.  Germline and sporadic mutations of the Met receptor have been described in kidney and hepatocellular carcinomas.  Overexpression of the HER-2/neu receptor in breast cancer has been assocd. with tumor progression.  The enzymic activity of RTKs is strictly regulated and is usually inhibited under basal conditions.  Receptor activation triggers a biochem. signaling cascade inside the cytoplasm, named signal transduction, which is subverted during the malignant transformation of cells.  Signal transduction by RTKs is a multistep process which includes: (i) Ligand binding and receptor dimerization, (ii) receptor phosphorylation on tyrosine residues; (iii) recruitment to the receptor and activation of cytoplasmic signaling mols. that transmit signals to the nucleus.  Each of the steps involved in this process can potentially be targeted to block the aberrant properties of tyrosine kinase receptors.  By using the MET oncogene as a model this review focuses on the strategies that can be applied to therapeutically target RTKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmKpFV7qgmVLVg90H21EOLACvtfcHk0liQ1MG8fHxQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVCqsrw%253D&md5=f83d61a5d349dad104758e87e6387ee8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1389450013348920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450013348920%26sid%3Dliteratum%253Aachs%26aulast%3DLongati%26aufirst%3DP.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DBardelli%26aufirst%3DA.%26atitle%3DReceptor%2520Tyrosine%2520Kinases%2520as%2520Therapeutic%2520Targets%253A%2520The%2520Model%2520of%2520the%2520Met%2520Oncogene%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2001%26volume%3D2%26spage%3D41%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Haddad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, C. P.</span><span> </span><span class="NLM_article-title">Hepatocyte Growth Factor Expression in Human Cancer and Therapy with Specific Inhibitors</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4243</span><span class="NLM_x">–</span> <span class="NLM_lpage">4252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=11908677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1amtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=4243-4252&author=R.+Haddadauthor=K.+E.+Lipsonauthor=C.+P.+Webb&title=Hepatocyte+Growth+Factor+Expression+in+Human+Cancer+and+Therapy+with+Specific+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors</span></div><div class="casAuthors">Haddad, Ramsi; Lipson, Kenneth E.; Webb, Craig P.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6B</span>),
    <span class="NLM_cas:pages">4243-4252</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">A review.  Hepatocyte growth factor/Scatter Factor (HGF/SF) mediated stimulation of the Met receptor tyrosine kinase results in pleiotropic cellular effects including proliferation, morphogenesis, motility and invasion.  In vivo, HGF/SF-Met activation has been shown to participate in tumorigenesis, angiogenesis and metastasis.  Coupled with accumulating evidence that aberrant HGF/SF-Met expression is frequently obsd. in a variety of human tumors, often in assocn. with progressive disease, these data present HGF/SF-Met as an attractive target for therapeutic intervention in human cancer.  In this review, we will present the most compelling evidence suggesting a key role for HGF/SF-Met signaling in tumorigenesis, and discuss several possible therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe6OmgwbFpTbVg90H21EOLACvtfcHk0liQ1MG8fHxQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1amtL4%253D&md5=04bb293ee488f6371aa8dd5044cdc89b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaddad%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DWebb%26aufirst%3DC.%2BP.%26atitle%3DHepatocyte%2520Growth%2520Factor%2520Expression%2520in%2520Human%2520Cancer%2520and%2520Therapy%2520with%2520Specific%2520Inhibitors%26jtitle%3DAnticancer%2520Res.%26date%3D2001%26volume%3D21%26spage%3D4243%26epage%3D4252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Maulik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kijima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgi, R.</span><span> </span><span class="NLM_article-title">Role of the Hepatocyte Growth Factor Receptor, c-Met, in Oncogenesis and Potential for Therapeutic Inhibition</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1016%2FS1359-6101%2801%2900029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=11750879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1ahuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=41-59&author=G.+Maulikauthor=A.+Shrikhandeauthor=T.+Kijimaauthor=P.+C.+Maauthor=P.+T.+Morrisonauthor=R.+Salgi&title=Role+of+the+Hepatocyte+Growth+Factor+Receptor%2C+c-Met%2C+in+Oncogenesis+and+Potential+for+Therapeutic+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition</span></div><div class="casAuthors">Maulik, Gautam; Shrikhande, Amol; Kijima, Takashi; Ma, Patrick C.; Morrison, Paul T.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-59</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review is given.  Receptor tyrosine kinases have become important therapeutic targets for anti-neoplastic molecularly targeted therapies.  C-Met is a receptor tyrosine kinase shown to be over-expressed and mutated in a variety of malignancies.  Stimulation of c-Met via its ligand hepatocyte growth factor also known as scatter factor (HGF/SF), leads to a plethora of biol. and biochem. effects in the cell.  There has been considerable knowledge gained on the role of c-Met-HGF/SF axis in normal and malignant cells.  This review summarizes the structure of c-Met and HGF/SF and their family members.  Since there are known mutations of c-Met in solid tumors, particularly in papillary renal cell carcinoma, we have summarized the various mutations and over-expression of c-Met known thus far.  Stimulation of c-Met can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventual metastasis.  The biol. functions altered by c-Met are quite unique and described in detail.  Along with biol. functions, various signal transduction pathways, including the cytoskeleton are altered with the activation of c-Met-HGF/SF loop.  We have recently shown the phosphorylation of focal adhesion proteins, such as paxillin and p125FAK in response to c-Met stimulation in lung cancer cells, and this is detailed here.  Finally, c-Met when mutated or over-expressed in malignant cells serves as an important therapeutic target and the most recent data in terms of inhibition of c-Met and downstream signal transduction pathways is summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2mu2QMKr_7Vg90H21EOLACvtfcHk0liQ1MG8fHxQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1ahuro%253D&md5=aead14efa103c522ef374b0a16e51b35</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1359-6101%2801%2900029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6101%252801%252900029-6%26sid%3Dliteratum%253Aachs%26aulast%3DMaulik%26aufirst%3DG.%26aulast%3DShrikhande%26aufirst%3DA.%26aulast%3DKijima%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DMorrison%26aufirst%3DP.%2BT.%26aulast%3DSalgi%26aufirst%3DR.%26atitle%3DRole%2520of%2520the%2520Hepatocyte%2520Growth%2520Factor%2520Receptor%252C%2520c-Met%252C%2520in%2520Oncogenesis%2520and%2520Potential%2520for%2520Therapeutic%2520Inhibition%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2002%26volume%3D13%26spage%3D41%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Date, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">Acquisition of Invasive Phenotype in Gallbladder Cancer Cells Via Mutual Interaction of Stromal Fibroblasts and Cancer Cells as Mediated by Hepatocyte Growth Factor</span> <span class="citation_source-journal">Jpn. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1111%2Fj.1349-7006.1996.tb00281.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=8698619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK28Xks1ejt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=702-710&author=K.+Matsumotoauthor=K.+Dateauthor=H.+Shimuraauthor=T.+Nakamura&title=Acquisition+of+Invasive+Phenotype+in+Gallbladder+Cancer+Cells+Via+Mutual+Interaction+of+Stromal+Fibroblasts+and+Cancer+Cells+as+Mediated+by+Hepatocyte+Growth+Factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor</span></div><div class="casAuthors">Matsumoto, Kunio; Date, Kazuhiko; Shimura, Hideo; Nakamura, Toshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-710</span>CODEN:
                <span class="NLM_cas:coden">JJCREP</span>;
        ISSN:<span class="NLM_cas:issn">0910-5050</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">Growth and motility of carcinoma cells are regulated through their interactions with host stromal cells, i.e., tumor-stromal interactions.  Hepatocyte growth factor (HGF), a ligand for c-Met tyrosine kinase, is a stromal-derived regulator of growth, motility, and morphogenesis.  HGF stimulated proliferation and motility of GB-d1 gallbladder carcinoma cells from a patient with gallbladder cancer.  HGF induced in vitro invasion of GB-d1 cells into a collagen gel matrix, and this potent, invasive effect was not seen with epidermal growth factor, transforming growth factor-β1, basic fibroblast growth factor, or platelet-derived growth factor.  Although GB-d1 did not produce HGF, the cells did not produce a factor which enhances HGF prodn. in human skin fibroblasts, and this factor proved to be interleukin-1β (IL-1β).  When GB-d1 cells were co-cultured with fibroblasts such that a collagen gel matrix was layered between the GB-d1 cells and fibroblasts, GB-d1 cells invaded the gel, but invasion of the cells in the co-culture system was inhibited by antibodies against HGF and partially inhibited by antibodies against IL-1β.  Thus, GB-d1 cell-derived IL-1β stimulates HGF prodn. in stromal fibroblasts and HGF up-regulated in the fibroblasts induces invasion of GB-d1 cells.  The looped interaction of carcinoma cells and stromal fibroblasts mediated by HGF and a HGF-inducer such as IL-1β may be one mechanism which would explain the acquisition of malignant phenotype through tumor-stromal interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZBGl7W8WPybVg90H21EOLACvtfcHk0liQ1MG8fHxQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1ejt74%253D&md5=16a94e67d95b86d35983d5db4be98ab0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.1996.tb00281.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.1996.tb00281.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DDate%26aufirst%3DK.%26aulast%3DShimura%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DAcquisition%2520of%2520Invasive%2520Phenotype%2520in%2520Gallbladder%2520Cancer%2520Cells%2520Via%2520Mutual%2520Interaction%2520of%2520Stromal%2520Fibroblasts%2520and%2520Cancer%2520Cells%2520as%2520Mediated%2520by%2520Hepatocyte%2520Growth%2520Factor%26jtitle%3DJpn.%2520J.%2520Cancer%2520Res.%26date%3D1996%26volume%3D87%26spage%3D702%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Jeffers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Enhanced Tumorigenicity and Invasion-Metastasis by Hepatocyte Growth Factor/Scatter Factor-Met Signaling in Human Cells Concomitant with Induction of the Urokinase Proteolysis Network</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=8622656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK28XhtFOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=1115-1125&author=M.+Jeffersauthor=S.+Rongauthor=G.+F.+Vande+Woude&title=Enhanced+Tumorigenicity+and+Invasion-Metastasis+by+Hepatocyte+Growth+Factor%2FScatter+Factor-Met+Signaling+in+Human+Cells+Concomitant+with+Induction+of+the+Urokinase+Proteolysis+Network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signaling in human cells concomitant with induction of the urokinase proteolysis network</span></div><div class="casAuthors">Jeffers, Michael; Rong, Sing; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1115-25</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatocyte growth factor/scatter factor (HGF/SF) is a pleiotropic effector of cells expressing the Met tyrosine kinase receptor.  Although HGF/SF is synthesized by mesenchymal cells and acts predominantly on epithelial cells, the authors have recently demonstrated that human sarcoma cell lines often inappropriately express high levels of Met and respond mitogenically to HGF/SF.  In the present report, the authors show that HGF/SF-Met signaling in the human leiomyosarcoma cell line SK-LMS-1 enhances its in vivo tumorigenicity, an effect for which the mitogenicity of this signaling pathway is likely to play a role.  In addn., the authors found that HGF/SF-Met signaling dramatically induces the in vitro invasiveness and in vivo metastatic potential of these cells.  The authors have studied the mol. basis by which HGF/SF-Met signaling mediates the invasive phenotype.  A strong correlation has previously been demonstrated between the activation of the urokinase plasminogen activator (uPA) proteolysis network and the acquisition of the invasive-metastatic phenotype, and the authors show here that HGF/SF-Met signaling significantly increases the protein levels of both uPA and its cellular receptor in SK-LMS-1 cells.  This results in elevated levels of cell-assocd. uPA and enhanced plasmin-generating ability by these cells.  These studies couple HGF/SF-Met signaling to the activation of proteases that mediate dissoln. of the extracellular matrix-basement membrane, an important property for cellular invasion-metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZbXnGjTq6LVg90H21EOLACvtfcHk0lg17Jqv-fT95Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFOls7k%253D&md5=1c663d7eead27a58e362e459860aecb7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeffers%26aufirst%3DM.%26aulast%3DRong%26aufirst%3DS.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DEnhanced%2520Tumorigenicity%2520and%2520Invasion-Metastasis%2520by%2520Hepatocyte%2520Growth%2520Factor%252FScatter%2520Factor-Met%2520Signaling%2520in%2520Human%2520Cells%2520Concomitant%2520with%2520Induction%2520of%2520the%2520Urokinase%2520Proteolysis%2520Network%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D1115%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Met, Metastasis, Motility and More</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1038%2Fnrm1261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=14685170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=915-925&author=C.+Birchmeierauthor=W.+Birchmeierauthor=E.+Gherardiauthor=G.+F.+Vande+Woude&title=Met%2C+Metastasis%2C+Motility+and+More"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Met, metastasis, motility and more</span></div><div class="casAuthors">Birchmeier, Carmen; Birhcmeier, Walter; Gherardi, Ermanno; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocyte growth factor. scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates.  In spite of this, Met uses mols. such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster - for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG_-6XRpZ-sLVg90H21EOLACvtfcHk0lg17Jqv-fT95Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D&md5=ff5a02c73415784480c628fe65299a81</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1261%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DMet%252C%2520Metastasis%252C%2520Motility%2520and%2520More%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D915%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Corso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">Cancer Therapy: Can the Challenge Be MET?</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=284-292&author=S.+Corsoauthor=P.+M.+Comoglioauthor=S.+Giordano&title=Cancer+Therapy%3A+Can+the+Challenge+Be+MET%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorso%26aufirst%3DS.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DCancer%2520Therapy%253A%2520Can%2520the%2520Challenge%2520Be%2520MET%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D284%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maulik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">C-Met: Structure, Functions, and Potential for Therapeutic Inhibition</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1023%2FA%3A1023768811842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=12884908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslyiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=309-325&author=P.+C.+Maauthor=G.+Maulikauthor=J.+Christensenauthor=R.+Salgia&title=C-Met%3A+Structure%2C+Functions%2C+and+Potential+for+Therapeutic+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met: Structure, functions and potential for therapeutic inhibition</span></div><div class="casAuthors">Ma, Patrick C.; Maulik, Gautam; Christensen, James; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-325</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Studies on signal transduction pathways have generated various promising mol. targets for therapeutic inhibition in cancer therapy.  Receptor tyrosine kinases represent an important class of such therapeutic targets.  C-Met is a receptor tyrosine kinase that has been shown to be overexpressed and/or mutated in a variety of malignancies.  A no. of c-Met activating mutations, many of which are located in the tyrosine kinase domain, have been detected in various solid tumors and have been implicated in invasion and metastasis of tumor cells.  It is known that stimulation of c-Met via its natural ligand, hepatocyte growth factor (also known as scatter factor, HGF/SF) results in a plethora of biol. and biochem. effects in the cell.  Activation of c-Met signaling can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventual metastasis.  In this review, the role of c-Met dysregulation in tumor progression and metastasis is discussed in detail with particular emphasis on c-Met mutations.  Moreover, we summarize current knowledge on various pathways of c-Met signal transduction, highlighting the central role in the cytoskeletal functions.  In this summary is included recent data in our lab. indicating that phosphorylation of focal adhesion proteins, such as paxillin, p125FAK, and PYK2, occurs in response to c-Met stimulation in lung cancer cells.  Most importantly, current data on c-Met suggest that when mutated or overexpressed in malignant cells, c-Met would serve as an important therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9rIdb5Ao4a7Vg90H21EOLACvtfcHk0ljZu_ngUQPdAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslyiurY%253D&md5=7b7bf60da872071a39ce313efd32fd1f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023768811842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023768811842%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DMaulik%26aufirst%3DG.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DC-Met%253A%2520Structure%252C%2520Functions%252C%2520and%2520Potential%2520for%2520Therapeutic%2520Inhibition%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2003%26volume%3D22%26spage%3D309%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met as a Target for Human Cancer and Characterization of Inhibitors for Therapeutic Intervention</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1016%2Fj.canlet.2004.09.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=15922853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2005&pages=1-26&author=J.+G.+Christensenauthor=J.+Burrowsauthor=R.+Salgia&title=c-Met+as+a+Target+for+Human+Cancer+and+Characterization+of+Inhibitors+for+Therapeutic+Intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span></div><div class="casAuthors">Christensen, James G.; Burrows, Jon; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinase (RTK) targeted agents such as trastuzumab, Imatinib, bevacizumab, and gefitinib inhibitors have illustrated the utility of targeting this protein class for treatment of selected cancers.  A unique member of the RTK family, c-Met, also represents an intriguing target for cancer therapy that is yet to be explored in a clin. setting.  The proto-oncogene, c-Met, encodes the high-affinity receptor for hepatocyte growth factor (HGF) or scatter factor (SF).  C-Met and HGF are each required for normal mammalian development and have been shown to be particularly important in cell migration, morphogenic differentiation, and organization of three-dimensional tubular structures (e.g. renal tubular cells, gland formation, etc.) as well as cell growth and angiogenesis.  Both c-Met and HGF have been shown to be deregulated in and to correlate with poor prognosis in a no. of major human cancers.  New data describing the constitutive phosphorylation of c-Met in a no. of human tumors is presented here along with a variety of mechanisms by which c-Met can become activated, including mutation and gene amplification.  In support of the clin. data implicating c-Met activation in the pathogenesis of human cancers, introduction of c-Met and HGF (or mutant c-Met) into cells conferred the properties of motility, invasiveness, and tumorigenicity to the transformed cells.  Conversely, the inhibition of c-Met with a variety of receptor antagonists inhibited the motility, invasiveness, and tumorigenicity of human tumor cell lines.  Consistent with this observation, small-mol. inhibitors of c-Met were developed that antagonized c-Met/HGF-dependent phenotypes and tumor growth in mouse models.  This review will address the potential for development of c-Met inhibitors for treatment of human cancers with particular emphasis on recent findings with small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTbSn0ouMILVg90H21EOLACvtfcHk0ljZu_ngUQPdAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D&md5=106b145cbf442e9fec9667817697658d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.044%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%2520as%2520a%2520Target%2520for%2520Human%2520Cancer%2520and%2520Characterization%2520of%2520Inhibitors%2520for%2520Therapeutic%2520Intervention%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D225%26spage%3D1%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span> </span><span class="NLM_article-title">HGF- and c-Met-Targeted Drugs: Hopes, Challenges, and their Future in Cancer Therapy</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1358%2Fdof.2006.031.09.1026670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=819-825&author=I.+Dussaultauthor=P.+Kaplan-Lefkoauthor=T.+Junauthor=A.+Coxonauthor=T.+L.+Burgess&title=HGF-+and+c-Met-Targeted+Drugs%3A+Hopes%2C+Challenges%2C+and+their+Future+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HGF- and c-Met-targeted drugs: hopes, challenges and their future in cancer therapy</span></div><div class="casAuthors">Dussault, Isabelle; Kaplan-Lefko, Paula; Jun, Tani; Coxon, Angela; Burgess, Teresa L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">819-825</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Cancer remains a formidable disease, with 1,372,910 new cases and 570,280 deaths in the United States alone in 2005 (http://www.cancer.org/docroot/stt/stt_0.asp).  Many types of cancers are still difficult to treat using conventional therapies.  For example, chemotherapeutic drugs are widely used, but their side effects can be devastating to the quality of life of patients and their efficacy is limited in late-stage cancers.  Therefore, efforts have been undertaken for the past several years to develop targeted drugs in the hope of improving efficacy and tolerability.  As these new drugs are starting to make their mark in the clinic, what can we expect in the future with anticancer drugs.  Already we are seeing the benefits of targeted therapies, different drug modalities, including antibodies, and more convenient forms of drug delivery.  Moreover, much attention is now being placed not only on attacking the cancer cells themselves, but also on intervening in the microenvironment in which they reside.  In this review, we will discuss the promise behind novel targeted therapies under development to inhibit signaling via the oncogenic HGF/c-Met pathway.  HGF and c-Met are exciting therapeutic targets that play important roles both directly in tumor cells and in the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1H3RCrcur7Vg90H21EOLACvtfcHk0lgXljuCT1KPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKnuw%253D%253D&md5=014dca5910768abf2478b0c7a6a29169</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.09.1026670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.09.1026670%26sid%3Dliteratum%253Aachs%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DJun%26aufirst%3DT.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26atitle%3DHGF-%2520and%2520c-Met-Targeted%2520Drugs%253A%2520Hopes%252C%2520Challenges%252C%2520and%2520their%2520Future%2520in%2520Cancer%2520Therapy%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D819%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Cao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oskarsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kort, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woude, G. F. V.</span><span> </span><span class="NLM_article-title">Neutralizing Monoclonal Antibodies to Hepatocyte Growth Factor/Scatter Factor (HGF/SF) Display Antitumor Activity in Animal Models</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">7443</span><span class="NLM_x">–</span> <span class="NLM_lpage">7448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=7443-7448&author=B.+Caoauthor=Y.+Suauthor=M.+Oskarssonauthor=P.+Zhaoauthor=E.+J.+Kortauthor=R.+J.+Fisherauthor=L.+M.+Wangauthor=G.+F.+V.+Woude&title=Neutralizing+Monoclonal+Antibodies+to+Hepatocyte+Growth+Factor%2FScatter+Factor+%28HGF%2FSF%29+Display+Antitumor+Activity+in+Animal+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DOskarsson%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DKort%26aufirst%3DE.%2BJ.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DWoude%26aufirst%3DG.%2BF.%2BV.%26atitle%3DNeutralizing%2520Monoclonal%2520Antibodies%2520to%2520Hepatocyte%2520Growth%2520Factor%252FScatter%2520Factor%2520%2528HGF%252FSF%2529%2520Display%2520Antitumor%2520Activity%2520in%2520Animal%2520Models%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D7443%26epage%3D7448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kim, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salhotra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laterra, J.</span><span> </span><span class="NLM_article-title">Systemic Anti-Hepatocyte Growth Factor Monoclonal Antibody Therapy Induces the Regression of Intracranial Glioma Xenografts</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1158%2F1078-0432.CCR-05-1793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=16489086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFaltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1292-1298&author=K.+J.+Kimauthor=L.+Wangauthor=Y.+C.+Suauthor=G.+Y.+Gillespieauthor=A.+Salhotraauthor=B.+Lalauthor=J.+Laterra&title=Systemic+Anti-Hepatocyte+Growth+Factor+Monoclonal+Antibody+Therapy+Induces+the+Regression+of+Intracranial+Glioma+Xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic Anti-Hepatocyte Growth Factor Monoclonal Antibody Therapy Induces the Regression of Intracranial Glioma Xenografts</span></div><div class="casAuthors">Kim, K. Jin; Wang, Lihong; Su, Yi-Chi; Gillespie, G. Yancey; Salhotra, Amandeep; Lal, Bachchu; Laterra, John</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1292-1298</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Hepatocyte growth factor (HGF) and its receptor Met are involved in the initiation, progression, and metastasis of numerous systemic and central nervous system tumors.  Thus, an anti-HGF monoclonal antibody (mAb) capable of blocking the HGF-Met interaction could have broad applicability in cancer therapy.  Exptl. Design: An anti-HGF mAb L2G7 that blocks binding of HGF to Met was generated by hybridoma technol., and its ability to inhibit the various biol. activities of HGF was measured by in vitro assays.  The ability of L2G7 to inhibit the growth of tumors was detd. by establishing s.c. and intracranial xenografts of human U87 and U118 glioma cell lines in nude mice, and treatment with 100 μg of L2G7 or control given i.p. twice per wk.  RESULTS: MAb L2G7 strongly inhibited all biol. activities of HGF measured in vitro, including cell proliferation, cell scattering, and endothelial tubule formation.  Treatment with L2G7 completely inhibited the growth of established s.c. xenografts in nude mice.  Moreover, systemic administration of L2G7 from day 5 induced the regression of intracranial U87 xenografts and dramatically prolonged the survival of tumor-bearing mice from a median of 39 to >90 days.  L2G7 treatment of large intracranial tumors (av. tumor size, 26.7 mm3) from day 18 induced substantial tumor regression (control group, 134.3 mm3; L2G7 treated group, 11.7 mm3) by day 29 and again prolonged animal survival.  CONCLUSIONS: These findings show that blocking the HGF-Met interaction with systemically given anti-HGF mAb can have profound antitumor effects even within the central nervous system, a site previously believed to be resistant to systemic antibody-based therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyA1OCh4M04bVg90H21EOLACvtfcHk0lgXljuCT1KPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFaltbs%253D&md5=4e1157723ff017d2f51f5864c5eb06ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1793%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DY.%2BC.%26aulast%3DGillespie%26aufirst%3DG.%2BY.%26aulast%3DSalhotra%26aufirst%3DA.%26aulast%3DLal%26aufirst%3DB.%26aulast%3DLaterra%26aufirst%3DJ.%26atitle%3DSystemic%2520Anti-Hepatocyte%2520Growth%2520Factor%2520Monoclonal%2520Antibody%2520Therapy%2520Induces%2520the%2520Regression%2520of%2520Intracranial%2520Glioma%2520Xenografts%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1292%26epage%3D1298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDorman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R.</span><span> </span><span class="NLM_article-title">Fully Human Monoclonal Antibodies to Hepatocyte Growth Factor with Therapeutic Potential Against Hepatocyte Growth Factor/c-Met-Dependent Human Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1729</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1721-1729&author=T.+Burgessauthor=A.+Coxonauthor=S.+Meyerauthor=J.+Sunauthor=K.+Rexauthor=T.+Tsurudaauthor=Q.+Chenauthor=S.+Y.+Hoauthor=L.+Liauthor=S.+Kaufmanauthor=K.+McDormanauthor=R.+C.+Cattleyauthor=J.+Sunauthor=G.+Elliotauthor=K.+Zhangauthor=X.+Fengauthor=X.+C.+Jiaauthor=L.+Greenauthor=R.+Radinskyauthor=R.+Kendall&title=Fully+Human+Monoclonal+Antibodies+to+Hepatocyte+Growth+Factor+with+Therapeutic+Potential+Against+Hepatocyte+Growth+Factor%2Fc-Met-Dependent+Human+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DTsuruda%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DMcDorman%26aufirst%3DK.%26aulast%3DCattley%26aufirst%3DR.%2BC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DElliot%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DX.%2BC.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DRadinsky%26aufirst%3DR.%26aulast%3DKendall%26aufirst%3DR.%26atitle%3DFully%2520Human%2520Monoclonal%2520Antibodies%2520to%2520Hepatocyte%2520Growth%2520Factor%2520with%2520Therapeutic%2520Potential%2520Against%2520Hepatocyte%2520Growth%2520Factor%252Fc-Met-Dependent%2520Human%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1721%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Martens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckerich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillbrandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwall, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamszus, K.</span><span> </span><span class="NLM_article-title">A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In Vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6144</span><span class="NLM_x">–</span> <span class="NLM_lpage">6152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1158%2F1078-0432.CCR-05-1418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=17062691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWhsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=6144-6152&author=T.+Martensauthor=N.+O.+Schmidtauthor=C.+Eckerichauthor=R.+Fillbrandtauthor=M.+Merchantauthor=R.+Schwallauthor=M.+Westphalauthor=K.+Lamszus&title=A+Novel+One-Armed+Anti-c-Met+Antibody+Inhibits+Glioblastoma+Growth+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth in vivo</span></div><div class="casAuthors">Martens, Tobias; Schmidt, Nils-Ole; Eckerich, Carmen; Fillbrandt, Regina; Merchant, Mark; Schwall, Ralph; Westphal, Manfred; Lamszus, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20, Pt. 1</span>),
    <span class="NLM_cas:pages">6144-6152</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Expression of the receptor tyrosine kinase c-Met and its ligand scatter factor/hepatocyte growth factor (SF/HGF) are strongly increased in glioblastomas, where they promote tumor proliferation, migration, invasion, and angiogenesis.  We used a novel one-armed anti-c-Met antibody to inhibit glioblastoma growth in vivo.  Exptl. Design: U87 glioblastoma cells (c-Met and SF/HGF pos.) or G55 glioblastoma cells (c-Met pos. and SF/HGF neg.) were used to generate intracranial orthotopic xenografts in nude mice.  The one-armed 5D5 (OA-5D5) anti-c-Met antibody was infused intratumorally using osmotic minipumps.  Following treatment, tumor vols. were measured and tumors were analyzed histol. for extracellular matrix (ECM) components and proteases relevant to tumor invasion.  Microarray analyses were done to det. the effect of the antibody on invasion-related genes.  Results: U87 tumor growth, strongly driven by SF/HGF, was inhibited >95% with OA-5D5 treatment.  In contrast, G55 tumors, which are not SF/HGF driven, did not respond to OA-5D5, suggesting that the antibody can have efficacy in SF/HGF-activated tumors.  In OA-5D5-treated U87 tumors, cell proliferation was reduced >75%, microvessel d. was reduced >90%, and apoptosis was increased >60%.  Furthermore, OA-5D5 treatment decreased tumor cell d. >2-fold, with a consequent increase in ECM deposition and increased immunoreactivity for laminin, fibronectin, and tenascin.  Microarray studies showed no increase in these ECM factors, rather down-regulation of urokinase-type plasminogen activator and matrix metalloproteinase 16 in glioblastoma cells treated with OA-5D5.  Conclusions: Local treatment with OA-5D5 can almost completely inhibit intracerebral glioblastoma growth when SF/HGF is driving tumor growth.  The mechanisms of tumor inhibition include antiproliferative, antiangiogenic, and proapoptotic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoClBrUgwIdRbVg90H21EOLACvtfcHk0lg1zPFS6Rcstw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWhsbbN&md5=18744a40c4a89eb8a721191887adc03a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1418%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DN.%2BO.%26aulast%3DEckerich%26aufirst%3DC.%26aulast%3DFillbrandt%26aufirst%3DR.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DSchwall%26aufirst%3DR.%26aulast%3DWestphal%26aufirst%3DM.%26aulast%3DLamszus%26aufirst%3DK.%26atitle%3DA%2520Novel%2520One-Armed%2520Anti-c-Met%2520Antibody%2520Inhibits%2520Glioblastoma%2520Growth%2520In%2520Vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D6144%26epage%3D6152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Date, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">HGF/NK4 is a Specific Antagonist for Pleiotrophic Actions of Hepatocyte Growth Factor</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=1997&pages=1-6&author=K.+Dateauthor=K.+Matsumotoauthor=H.+Shimuraauthor=M.+Tanakaauthor=T.+Nakamura&title=HGF%2FNK4+is+a+Specific+Antagonist+for+Pleiotrophic+Actions+of+Hepatocyte+Growth+Factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDate%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DShimura%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DHGF%252FNK4%2520is%2520a%2520Specific%2520Antagonist%2520for%2520Pleiotrophic%2520Actions%2520of%2520Hepatocyte%2520Growth%2520Factor%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D420%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tomioka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maehara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">Inhibition of Growth, Invasion, and Metastasis of Human Pancreatic Carcinoma Cells by NK4 in an Orthotopic Mouse Model</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7518</span><span class="NLM_x">–</span> <span class="NLM_lpage">7524</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7518-7524&author=D.+Tomiokaauthor=N.+Maeharaauthor=K.+Kubaauthor=K.+Mizumotoauthor=M.+Tanakaauthor=K.+Matsumotoauthor=T.+Nakamura&title=Inhibition+of+Growth%2C+Invasion%2C+and+Metastasis+of+Human+Pancreatic+Carcinoma+Cells+by+NK4+in+an+Orthotopic+Mouse+Model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomioka%26aufirst%3DD.%26aulast%3DMaehara%26aufirst%3DN.%26aulast%3DKuba%26aufirst%3DK.%26aulast%3DMizumoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520Growth%252C%2520Invasion%252C%2520and%2520Metastasis%2520of%2520Human%2520Pancreatic%2520Carcinoma%2520Cells%2520by%2520NK4%2520in%2520an%2520Orthotopic%2520Mouse%2520Model%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7518%26epage%3D7524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Brockmann, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadimitriou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillbrandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamszus, K.</span><span> </span><span class="NLM_article-title">Inhibition of Intracerebral Glioblastoma Growth by Local Treatment with the Scatter Factor/Hepatocyte Growth Factor-Antagonist NK4</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4578</span><span class="NLM_x">–</span> <span class="NLM_lpage">4585</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotVSht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=4578-4585&author=M.+A.+Brockmannauthor=A.+Papadimitriouauthor=M.+Brandtauthor=R.+Fillbrandtauthor=M.+Westphalauthor=K.+Lamszus&title=Inhibition+of+Intracerebral+Glioblastoma+Growth+by+Local+Treatment+with+the+Scatter+Factor%2FHepatocyte+Growth+Factor-Antagonist+NK4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Intracerebral Glioblastoma Growth by Local Treatment with the Scatter Factor/Hepatocyte Growth Factor-Antagonist NK4</span></div><div class="casAuthors">Brockmann, Marc A.; Papadimitriou, Apollon; Brandt, Michael; Fillbrandt, Regina; Westphal, Manfred; Lamszus, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4578-4585</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Scatter factor/hepatocyte growth factor (SF/HGF) and its tyrosine kinase receptor MET are strongly up-regulated in malignant gliomas.  The SF/HGF-MET system contributes to glioma invasion and angiogenesis via autocrine and paracrine mechanisms.  We analyzed whether local treatment with NK4, an antagonistic fragment of SF/HGF, could inhibit glioma growth in vivo.  A guide-screw system was used to implant tumor cells intra-cerebrally and to perform therapeutic injections.  Mice received daily intratumoral injections of NK4 or buffer as of day 1 or 7 after tumor cell injection until day 20.  Functional effects of NK4 on glioma and endothelial cells were analyzed in vitro.  Tumor vol. was reduced by 61.1% in mice treated with NK4 compared with controls when treatment was initiated on day 1 (P < 0.05) and by 61.4% when treatment was initiated on day 7 (P < 0.001).  Intratumoral microvessel d. was reduced by 64.9% when treatment started on day 1 and by 36.7% when it started on day 7.  The proliferative activity of the tumor cells was reduced by >30% regardless of when NK4-treatment was initiated.  The apoptotic fraction of tumor cells was increased 2-fold and 1.5-fold when animals were treated with NK4 as of day 1 or day 7, resp.  In vitro, NK4 inhibited SF/HGF-induced glioblastoma, and endothelial cell migration and proliferation in a dose-dependent fashion.  Thus, NK4 inhibits glioblastoma growth in vivo, most likely via anti-mitogenic, anti-motogenic, pro-apoptotic, and anti-angiogenic mechanisms.  Given the strong up-regulation of SF/HGF and MET in human malignant gliomas, NK4 holds promise as a direct interstitial therapeutic agent for these fatal tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeY5ANkMJPSbVg90H21EOLACvtfcHk0lg1zPFS6Rcstw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotVSht7o%253D&md5=e4f0c001dac94d5d054d70a4543ca620</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrockmann%26aufirst%3DM.%2BA.%26aulast%3DPapadimitriou%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DFillbrandt%26aufirst%3DR.%26aulast%3DWestphal%26aufirst%3DM.%26aulast%3DLamszus%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520Intracerebral%2520Glioblastoma%2520Growth%2520by%2520Local%2520Treatment%2520with%2520the%2520Scatter%2520Factor%252FHepatocyte%2520Growth%2520Factor-Antagonist%2520NK4%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D4578%26epage%3D4585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Michieli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basilico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavassa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sottile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Targeting the Tumor and its Microenvironment by a Dual-Function Decoy Met Receptor</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=61-73&author=P.+Michieliauthor=M.+Mazzoneauthor=C.+Basilicoauthor=S.+Cavassaauthor=A.+Sottileauthor=L.+Naldiniauthor=P.+M.+Comoglio&title=Targeting+the+Tumor+and+its+Microenvironment+by+a+Dual-Function+Decoy+Met+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMichieli%26aufirst%3DP.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DBasilico%26aufirst%3DC.%26aulast%3DCavassa%26aufirst%3DS.%26aulast%3DSottile%26aufirst%3DA.%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DTargeting%2520the%2520Tumor%2520and%2520its%2520Microenvironment%2520by%2520a%2520Dual-Function%2520Decoy%2520Met%2520Receptor%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D61%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kong-Beltran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, D.</span><span> </span><span class="NLM_article-title">The Sema Domain of Met Is Necessary for Receptor Dimerization and Activation</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=75-84&author=M.+Kong-Beltranauthor=J.+Stamosauthor=D.+Wickramasinghe&title=The+Sema+Domain+of+Met+Is+Necessary+for+Receptor+Dimerization+and+Activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKong-Beltran%26aufirst%3DM.%26aulast%3DStamos%26aufirst%3DJ.%26aulast%3DWickramasinghe%26aufirst%3DD.%26atitle%3DThe%2520Sema%2520Domain%2520of%2520Met%2520Is%2520Necessary%2520for%2520Receptor%2520Dimerization%2520and%2520Activation%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D75%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Abounader, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fielding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Book, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laterra, J.</span><span> </span><span class="NLM_article-title">Reversion of Human Glioblastoma Malignancy by U1 Small Nuclear RNA/Ribozyme Targeting of Scatter Factor/Hepatocyte Growth Factor and c-Met Expression</span> <span class="citation_source-journal">J. Natl. Cancer. Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1548</span><span class="NLM_x">–</span> <span class="NLM_lpage">1556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1548-1556&author=R.+Abounaderauthor=S.+Ranganathanauthor=B.+Lalauthor=K.+Fieldingauthor=A.+Bookauthor=H.+Dietzauthor=P.+Burgerauthor=J.+Laterra&title=Reversion+of+Human+Glioblastoma+Malignancy+by+U1+Small+Nuclear+RNA%2FRibozyme+Targeting+of+Scatter+Factor%2FHepatocyte+Growth+Factor+and+c-Met+Expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression</span></div><div class="casAuthors">Abounader, Roger; Ranganathan, Srikanth; Lal, Bachchu; Fielding, Kevin; Book, Adam; Dietz, Hal; Burger, Peter; Laterra, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1548-1556</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Expression of scatter factor (SF), also known as hepatocyte growth factor (HGF), and its receptor, c-met, is often assocd. with malignant progression of human tumors, including gliomas.  Overexpression of SF/HGF in exptl. gliomas enhances tumorigenicity and tumor-assocd. angiogenesis (i.e., growth of new blood vessels).  However, the role of endogenous SF/HGF or c-met expression in the malignant progression of gliomas has not been examd. directly.  In this study, we tested the hypothesis that human glioblastomas can be SF/HGF-c-met dependent and that a redn. in endogenous SF/HGF or c-met expression can lead to inhibition of tumor growth and tumorigenicity.  Expression of the SF/HGF and c-met genes was inhibited by transfecting glioblastoma cells with chimeric transgenes consisting of U1 small nuclear RNA, a hammerhead ribozyme, and antisense sequences.  The effects of reduced SF/HGF and c-met expression on (1) SF/HGF-dependent induction of immediate early genes (c-fos and c-jun), indicative of signal transduction; (2) anchorage-independent colony formation (clonogenicity), an in vitro correlate of solid tumor malignancy; and () intracranial tumor formation were quantified in immunodeficient mice.  Statistical tests were two-sided.  Introduction of the transgenes into glioblastoma cells reduced expression of the SF/HGF and c-met genes to as little as 2% of control cell levels.  Redn. in c-met expression specifically inhibited SF/HGF-dependent signal transduction (P<.01).  Inhibition of SF/HGF or c-met expression in glioblastoma cells possessing an SF/HGF-c-met autocrine loop reduced tumor cell clonogenicity (P = .005 for SF/HGF and P=.009 for c-met) and substantially inhibited tumorigenicity (P<.0001) and tumor growth in vivo (P<.0001).  To our knowledge, this is the first successful inhibition of SF/HGF and c-met expression in a tumor model directly demonstrating a role for endogenous SF/HGF and c-met in human glioblastoma.  Our results suggest that targeting the SF/HGF-c-met signaling pathway may be an important approach in controlling tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YkaYtwUd4rVg90H21EOLACvtfcHk0lhQEpLFeCdnrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVCrt7o%253D&md5=d1eecd126806ca198930b4b3c8fe2f04</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbounader%26aufirst%3DR.%26aulast%3DRanganathan%26aufirst%3DS.%26aulast%3DLal%26aufirst%3DB.%26aulast%3DFielding%26aufirst%3DK.%26aulast%3DBook%26aufirst%3DA.%26aulast%3DDietz%26aufirst%3DH.%26aulast%3DBurger%26aufirst%3DP.%26aulast%3DLaterra%26aufirst%3DJ.%26atitle%3DReversion%2520of%2520Human%2520Glioblastoma%2520Malignancy%2520by%2520U1%2520Small%2520Nuclear%2520RNA%252FRibozyme%2520Targeting%2520of%2520Scatter%2520Factor%252FHepatocyte%2520Growth%2520Factor%2520and%2520c-Met%2520Expression%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1548%26epage%3D1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koterba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herynk, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallick, G. E.</span><span> </span><span class="NLM_article-title">Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">5161</span><span class="NLM_x">–</span> <span class="NLM_lpage">5170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVOgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=5161-5170&author=S.+J.+Kimauthor=M.+Johnsonauthor=K.+Koterbaauthor=M.+H.+Herynkauthor=H.+Ueharaauthor=G.+E.+Gallick&title=Reduced+c-Met+Expression+by+an+Adenovirus+Expressing+a+c-Met+Ribozyme+Inhibits+Tumorigenic+Growth+and+Lymph+Node+Metastases+of+PC3-LN4+Prostate+Tumor+Cells+in+an+Orthotopic+Nude+Mouse+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model</span></div><div class="casAuthors">Kim, Sun Jin; Johnson, Marjorie; Koterba, Kristen; Herynk, Matthew H.; Uehara, Hisanori; Gallick, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5161-5170</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The expression of c-Met, the receptor protein tyrosine kinase for hepatocyte growth factor/scatter factor, frequently increases during prostate tumor progression.  However, whether reduced c-Met expression inhibits tumor growth and metastasis has not been ascertained.  C-Met expression was reduced by infection of an adenovirus expressing a c-Met ribozyme into the highly metastatic human prostate cancer cell line PC3-LN4.  In vitro, effects on c-Met, Akt, and extracellular signal-regulated kinase 1/2 expression and phosphorylation, Src expression and activity, and vascular endothelial growth factor expression were detd., as were effects on cell migration and invasion.  Prostate tumor formation and metastasis to regional lymph nodes in nude mice were examd. after both ex vivo and in vivo infection of cells.  Infection of PC3-LN4 cells with the Ad-c-Met-expressing ribozyme decreased steady-state c-Met levels, decreased Src kinase activity, decreased vascular endothelial growth factor expression, and decreased migration and invasion vs. the pU1 (control) virus.  Significant inhibition of tumorigenicity (histol. confirmed tumors in only 1 of 10 mice) and consequent lymph node metastasis were obsd. upon ex vivo infection of Ad-c-Met.  Similarly, gene therapy expts. led to complete inhibition of tumor growth in 7 of 8 mice.  Redn. in c-Met expression substantially inhibits both tumor growth and lymph node metastasis of PC3-LN4 cells in orthotopic nude mouse models.  Therefore, targeting the c-Met signaling pathways may be important in controlling tumor growth and metastasis in human prostate cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjS2eXDUC1l7Vg90H21EOLACvtfcHk0lhQEpLFeCdnrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVOgur8%253D&md5=fa4e48e3a4034972f5e34602f0d05f36</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DKoterba%26aufirst%3DK.%26aulast%3DHerynk%26aufirst%3DM.%2BH.%26aulast%3DUehara%26aufirst%3DH.%26aulast%3DGallick%26aufirst%3DG.%2BE.%26atitle%3DReduced%2520c-Met%2520Expression%2520by%2520an%2520Adenovirus%2520Expressing%2520a%2520c-Met%2520Ribozyme%2520Inhibits%2520Tumorigenic%2520Growth%2520and%2520Lymph%2520Node%2520Metastases%2520of%2520PC3-LN4%2520Prostate%2520Tumor%2520Cells%2520in%2520an%2520Orthotopic%2520Nude%2520Mouse%2520Model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D5161%26epage%3D5170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pride, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinnan, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">A Novel Small Molecule Met Inhibitor Induces Apoptosis in Cells Transformed by the Oncogenic TPR-MET Tyrosine Kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">5462</span><span class="NLM_x">–</span> <span class="NLM_lpage">5469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=14500382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntleku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5462-5469&author=M.+Sattlerauthor=Y.+B.+Prideauthor=P.+Maauthor=J.+L.+Gramlichauthor=S.+C.+Chuauthor=L.+A.+Quinnanauthor=S.+Shirazianauthor=C.+Liangauthor=K.+Podarauthor=J.+G.+Christensenauthor=R.+Salgia&title=A+Novel+Small+Molecule+Met+Inhibitor+Induces+Apoptosis+in+Cells+Transformed+by+the+Oncogenic+TPR-MET+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Small Molecule Met Inhibitor Induces Apoptosis in Cells Transformed by the Oncogenic TPR-MET Tyrosine Kinase</span></div><div class="casAuthors">Sattler, Martin; Pride, Yuri B.; Ma, Patrick; Gramlich, Jessica L.; Chu, Stephanie C.; Quinnan, Laura A.; Shirazian, Sheri; Liang, Congxin; Podar, Klaus; Christensen, James G.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5462-5469</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Met receptor tyrosine kinase has been shown to be overexpressed or mutated in a variety of solid tumors and has, therefore, been identified as a good candidate for molecularly targeted therapy.  Activation of the Met tyrosine kinase by the TPR gene was originally described in vitro through carcinogen-induced rearrangement.  The TPR-MET fusion protein contains constitutively elevated Met tyrosine kinase activity and constitutes an ideal model to study the transforming activity of the Met kinase.  We found, when introduced into an interleukin 3-dependent cell line, TPR-MET induces factor independence and constitutive tyrosine phosphorylation of several cellular proteins.  One major tyrosine phosphorylated protein was identified as the TPR-MET oncoprotein itself.  Inhibition of the Met kinase activity by the novel small mol. drug SU11274 [(3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide] led to time- and dose-dependent reduced cell growth.  The inhibitor did not affect other tyrosine kinase oncoproteins, including BCR-ABL, TEL-JAK2, TEL-PDGFβR, or TEL-ABL.  The Met inhibitor induced G1 cell cycle arrest and apoptosis with increased Annexin V staining and caspase 3 activity.  The autophosphorylation of the Met kinase was reduced on sites that have been shown previously to be important for activation of pathways involved in cell growth and survival, esp. the phosphatidylinositol-3'-kinase and the Ras pathway.  In particular, we found that the inhibitor blocked phosphorylation of AKT, GSK-3β, and the pro-apoptotic transcription factor FKHR.  The characterization of SU11274 as an effective inhibitor of Met tyrosine kinase activity illustrates the potential of targeting for Met therapeutic use in cancers assocd. with activated forms of this kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvIwRT4z1IbVg90H21EOLACvtfcHk0ljyRmuYF2C3UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntleku7s%253D&md5=3223841b665e6b95f3dab0f18ce64dbe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DPride%26aufirst%3DY.%2BB.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DGramlich%26aufirst%3DJ.%2BL.%26aulast%3DChu%26aufirst%3DS.%2BC.%26aulast%3DQuinnan%26aufirst%3DL.%2BA.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DA%2520Novel%2520Small%2520Molecule%2520Met%2520Inhibitor%2520Induces%2520Apoptosis%2520in%2520Cells%2520Transformed%2520by%2520the%2520Oncogenic%2520TPR-MET%2520Tyrosine%2520Kinase%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5462%26epage%3D5469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiewlich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasile, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span> </span><span class="NLM_article-title">Potent and Selective Inhibitors of the Met [Hepatocyte Growth Factor/Scatter Factor (HGF/SF) Receptor] Tyrosine Kinase Block HGF/SF-Induced Tumor Cell Growth and Invasion</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=14617781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1085-1092&author=X.+Wangauthor=P.+Leauthor=C.+Liangauthor=J.+Chanauthor=D.+Kiewlichauthor=T.+Millerauthor=D.+Harrisauthor=L.+Sunauthor=A.+Riceauthor=S.+Vasileauthor=R.+A.+Blakeauthor=A.+R.+Howlettauthor=N.+Patelauthor=G.+McMahonauthor=K.+E.+Lipson&title=Potent+and+Selective+Inhibitors+of+the+Met+%5BHepatocyte+Growth+Factor%2FScatter+Factor+%28HGF%2FSF%29+Receptor%5D+Tyrosine+Kinase+Block+HGF%2FSF-Induced+Tumor+Cell+Growth+and+Invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion</span></div><div class="casAuthors">Wang, Xueyan; Le, Phuong; Liang, Congxin; Chan, Julie; Kiewlich, David; Miller, Todd; Harris, Dave; Sun, Li; Rice, Audie; Vasile, Stefan; Blake, Robert A.; Howlett, Anthony R.; Patel, Neela; McMahon, Gerald; Lipson, Kenneth E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1085-1092</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The hepatocyte growth factor/scatter factor (HGF/SF) receptor, Met, mediates various cellular responses on activation with its ligand, including proliferation, survival, motility, invasion, and tubular morphogenesis.  Met expression is frequently up-regulated in sarcomas and carcinomas.  Exptl. evidence suggests that Met activation correlates with poor clin. outcome and the likelihood of metastasis.  Therefore, inhibitors of Met tyrosine kinase may be useful for the treatment of a wide variety of cancers that have spread from the primary site.  We have discovered potent and selective pyrrole-indolinone Met kinase inhibitors and characterized them for their ability to inhibit HGF/SF-induced cellular responses in vitro.  These compds. inhibit HGF/SF-induced receptor phosphorylation in a dose-dependent manner.  They also inhibit the HGF/SF-induced motility and invasion of epithelial and carcinoma cells.  Therefore, these compds. represent a class of prototype small mols. that selectively inhibit the Met kinase and could lead to identification of compds. with potential therapeutic utility in treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVAQRRxT_J1rVg90H21EOLACvtfcHk0ljyRmuYF2C3UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCqtL8%253D&md5=3b3141600b15ed4f9c97d86fb7ade81d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DKiewlich%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DRice%26aufirst%3DA.%26aulast%3DVasile%26aufirst%3DS.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DHowlett%26aufirst%3DA.%2BR.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26atitle%3DPotent%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Met%2520%255BHepatocyte%2520Growth%2520Factor%252FScatter%2520Factor%2520%2528HGF%252FSF%2529%2520Receptor%255D%2520Tyrosine%2520Kinase%2520Block%2520HGF%252FSF-Induced%2520Tumor%2520Cell%2520Growth%2520and%2520Invasion%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D1085%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruganti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramphal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D. B.</span><span> </span><span class="NLM_article-title">A Selective Small Molecule Inhibitor of c-Met Kinase Inhibits c-Met-Dependent Phenotypes In Vitro and Exhibits Cytoreductive Antitumor Activity In Vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7345</span><span class="NLM_x">–</span> <span class="NLM_lpage">7355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7345-7355&author=J.+G.+Christensenauthor=R.+Schreckauthor=J.+Burrowsauthor=P.+Kurugantiauthor=E.+Chanauthor=P.+Leauthor=J.+Chenauthor=X.+Wangauthor=L.+Ruslimauthor=R.+Blakeauthor=K.+E.+Lipsonauthor=J.+Ramphalauthor=S.+Doauthor=J.+J.+Cuiauthor=J.+M.+Cherringtonauthor=D.+B.+Mendel&title=A+Selective+Small+Molecule+Inhibitor+of+c-Met+Kinase+Inhibits+c-Met-Dependent+Phenotypes+In+Vitro+and+Exhibits+Cytoreductive+Antitumor+Activity+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DKuruganti%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DRamphal%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DA%2520Selective%2520Small%2520Molecule%2520Inhibitor%2520of%2520c-Met%2520Kinase%2520Inhibits%2520c-Met-Dependent%2520Phenotypes%2520In%2520Vitro%2520and%2520Exhibits%2520Cytoreductive%2520Antitumor%2520Activity%2520In%2520Vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7345%26epage%3D7355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cui, J. J.</span><span> </span><span class="NLM_article-title">Inhibitors Targeting Hepatocyte Growth Factor Receptor and their Potential Therapeutic Applications</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1517%2F13543776.17.9.1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1035-1045&author=J.+J.+Cui&title=Inhibitors+Targeting+Hepatocyte+Growth+Factor+Receptor+and+their+Potential+Therapeutic+Applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications</span></div><div class="casAuthors">Cui, Jingrong Jean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1035-1045</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The hepatocyte growth factor (HGF)/c-Met signaling pathway is important in mediating a wide range of biol. activities, including embryol. development, wound healing, tissue regeneration, angiogenesis, proliferation, survival, scattering, motility, invasion and morphogenic differentiation.  HGF and/or c-Met are expressed at abnormally high levels in a large variety of solid tumors.  Various c-Met mutations have been described in many solid tumors and some hematol. malignancies.  Therefore, inhibition of the HGF/c-Met signaling pathway has great potential in mol. targeted cancer therapy.  Many patent applications assocd. with inhibition of the HGF/c-Met axis have been published in the past few years.  There are four small mol. c-Met inhibitors presently in clin. trials.  This review focuses on recent patent applications for small mol. c-Met inhibitors and their potential applications in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwCxL0QxmH-LVg90H21EOLACvtfcHk0ljyRmuYF2C3UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7P&md5=11d01e76a70de95edd486293fd94b62d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.9.1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.9.1035%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DInhibitors%2520Targeting%2520Hepatocyte%2520Growth%2520Factor%2520Receptor%2520and%2520their%2520Potential%2520Therapeutic%2520Applications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D1035%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8006189&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.+P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+Orally+Available+Small-Molecule+Inhibitor+of+c-Met%2C+PF-2341066%2C+Exhibits+Cytoreductive+Antitumor+Efficacy+through+Antiproliferative+and+Antiangiogenic+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0lhB9jlznKIHNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520Orally%2520Available%2520Small-Molecule%2520Inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520Exhibits%2520Cytoreductive%2520Antitumor%2520Efficacy%2520through%2520Antiproliferative%2520and%2520Antiangiogenic%2520Mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-Related Mutations</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">2675</span><span class="NLM_x">–</span> <span class="NLM_lpage">2683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=2675-2683&author=S.+F.+Bellonauthor=P.+Kaplan-Lefkoauthor=Y.+Yangauthor=Y.+Zhangauthor=J.+Moriguchiauthor=K.+Rexauthor=C.+W.+Johnsonauthor=P.+E.+Roseauthor=A.+M.+Longauthor=A.+B.+O%E2%80%99Connorauthor=Y.+Guauthor=A.+Coxonauthor=T.+S.+Kimauthor=A.+Taskerauthor=T.+L.+Burgessauthor=I.+Dussault&title=c-Met+Inhibitors+with+Novel+Binding+Mode+Show+Activity+against+Several+Hereditary+Papillary+Renal+Cell+Carcinoma-Related+Mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DC.%2BW.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DT.%2BS.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3Dc-Met%2520Inhibitors%2520with%2520Novel%2520Binding%2520Mode%2520Show%2520Activity%2520against%2520Several%2520Hereditary%2520Papillary%2520Renal%2520Cell%2520Carcinoma-Related%2520Mutations%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D2675%26epage%3D2683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridrich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span> </span><span class="NLM_article-title">Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2879</span><span class="NLM_x">–</span> <span class="NLM_lpage">2882</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800043g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFShtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2879-2882&author=B.+K.+Albrechtauthor=J.-C.+Harmangeauthor=D.+Bauerauthor=L.+Berryauthor=C.+Bodeauthor=A.+A.+Boezioauthor=A.+Chenauthor=D.+Choquetteauthor=I.+Dussaultauthor=C.+Fridrichauthor=S.+Hiraiauthor=D.+Hoffmanauthor=J.+F.+Larrowauthor=P.+Kaplan-Lefkoauthor=J.+Linauthor=J.+Lohmanauthor=A.+M.+Longauthor=J.+Moriguchiauthor=A.+O%E2%80%99Connorauthor=M.+H.+Potashmanauthor=M.+Reeseauthor=K.+Rexauthor=A.+Siegmundauthor=K.+Shahauthor=R.+Shimanovichauthor=S.+K.+Springerauthor=Y.+Tefferaauthor=Y.+Yangauthor=Y.+Zhangauthor=S.+F.+Bellon&title=Discovery+and+Optimization+of+Triazolopyridazines+as+Potent+and+Selective+Inhibitors+of+the+c-Met+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase</span></div><div class="casAuthors">Albrecht, Brian K.; Harmange, Jean-Christophe; Bauer, David; Berry, Loren; Bode, Christiane; Boezio, Alessandro A.; Chen, April; Choquette, Deborah; Dussault, Isabelle; Fridrich, Cary; Hirai, Satoko; Hoffman, Doug; Larrow, Jay F.; Kaplan-Lefko, Paula; Lin, Jasmine; Lohman, Julia; Long, Alexander M.; Moriguchi, Jodi; O'Connor, Anne; Potashman, Michele H.; Reese, Monica; Rex, Karen; Siegmund, Aaron; Shah, Kavita; Shimanovich, Roman; Springer, Stephanie K.; Teffera, Yohannes; Yang, Yajing; Zhang, Yihong; Bellon, Steven F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2879-2882</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumorigenesis is a multistep process in which oncogenes play a key role in tumor formation, growth, and maintenance.  MET was discovered as an oncogene that is activated by its ligand, hepatocyte growth factor.  Deregulated signaling in the c-Met pathway has been obsd. in multiple tumor types.  Herein we report the discovery of potent and selective triazolopyridazine small mols. that inhibit c-Met activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVeQ8sYpasHLVg90H21EOLACvtfcHk0lhB9jlznKIHNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFShtLk%253D&md5=c0aec3ca102d90869884c139372f60a0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm800043g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800043g%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DHoffman%26aufirst%3DD.%26aulast%3DLarrow%26aufirst%3DJ.%2BF.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DReese%26aufirst%3DM.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSpringer%26aufirst%3DS.%2BK.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Triazolopyridazines%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520c-Met%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2879%26epage%3D2882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fujiwara, Y.; Senga, T.; Nishitoba, T.; Osawa, T.; Miwa, A.; Nakamura, K.</span><div class="note"><p class="first last">Quinoline Derivative and Quinazoline Derivative Inhibiting Self-Phosphorylation of Hepatocytus Proliferator Receptor, and Medicinal Composition Containing the Same. PCT Int. Appl. WO03000660A1</p></div>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fujiwara%2C+Y.%3B+Senga%2C+T.%3B+Nishitoba%2C+T.%3B+Osawa%2C+T.%3B+Miwa%2C+A.%3B+Nakamura%2C+K.Quinoline+Derivative+and+Quinazoline+Derivative+Inhibiting+Self-Phosphorylation+of+Hepatocytus+Proliferator+Receptor%2C+and+Medicinal+Composition+Containing+the+Same.+PCT+Int.+Appl.+WO03000660A1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DFujiwara%26aufirst%3DY.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">Compound <b>4</b> exhibited a <i>K</i><sub>i</sub> of 219 nM against KDR, a <i>K</i><sub>i</sub> of 65 nM against RON, and a <i>K</i><sub>i</sub> of 211 nM against IGFR.</p></div><span class="NLM_contrib-group">Harmange, J. C.; Booker, S.; Bauer, D.; Kim, T. S.; Cheng, Y.; Xu, S.; Xi, N.; Kim, J. L.; Tasker, A.</span> Preparation of Heteroaryloxy Substituted Quinolines for Treating or Preventing HGF Mediated Diseases. PCT Int. Appl. WO05073224A2,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+4+exhibited+a+Ki+of+219+nM+against+KDR%2C+a+Ki+of+65+nM+against+RON%2C+and+a+Ki+of+211+nM+against+IGFR.Harmange%2C+J.+C.%3B+Booker%2C+S.%3B+Bauer%2C+D.%3B+Kim%2C+T.+S.%3B+Cheng%2C+Y.%3B+Xu%2C+S.%3B+Xi%2C+N.%3B+Kim%2C+J.+L.%3B+Tasker%2C+A.+Preparation+of+Heteroaryloxy+Substituted+Quinolines+for+Treating+or+Preventing+HGF+Mediated+Diseases.+PCT+Int.+Appl.+WO05073224A2%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Spychala, J.</span><span> </span><span class="NLM_article-title">A Facile Preparation of N2-Arylisocytosines</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1080%2F00397919708006796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK2sXjtF2iu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1997&pages=1943-1949&author=J.+Spychala&title=A+Facile+Preparation+of+N2-Arylisocytosines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A facile preparation of N2-arylisocytosines</span></div><div class="casAuthors">Spychala, Jaroslaw</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1943-1949</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">N2-Arylisocytosines I (R = H, 2-, 3-, 4-Me, 2-, 3-, 4-Cl, 4-CN, 4-CH2CN) were obtained in good yields varying from 59 to 96% by a simple two-step process starting from 2-thiouracil via readily accessible 2-(methylthio)pyrimidin-4(3H)-one and RC6H4NH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYlGY1jYicDrVg90H21EOLACvtfcHk0lijFeb06iuXww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtF2iu70%253D&md5=172ee28bd7f77754445cd8480b0fd3ac</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1080%2F00397919708006796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919708006796%26sid%3Dliteratum%253Aachs%26aulast%3DSpychala%26aufirst%3DJ.%26atitle%3DA%2520Facile%2520Preparation%2520of%2520N2-Arylisocytosines%26jtitle%3DSynth.%2520Commun.%26date%3D1997%26volume%3D27%26spage%3D1943%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Walker, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barder, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martilelli, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">A Rationally Designed Universal Catalyst for Suzuki-Miyaura Coupling Processes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1002%2Fanie.200353615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFSisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=1871-1876&author=S.+D.+Walkerauthor=T.+E.+Barderauthor=J.+R.+Martilelliauthor=S.+L.+Buchwald&title=A+Rationally+Designed+Universal+Catalyst+for+Suzuki-Miyaura+Coupling+Processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A rationally designed universal catalyst for Suzuki-Miyaura coupling processes</span></div><div class="casAuthors">Walker, Shawn D.; Barder, Timothy E.; Martinelli, Joseph R.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1871-1876</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Scope, reactivity, and stability of a catalyst system, contg. a palladium catalyst and phosphine ligand I, in the Suzuki-Miyaura coupling reaction, is reported.  Sterically hindered biaryls, e.g., II, were prepd., in high yields, by coupling of arylboronic acids with aryl bromides and chlorides.  Furthermore, coupling of aryl chlorides with n-hexyl-9-BBN or alkylboronic acids afforded the corresponding alkylarenes in excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf9KouyAWdILVg90H21EOLACvtfcHk0lijFeb06iuXww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFSisr0%253D&md5=779716e7fdafd2419346173a558ec8c9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fanie.200353615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200353615%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DS.%2BD.%26aulast%3DBarder%26aufirst%3DT.%2BE.%26aulast%3DMartilelli%26aufirst%3DJ.%2BR.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520Rationally%2520Designed%2520Universal%2520Catalyst%2520for%2520Suzuki-Miyaura%2520Coupling%2520Processes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D1871%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Angiolelli, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalnuovo, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, T. P.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling of Benzylzinc Reagents with Methylthio N-Heterocycles: A New Coupling Reaction with Unusual Selectivity</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=905-907&author=M.+E.+Angiolelliauthor=A.+L.+Casalnuovoauthor=T.+P.+Selby&title=Palladium-Catalyzed+Cross-Coupling+of+Benzylzinc+Reagents+with+Methylthio+N-Heterocycles%3A+A+New+Coupling+Reaction+with+Unusual+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngiolelli%26aufirst%3DM.%2BE.%26aulast%3DCasalnuovo%26aufirst%3DA.%2BL.%26aulast%3DSelby%26aufirst%3DT.%2BP.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520of%2520Benzylzinc%2520Reagents%2520with%2520Methylthio%2520N-Heterocycles%253A%2520A%2520New%2520Coupling%2520Reaction%2520with%2520Unusual%2520Selectivity%26jtitle%3DSynlett%26date%3D2000%26volume%3D6%26spage%3D905%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Thomas, A. P.; Hennequin, L. F. A.; Ple, P. A.</span><div class="note"><p class="first last">Qinoline Derivatives Inhibiting the Effect of Growth Factors such as VEGF. PCT Int. Appl. WO9813350A1, 1998.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Ple%2C+P.+A.Qinoline+Derivatives+Inhibiting+the+Effect+of+Growth+Factors+such+as+VEGF.+PCT+Int.+Appl.+WO9813350A1%2C+1998."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BP." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ife, R. J.; Leach, C. A.</span><div class="note"><p class="first last">Amidine Derivatives as Gastric Acid Secretion Inhibitors. PCT Int. Appl. WO9426715A1</p></div>, 1994.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ife%2C+R.+J.%3B+Leach%2C+C.+A.Amidine+Derivatives+as+Gastric+Acid+Secretion+Inhibitors.+PCT+Int.+Appl.+WO9426715A1%2C+1994."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DIfe%26aufirst%3DR.%2BJ." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Brown, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardo, G.</span><span> </span><span class="NLM_article-title">Heterocyclic Amplifiers of Phleomycin. VII. Phenyl-, Tolyl-, Phenoxy- and Benzylpyrimidines: Also Some Carbocyclic Analogs</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1985&pages=825-833&author=D.+J.+Brownauthor=B.+J.+Croninauthor=S.+B.+Lanauthor=G.+Nardo&title=Heterocyclic+Amplifiers+of+Phleomycin.+VII.+Phenyl-%2C+Tolyl-%2C+Phenoxy-+and+Benzylpyrimidines%3A+Also+Some+Carbocyclic+Analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BJ.%26aulast%3DCronin%26aufirst%3DB.%2BJ.%26aulast%3DLan%26aufirst%3DS.%2BB.%26aulast%3DNardo%26aufirst%3DG.%26atitle%3DHeterocyclic%2520Amplifiers%2520of%2520Phleomycin.%2520VII.%2520Phenyl-%252C%2520Tolyl-%252C%2520Phenoxy-%2520and%2520Benzylpyrimidines%253A%2520Also%2520Some%2520Carbocyclic%2520Analogs%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D1985%26volume%3D38%26spage%3D825%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lokensgard, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartz, W. J.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-(α-Methoxyalkyl) Amides from Imidates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5609</span><span class="NLM_x">–</span> <span class="NLM_lpage">5611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00350a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=5609-5611&author=J.+P.+Lokensgardauthor=J.+W.+Fischerauthor=W.+J.+Bartz&title=Synthesis+of+N-%28%CE%B1-Methoxyalkyl%29+Amides+from+Imidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo00350a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00350a035%26sid%3Dliteratum%253Aachs%26aulast%3DLokensgard%26aufirst%3DJ.%2BP.%26aulast%3DFischer%26aufirst%3DJ.%2BW.%26aulast%3DBartz%26aufirst%3DW.%2BJ.%26atitle%3DSynthesis%2520of%2520N-%2528%25CE%25B1-Methoxyalkyl%2529%2520Amides%2520from%2520Imidates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1985%26volume%3D50%26spage%3D5609%26epage%3D5611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Recent Advances in the Cross-Coupling Reactions of Organoboron Derivatives with Organic Electrophiles, 1995−1998</span> <span class="citation_source-journal">J. Organomet. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">576</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm8006189&amp;key=10.1016%2FS0022-328X%2898%2901055-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=1999&pages=147-168&author=A.+Suzuki&title=Recent+Advances+in+the+Cross-Coupling+Reactions+of+Organoboron+Derivatives+with+Organic+Electrophiles%2C+1995%E2%88%921998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995-1998</span></div><div class="casAuthors">Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">147-168</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">The Pd-catalyzed cross-coupling reaction between organoboron compds. and org. halides or triflates provides a powerful and general methodol. for the formation of C-C bonds.  Recently, this reaction was called the Suzuki coupling, Suzuki reaction, or Suzuki-Miyaura coupling, although the authors never referred to it as such previously.  In this review, this name will be used with hesitation, simply to express the coupling reaction.  The availability of the reagents and the mild reaction conditions all contribute to the versatility of this reaction.  The coupling reaction offers several addnl. advantages, such as being largely unaffected by the presence of H2O, tolerating a broad range of functional groups, and proceeding generally regio- and stereoselectively.  Also, the inorg. byproduct of the reaction is nontoxic and easily removed from the reaction mixt. thereby making the Suzuki coupling suitable not only for labs. but also for industrial processes.  The authors published previously a comprehensive review of the reaction which covered mainly the refs. until the end of 1994.  Thereafter, a large no. of papers related to the coupling reaction are reported.  Consequently, such new results presented from 1995 to May 1998 are summarized in this review, with 139 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCbrdm1cvkLVg90H21EOLACvtfcHk0lih3_KEjpdI7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D&md5=be2fdd114211afa4abdf106008dd9845</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2898%2901055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252898%252901055-9%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Derivatives%2520with%2520Organic%2520Electrophiles%252C%25201995%25E2%2588%25921998%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1999%26volume%3D576%26spage%3D147%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Negishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okukado, N. J.</span><span> </span><span class="NLM_article-title">Selective Carbon−Carbon Bond Formation via Transition Metal Catalysis. 3. A Highly Selective Synthesis of Unsymmetrical Biaryls and Diarylmethanes by the Nickel- or Palladium-Catalyzed Reaction of Aryl- and Benzylzinc Derivatives with Aryl Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1821</span><span class="NLM_x">–</span> <span class="NLM_lpage">1823</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00430a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1977&pages=1821-1823&author=E.+Negishiauthor=A.+O.+Kingauthor=N.+J.+Okukado&title=Selective+Carbon%E2%88%92Carbon+Bond+Formation+via+Transition+Metal+Catalysis.+3.+A+Highly+Selective+Synthesis+of+Unsymmetrical+Biaryls+and+Diarylmethanes+by+the+Nickel-+or+Palladium-Catalyzed+Reaction+of+Aryl-+and+Benzylzinc+Derivatives+with+Aryl+Halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo00430a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00430a041%26sid%3Dliteratum%253Aachs%26aulast%3DNegishi%26aufirst%3DE.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DOkukado%26aufirst%3DN.%2BJ.%26atitle%3DSelective%2520Carbon%25E2%2588%2592Carbon%2520Bond%2520Formation%2520via%2520Transition%2520Metal%2520Catalysis.%25203.%2520A%2520Highly%2520Selective%2520Synthesis%2520of%2520Unsymmetrical%2520Biaryls%2520and%2520Diarylmethanes%2520by%2520the%2520Nickel-%2520or%2520Palladium-Catalyzed%2520Reaction%2520of%2520Aryl-%2520and%2520Benzylzinc%2520Derivatives%2520with%2520Aryl%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1977%26volume%3D42%26spage%3D1821%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Potashman, M.; Kim, T. S.; Bellon, S.; Booker, S.; Cheng, Y.; Kim, J. L.; Tasker, A.; Xi, N.; Xu, S.; Harmange, J. C.; Borg, G.; Weiss, M.; Hodous, B. L.; Graceffa, R.; Buckner, W. H.; Masse, C. E.; Choquette, D.; Martin, M. W.; Germain, J.; Dipietro, L. V.; Chaffee, S. C.; Nunes, J. J.; Buchanan, J. L.; Habgood, G. J.; McGowan, D. C.; Whittington, D. A.</span><div class="note"><p class="first last">Preparation of Heteroaryl Substituted Napthalenes as Inhibitors of Lck, VEGFR, and/or HGF Related Activity. PCT Int. Appl. WO05070891A2</p></div>, 2005.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Potashman%2C+M.%3B+Kim%2C+T.+S.%3B+Bellon%2C+S.%3B+Booker%2C+S.%3B+Cheng%2C+Y.%3B+Kim%2C+J.+L.%3B+Tasker%2C+A.%3B+Xi%2C+N.%3B+Xu%2C+S.%3B+Harmange%2C+J.+C.%3B+Borg%2C+G.%3B+Weiss%2C+M.%3B+Hodous%2C+B.+L.%3B+Graceffa%2C+R.%3B+Buckner%2C+W.+H.%3B+Masse%2C+C.+E.%3B+Choquette%2C+D.%3B+Martin%2C+M.+W.%3B+Germain%2C+J.%3B+Dipietro%2C+L.+V.%3B+Chaffee%2C+S.+C.%3B+Nunes%2C+J.+J.%3B+Buchanan%2C+J.+L.%3B+Habgood%2C+G.+J.%3B+McGowan%2C+D.+C.%3B+Whittington%2C+D.+A.Preparation+of+Heteroaryl+Substituted+Napthalenes+as+Inhibitors+of+Lck%2C+VEGFR%2C+and%2For+HGF+Related+Activity.+PCT+Int.+Appl.+WO05070891A2%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPotashman%26aufirst%3DM." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Harmange, J. C.; Booker, S.; Bauer, D.; Kim, T. S.; Cheng, Y.; Xu, S.; Xi, N.; Kim, J. L.; Tasker, A.</span><div class="note"><p class="first last">Preparation of Heteroaryloxy Substituted Quinolines for Treating or Preventing HGF Mediated Diseases. PCT Int. Appl. WO05073224A2</p></div>, 2005.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Harmange%2C+J.+C.%3B+Booker%2C+S.%3B+Bauer%2C+D.%3B+Kim%2C+T.+S.%3B+Cheng%2C+Y.%3B+Xu%2C+S.%3B+Xi%2C+N.%3B+Kim%2C+J.+L.%3B+Tasker%2C+A.Preparation+of+Heteroaryloxy+Substituted+Quinolines+for+Treating+or+Preventing+HGF+Mediated+Diseases.+PCT+Int.+Appl.+WO05073224A2%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHarmange%26aufirst%3DJ.%2BC." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><div class="note"><p class="first last">A table of the studied kinases is presented in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+table+of+the+studied+kinases+is+presented+in+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Still, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, A.</span><span> </span><span class="NLM_article-title">Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2923</span><span class="NLM_x">–</span> <span class="NLM_lpage">2925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00408a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm8006189&amp;key=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=2923-2925&author=W.+C.+Stillauthor=M.+Kahnauthor=A.+Mitra&title=Rapid+Chromatographic+Technique+for+Preparative+Separations+with+Moderate+Resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid chromatographic technique for preparative separations with moderate resolution</span></div><div class="casAuthors">Still, W. Clark; Kahn, Michael; Mitra, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2923-5</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A simple adsorption chromatog. technique has been developed for rapid (<15 min) sepns.  The technique uses a short (e.g., 5 in.) column of 40-63-μm silica gel and operates at high flow rates (2.0 vertical in./min) to allow the sepn. of multigram quantities of compds. which are resolved on anal. TLC by as little as ΔRf 0.15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsgCIAoC4VbVg90H21EOLACvtfcHk0lglM80WUYEBBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D&md5=34e721c237babee0665e2f9c6f6a3999</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo00408a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00408a041%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DW.%2BC.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DA.%26atitle%3DRapid%2520Chromatographic%2520Technique%2520for%2520Preparative%2520Separations%2520with%2520Moderate%2520Resolution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D2923%26epage%3D2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Polverino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMelfi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bready, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neervannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talvenheimo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montestruque, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R.</span><span> </span><span class="NLM_article-title">AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor Xenografts</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8715</span><span class="NLM_x">–</span> <span class="NLM_lpage">8721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8715-8721&author=A.+Polverinoauthor=A.+Coxonauthor=C.+Starnesauthor=Z.+Diazauthor=T.+DeMelfiauthor=L.+Wangauthor=J.+Breadyauthor=J.+Estradaauthor=R.+Cattleyauthor=S.+Kaufmanauthor=D.+Chenauthor=Y.+Ganauthor=G.+Kumarauthor=J.+Meyerauthor=S.+Neervannanauthor=G.+Alvaauthor=J.+Talvenheimoauthor=S.+Montestruqueauthor=A.+Taskerauthor=V.+Patelauthor=R.+Radinskyauthor=R.+Kendall&title=AMG+706%2C+an+Oral%2C+Multikinase+Inhibitor+that+Selectively+Targets+Vascular+Endothelial+Growth+Factor%2C+Platelet-Derived+Growth+Factor%2C+and+Kit+Receptors%2C+Potently+Inhibits+Angiogenesis+and+Induces+Regression+in+Tumor+Xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolverino%26aufirst%3DA.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DStarnes%26aufirst%3DC.%26aulast%3DDiaz%26aufirst%3DZ.%26aulast%3DDeMelfi%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBready%26aufirst%3DJ.%26aulast%3DEstrada%26aufirst%3DJ.%26aulast%3DCattley%26aufirst%3DR.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DGan%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DNeervannan%26aufirst%3DS.%26aulast%3DAlva%26aufirst%3DG.%26aulast%3DTalvenheimo%26aufirst%3DJ.%26aulast%3DMontestruque%26aufirst%3DS.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DRadinsky%26aufirst%3DR.%26aulast%3DKendall%26aufirst%3DR.%26atitle%3DAMG%2520706%252C%2520an%2520Oral%252C%2520Multikinase%2520Inhibitor%2520that%2520Selectively%2520Targets%2520Vascular%2520Endothelial%2520Growth%2520Factor%252C%2520Platelet-Derived%2520Growth%2520Factor%252C%2520and%2520Kit%2520Receptors%252C%2520Potently%2520Inhibits%2520Angiogenesis%2520and%2520Induces%2520Regression%2520in%2520Tumor%2520Xenografts%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8715%26epage%3D8721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1W','PDB','1R1W'); return false;">PDB: 1R1W</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i69"><a href="/doi/suppl/10.1021/jm8006189">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33766"></div></div></div></div></div><hr /></hr><p class="last">Elemental analyses and HPLC methods for key compounds and X-ray data for <b>7</b> and <b>50</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8006189/suppl_file/jm8006189_si_001.pdf">jm8006189_si_001.pdf (160.64 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8006189&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm8006189%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-18%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8006189" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                764KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a84869893d7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
